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Thesis Abstract 
 
Herein it is presented a further development of the well-established catalytic asymmetric 
allylation of aldehydes 1 leading to enantiopure homoallylic alcohols 2 (Scheme1).  
 
 
Scheme 1 
 
Stereogenic centre(s) served as the foundation for synthesis of a variety of other advanced 
intermediates and building blocks with multiple chiral centres (Scheme 2).  
- New approaches to homoallylic alcohols 5 were dementrated with excellent control of 
chiral centers 
- Biologically relevant carbohydrate analogues 4 were synthesised in four possible 
configurations using singlet oxygen raction as the key step 
-  δ-hydroxy-β-amino acids 7 were synthetised diastereoselectively using Pd catalysis as 
the key step.  
- A novel approach to synthesis of  isoxazolidines and pyrazolidines 6 was 
demonstrated  
 
 
Scheme 2 
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Abbreviations and Acronyms   
  
Ac                     -            Acetyl   
AcOH               -            Acetic acid   
aq     -    Aqueous 
Bn                     -            Benzyl   
Bu                     -            Butyl  
oC     -            Degrees centigrade 
Cat, cat*           -            Catalyst, chiral catalyst  
Cy                     -            Cyclohexyl  
DCM     -            Dichloromethane 
DIPEA    -     Hünig’s base, N,N-Diisopropylethylamine 
DMAP    -     4-Dimethylaminopyridine 
DMF                 -            Dimethylformamide   
DMSO              -            Dimethylsulfoxide   
dr    -     Diastereoisomeric ratio 
ee                      -            Enantiomeric excess   
Et                      -            Ethyl  
Equiv                -     Equivalents 
EWG                -             Electron withdrawing group 
HMPA              -             Hexamethylphosphoramide   
i-, iso-               -             Isomeric (branched alkyl chain)  
L, L*                 -             Ligand, chiral ligand  
LA, LA*           -             Lewis acid, chiral Lewis acid  
LB, LB*           -             Lewis base, chiral Lewis base  
M                      -             Metal   
m-CPBA   -             meta-chloroperoxybenzoic acid 
Me                    -             Methyl  
MeCN               -            Acetonitrile  
mmol                -            Millimole 
n-                       -            Normal (linear alkyl chain)   
Napht                -            Naphthyl  
NHPI                -            N-Hydroxyphthalimide 
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Nu                     -             Nucleophile   
[ox]                   -             Oxidising agent, oxidation, oxidative conditions   
Ph                     -             Phenyl  
Pr                      -             Propyl  
Py    -             Pyridine 
[red]                 -              Reducing agent, reduction, reductive conditions 
RT                    -              Room temperature 
s-, sec-              -              Secondary (branched alkyl chain)   
sat                     -              saturated 
TBHP               -              tert-Butyl hydroperoxide   
t-, tert-              -              Tertiary (branched alkyl chain)  
TBDMS            -              tert-Butyldimethylsilyl   
TFA                  -              Trifluoroacetic acid   
TfOH                -              Trifluoromethanesulfonic acid   
TMS                 -               Trimethylsilyl    
p-Tol                -               p-Toluyl, p-methylphenyl 
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1. Enantioselective Allylation and Allyl Transfer 
 
1.1 Literature Review 
1.1.1 Stoichiometric Asymmetric Allylation of Aldehydes with Boranes 
Allylation of the carbonyl group is one of the fundamental reactions for creating a new 
carbon-carbon bond. Since the pioneering work by Grignard1a and Barbier1b over a hundred 
years ago, the allylating reagents continued to evolve. Allylation of carbonyls with 
organometallics (B,2h,2i Si,2j-m Sn,2n Cr,2o,2p Ti,2q etc.2a-g) remains a powerful strategic reaction 
that creates up to two chiral centers. In the 1970s, the pursuit of an asymmetric version of this 
reaction began. The earliest attempts of borane allylation were reported by Mikhailov and 
Bubnov,3 who introduced triallyl boranes 10 as the first reagents capable of stereoselective 
SE2’ reaction on carbonyl compounds 9 resulting in a wide range of homoallylic alcohols 12 
(Scheme 3). 
 
Scheme 3 
Several years later, Hoffman and Herold published an asymmetric version of this type of 
reaction.4 They used modified camphor 13 to introduce a stereogenic centre to a series of 
secondary homoallylic alcohols 14 with moderate to good levels of enantioselectivity 
(Scheme 4). 
 
Scheme 4 
This methodology was followed by Brown and Jadhav who used naturally occurring α-pinene 
and in a series of reactions built a highly stereoselective chiral matrix 15. This allowed them 
to obtain homoallylic alcohols 16 with excellent enantioselectivity (Scheme 5).5 
 9 
 
Scheme 5 
The high yields and excellent enantioselectivity shown by β-allyldiisopinocampheylborane 
(Ipc2BCH2CH=CH2) 15 ensured that it remains till the present day among the most widely 
used asymmetric allylating reagents. Following on the work of Hoffman and Brown, a few 
years later Reetz introduced the nitrogen derivatisation of camphor and its application as a 
chiral auxiliary for allylboranes (Scheme 6).6  
 
Scheme 6 
Another interesting approach to enantioselective allylation was developed by Roush and co-
workers.7 In 1985, they reported on DIPT (diisopropyl tartrate) as a chiral auxiliary to 
derivatise allyl boronates 19 in order to prepare a series of enantioenriched alcohols 20 
(Scheme 7).  
 
Scheme 7 
This idea was further developed by Corey and coworkers, who used the tosyl amide of readily 
available 1,2-diamino-1,2-diphenylethane 21 which can be obtained in both S,S and R,R forms 
(Scheme 8).8 
 
Scheme 8 
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1.1.2 Asymmetric allylation of aldehydes catalysed by Lewis acids  
The next milestone in the synthesis of homoallylic alcohols was set by Sakurai and Hosomi, 
who used Lewis acid catalysts for facilitating the nucleophilic attack of allyl silane (Scheme 
9).9 The reaction is initiated e.g, by TiCl4, which coordinates to the carbonyl oxygen 23, 
thereby increasing its electrophilicity. Nucleophilic attack by allylsilane 24, followed by 
cleavage of TMS group 25, furnishes the product 26. High reactivity of allyl silanes toward 
carbonyls in this reaction can be explained by σ (Si-C)-pi conjugation, known as the β-silicon 
effect.10 
Scheme 9 
The reaction proceeds presumably through an open transition state: when C3 substituted 
allylsilanes (e.g. crotyl trimethylsilane) are submitted to the reaction, the major product is the 
syn disastereoisomer for both the E 28 and Z 29 isomers of the starting silanes (Scheme 
10).11,12 However, the E isomer produces practically pure syn product 32 while the Z 
configuration gives a 2:1 mixture of alcohols. 
 
Scheme 10 
There are known catalytic versions of this reaction that employ other transition metal 
catalysts.13 In the last two decades, examples of the asymmetric Sakurai allylation of ketones 
and aldehydes regularly appear in the literature. Metals like Ti14 (35, Scheme 11), Ag15 (39, 
Scheme 12), Sc16 (43, Scheme 13) are commonly used in catalyst molecules but other Lewis 
acids are also known to be very effective.17  
 11 
 
Scheme 11 
 
Scheme 12 
Scheme 13 
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1.1.3 Allylation Of Aldehydes Catalysed By Lewis Bases 
The mechanism by which chiral Lewis bases promote asymmetric allylation is conceptually 
different from the one presented for Lewis acids (vide supra). The reactions catalysed by 
Lewis bases, however, offer a range of novel and synthetically useful transformations.18 Use 
of Lewis base catalyst changes the chemical reactivity of the organometallic reagents in a 
number of ways. It can increase the nucleophilicity or electrophilicity of the reagents by 
modulation of the electronic properties.19 Lewis base-catalysed processes employing non-
metallic reagents are not very common in organic synthesis.  The main reason is the lack of 
target Lewis acidic sites in the carbon based molecules and no possibility of valence 
expansion on carbon atoms. On the other hand, the silicon atom is known to create 
hypervalent bonding systems and thus Lewis base catalysts have been successfully utilised in 
reactions with organosilicon compounds. 
Silicon normally engages in bonding with only four other atoms, which completes the 
electronic requirement for an outer-shell octet. In SiL4, the molecule has a tetrahedral 
geometry, and therefore the central silicon atom displays sp3 hybridization.18 The ability of 
silicon to expand its coordination shell, which is similar to phosphorus and antimony, has 
been intensively exploited only during the last two decades. 20 However, simple silicon 
compounds with coordination number higher than four were known since early 19th century 
(44, 45 Figure 1). 2 
 
Figure 1 
Expansion of the SiL4 species to a pentacoordinate silicon complex (SiL5) requires a p orbital 
to engage in hypervalent three-centre four-electron (3c-4e) bonding. The latter bonding type 
results in more electron density located at the peripheral ligands and electron deficiency at the 
central atom. This can be explained through a molecular orbital diagram (Scheme 14).   
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Scheme 14 
The trigonal bipyramidal structure of silicon pentavalent complexes employs sp2 
hybridization of the central silicon atom. Further expansion of the coordination sphere to an 
octahedral, hexacoordinate complex (SiL6), requires a second p orbital to engage in 
hypervalent bonding, and the silicon atom to be formally sp hybridized. According to Bent’s 
rule, highly electronegative elements, which are usually hypervalently bonded (F, Cl, OR), 
prefer p-character bond (Scheme 15).24 The formation of hypervalent p-symmetry orbitals 
effectively lowers the energy of the hybrid orbitals involved in covalent bonding by 
increasing the proportion of “s character” in these orbitals, leaving nonbonding p-MO for 
extra valency.18,23 
 
Scheme 15 
The changes in bond order induced by adduct formation allow for the simultaneous 
enhancement of nucleophilic and electrophilic character dependent on bond polarizability 
during acid-base interactions.18 The behaviour of hypervalent species and why this often leads 
to novel forms of reactivity is best understood through Gutmann's empirical analysis of acid–
base interactions.22 Formation of an acid–base adduct leads to an overall increase in the 
electron density in the acceptor fragment of the adduct, but the distribution of this electron 
density is not equal among the atoms.  
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Redistribution of electron density has noticeable consequences on the bond lengths. These 
observations became the basis of Gutmann's four empirical rules of molecular adduct. 
Application of the rules can be illustrated by changes in antimony pentachloride 47 X-ray 
structure upon Lewis base 46 binding (Scheme 16).22 
- The smaller the intramolecular distance between the donor (D) and the acceptor (A), the 
greater the induced lengthening of the peripheral bonds (A-X) 
- The longer the bond between D and A, the greater the degree of polarization of electron 
density across that bond 
- When the coordination number of an atom increases, so do the lengths of all the bonds 
originating from that coordination centre. 
- The bonds adjacent to D and A will either contract or elongate to compensate for the 
changes in electron density at D and A. 
 
Scheme 16 
 
Induction of noticeable changes in the bond lengths throughout the complex is a clear 
manifestation of both the first and fourth rules.18 
Changing valency and electronics of the silicon centre has a direct impact on the nucleophile 
(R) transfer in Lewis base catalysed reactions (Scheme 17).25a 
 
Scheme 17 
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Tetra-coordinate organosilicon compound 49 is a weak Lewis acid and has poor ability for 
nucleophilic transfer of R. Pentavalent state 50 is reached by attack of neutral or negatively 
charged nucleophile (e.g., DMF, HMPA, F- ) on the silicon centre. The resulting complex is 
more Lewis acidic and R-nucleophilic as hypervalency causes an increase of the positive 
charge on silicon and negative charge on its ligands (Scheme 17). Attachment of the next 
ligand to form a hexacoordinate species 51 is usually the rate determining step. At this point 
the silicon atom reaches it highest positive charge and the R group is transferred. 25b  
Kira and coworkers conducted computational studies over a series of fluorosilicon compounds 
which showed how fluorine ligation impacts both electrophilicity and nucleophilicity of the 
molecule.25c   
 
Scheme 18  
The most important is the increasing polarity of the molecule as electron density rises on the 
nucleophilic γ carbon and drops on silicon (Scheme 18). 
The first use of fluorine ions as the Lewis-basic catalyst for allylation with allyltrifluorosilane 
(55 and 56) was presented by Kira and Sakurai.26 The reaction showed different syn/anti 
selectivity than Lewis acid catalysis and the ratio of alcohols (58 and 59) obtained in identical 
conditions was entirely based on the E : Z ratio of the starting crotylsilanes (Scheme 19). 
 16 
 
Scheme 19 
The results were completely different from previous protocols that employ Lewis acid 
catalysts indicating that another mechanism must be involved. The authors suggested that 
enhanced Lewis acidity of the pentacoordinated silicon fluoride 60 is capable to attract 
carbonyl oxygen and activate it for nucleophilic attack. Increased electrophilicity of the 
carbonyl group coordinated to silicon triggers the allyl transfer.26 The high diastereoselctivity 
observed in this case was attributed to the six-memebered cyclic transition states 61 and 62 
(Scheme 20). 
Scheme 20 
The idea of activation of organotrichlorosilanes with Lewis bases was further developed by 
Kobayashi and Nishio.27 They discovered that common organic solvents, such as DMF and 
HMPA, are highly efficient and selective initiators for reactions with trichlorosilanes 63. 
Excellent regio and stereoselectivity, which mirrored the geometrical E/Z purity of the starting 
material, lend further credence to the operation of the six memebered cyclic transition state 64 
concept (Scheme 21). 
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Scheme 21 
To confirm that the hypervalent silicate is the key intermediate in this reaction, Kobayashi and 
Nishio conducted 29Si NMR experiments.27 Dramatic changes in the chemical shifts of 
crotyltrichlorosilane were attributed to coordination of certain solvents to the silicon atom 
(Table 1). 
Table 1. Crotyl trichlorosilane 29Si NMR chemical shift in various solvents.27 
 
No Solvent Chemical shift 
(ppm) 
1 CDCl3 +8.0 
2 CD3CN +8.6 
3 C6D6 +7.9 
4 THF-d8 +8.5 
5 DMF-d7 -170 
6 HMPA -22 
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1.1.4 Asymmetric Lewis-basic catalysts 
These experiments set the foundation for the modern Lewis base mediated asymmetric 
allylations. Chiral analogues of both DMF and HMPA were developed, and the field is 
continuously evolving.  
The undisputed pioneer in the HMPA-derived chiral Lewis basic catalysis is Denmark, whos 
group first reported an enantioselective variant of this reaction.28 They obtained excellent 
anti/syn selectivity for alcohols 66 with moderate yield and ee (Scheme 22).     
 
Scheme 22 
Shortly after, Iseki and Kobayashi and coworkers came up with the proline based chiral 
HMPA derivative 70.29a In the course of optimisation supported by PM-3 calculations, their 
catalysts (Scheme 23) exhibited better selectivity, yields and TON than the original Denmark 
molecule.29b 
 
Scheme 23 
Detailed mechanistic studies were conducted by Denmark and Fu, who concluded that 
dependence of enantioselectivity on catalyst loading might be caused by two phosphoramide 
pathways. Coordination of either one 71 or two 72 catalyst molecules leads to homoallylic 
alcohols 73 of low or high enantioselectivity respectively (Scheme 24).30 
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Scheme 24 
Based on these findings, they synthesised a series of bidentate phosphoramides, among which 
the most selective was the dimeric catalyst with a five-carbon linker 75 (Scheme 25).30  
 
Scheme 25 
Other examples of the phosphorus-based Lewis-basic chiral catalysts include diphosphine 
oxides, which are also able to coordinate trichlorosilyl derivatives and generate hypervalent 
silicate structures. Initial experiments by Nakajima and coworkers yielded only moderate 
enantioselectivity but brought the idea to the further development.31 The axially chiral 
biheteroaryl-diphosphine oxide 77 reported by Simoni and coworkers provided excellent 
selectivity, especially with electron-poor aromatic aldehydes (Scheme 26).32 
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Scheme 26 
An interesting class of Lewis base catalyst are chiral derivatives of DMF 80. Iseki et al33 
reported asymmetric allylation of aliphatic aldehydes 78 with excellent yields and ees. 
Remarkably, the selectivity was very high for simple aliphatic aldehydes, but it decayed for 
aromatic and conjugated ones. A dramatic increase of selectivity was observed after addition 
of a stoichiometric amount of HMPA (Scheme 27).  
 
Scheme 27 
Heteroaromatic N-oxides possess an electron pair with high donating properties. The strong 
Lewis basicity of the oxygen, combined with high affinity for silicon, represents a perfect 
candidate for development of a new class of Lewis-basic catalysts.34 In 1998, Nakajima and 
coworkers reported on the first use of the axially chiral biquinoline N,N’-dioxides 82 for 
asymmetric allylation of aldehydes and proposed a cyclic chair-like transition structure, where 
electron pairs from both N-oxides are involved in hypervalent coordination to silicon 83 
(Scheme 28).35 
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Scheme 28 
This work was followed by Hayashi’s group who introduced catalysts based on substituted 
bipyridine N-oxide 82. They reported impressive level of enantioselectivity, up to 98% ee, 
accompanied with a very low catalyst loading and a short reaction time (Scheme 29).36 
 
Scheme 29 
Prior to Hayashi’s publication, Malkov, Kočovský and coworkers reported on a series of 
catalysts derived from  terpene-based bipyridine N-monoxides.37 Enantiopurities in the case of 
Me2PINDOX 83 and iso-PINDOX 84 reached 98% and 97% respectively, which can be 
attributed to the impact of both central and axial chirality present in the molecule (Figure 2). 
The substancial steric hindrance, however, may be the reason of lower activity, so that 10 
mol% catalyst loading was required. Very high selectivity was explained by analogus double 
chelation mechanism via O and N atoms.38 
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Figure 2 
Another type of asymmetric Lewis-basic catalyst reported by Malkov Kočovský and 
coworkers was QUINOX 86. This catalysts selectivity was based solely on axial chirality. 
Under optimised conditions, it provided alcohols 85 with excellent enantioselectivity, 
especially for aldehydes with electron withdrawing groups, and (Z)-crotyl trichlorosilane 68.39 
On the other hand, using this catalyst for highly electron rich aldehydes (e.g., 4-MeO-
PhCHO) produced only 16% ee (Scheme 30). 
 
Scheme 30 
In 2005 the Malkov and Kočovský group reported on the synthesis and application of yet 
another type of N-oxide Lewis-base catalyst.40 The molecule named METHOX 88 shows 
unmatched enantioselectivity at reasonable catalyst loading for both electron-poor and 
electron-rich aromatic aldehydes (Scheme 31). Another interesting feature of the catalyst is its 
high selectivity over a wide range of temperatures. Numerous experiments showed drop from 
96% ee at -40oC to respectable 87% ee at RT with constant, nearly quantitive yields. High 
kinetic preference for the (E)-isomer of crotyl trichlorosilane 63 allows the reaction with 
technical grade starting material to give pure anti diatereoisomer with excellent ee and dr. 
 23 
Scheme 31 
Allylation of aliphatic and conjugated aldehydes has not been extensively investigated. In all 
the publications overviewed so far, selectivity of the catalyst was demonstrated with use of 
aromatic aldehydes. In reports, where cinnamyl aldehyde was employed, a dramatic drop of 
the ee was usually observed.28,36b This severely limits the scope of alcohols and the practical 
use of this asymmetric allylation methodology as a key, chirality introducing step.  
Development of a novel N,N-dioxide 91 catalyst was reported recently by Kotora and 
coworkers.41 The catalyst exhibits high enantioselectivity 90 (up to 98% ee) for a series of 
multisubstituted α,β-unsaturated aldehydes 89 (Scheme 32).  
 
Scheme 32 
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1.2 Methox-catalysed allylation of the aliphatic aldehydes  
 
The project was completed with the assistance of final year undergraduate student Yvonne 
Jewkes and Erasmus exchange student Jiří Mikušek 
 
1.2.1 Abstract 
A highly enantio- and diastereo-selective protocol for the allylation of conjugated unsaturated 
aldehydes 92 catalysed by Methox 3 has been developed. The respective homoallylic alcohols 
were obtained in good yields and good-to-excellent ee (up to 96%) (Scheme 33). 
 
R2
O
H
R4
R3
R1 SiCl3
R1 = H, Me
R2, R3, R4 = aromatic or aliphatic substituents
+ R2
R4
R3
CH3CN, DiPEA
- 40 oC
up to 87% yield
up to 96% ee
36:1 anti :syn
N
OMe
MeO OMe
O
(+) METHOX
cat* (10%)
OH
R1
63 92 93
3
 
Scheme 33 
 
1.2.2 Project aim 
 
Methox proved to be effective and universal catalyst for asymmetric allylations and 
demonstrated high selectivity for a range of aromatic aldehydes. The initial experiments with 
Methox-catalysed allylation of cinnamyl aldehyde showed ee as high as 88%, while most of 
the catalysts presented in the preceding introduction section proved less efficient, except for 
mono-N-oxide 84 (Figure 2).37b Encouraged by this success, we became interested in the 
expansion of Methox’s scope. Most of the previously mentioned catalysts proved ineffective 
when aliphatic aldehydes were used as an electrophile. On the other hand, Kobayashi’s 
formamide,33 although achieving very good results for aliphatic aldehydes was rather 
inefficient in the case of their aromatic congeners. We felt that it would be advantageous to 
prove that Methox can be an effective catalyst for both aromatic and aliphatic aldehydes. 
Previous studies of the Methox catalysed allylations focused mainly on the influence of ring 
substitution in aromatic aldehydes. Now, we will focus on a wide range of non-aromatic 
unsaturated aldehydes. This project aimed to open a new and simple route towards a series of 
homoallylic alcohols that have not been synthesised before by this method.  
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1.2.3 Synthesis of Methox – chiral Lewis base catalyst   
Methox can be synthesised in several relatively simple steps (Scheme 34).40 The synthesis 
starts with inexpensive natural α-pinene 94, which affords pinocarvone 95 by ene reaction 
with singlet oxygen.42 Singlet oxygen reactions will be discussed in more detail in Chapter 3. 
This approach allows the use of both enantiomers of the naturally occurring α-pinene 
(Scheme 34). Pinocarvone acts as the Michael acceptor for the Kröhnke salt 97 prepared from 
pyridine, iodine and the appropriate acetophenone 96.43 The two components are refluxed 
together with ammonium acetate in acetic acid. Michael reaction, followed by amination of 
both carbonyls leads to the chiral pyridine derivative 98.43 The pyridine is then deprotonated 
with LDA and the methyl group is introduced distaereoselectively 99. The final step is 
oxidation of the pyridine nucleus into N-oxide, followed by recrystallisation to upgrade the 
enantiopurity of Methox 3 to 99% ee. 
 
 
Scheme 34 
 
 
 26 
1.2.4 Results and discussion 
Previous catalysts developed in our group, such as Quinox and Pindox, exhibit moderate to 
good enantioselectivity for conjugated aldehydes.37a,37b Enantioselectivity of 96% ee was 
obtained for cinnamyl aldehyde with iso-Pindox but a low yield of 25% and complicated 
catalyst synthesis limit its practical use. Reaction with cinnamyl aldehyde gave 51% ee with 
Quinox but only after lowering the temperature to –90 oC, which inevitably affected the 
reaction rate and yield. Allylation of its saturated analogue: 3-phenylpropanal gave only 49% 
ee, highlighting the importance of the conjugation for attaining good enantioselectivity. High 
selectivities obtained for α,β unsaturated aldehydes, comparable with aromatic substrates, 
were attributed to lowered electrophilicity of carbonyl in the conjugated system.55 Aliphatic 
aldehydes, due to higher reactivity, are reversibly consumed in the formation of a 1-chloro-1-
silyloxy derivative. Chlorinated product is favoured in the equilibrium therefore no allylation 
product is observed.   
In the course of our study we examined several commercially available conjugated aldehydes 
and a few more synthesised by methods leading to either α- or β-substituted products (Figure 
3). 
 
 
Figure 3 
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1.2.5 Synthesis of starting α,β-unsaturated aldehydes 
In order to examine Methox in the allylation of conjugated aldehydes we used commercially 
available compounds with a variety of α- and β-substitution patterns. To further extend the 
range of substrates, we employed two different methods to convert saturated aldehydes 101 
and 102 into the desired starting materials 100e and 100j. 
Two of α–substituted unsaturated aldehydes were prepared by Mannich-type condensation of 
aldehyde with aqueous formaldehyde in the presence of pyrrolidine and benzoic acid (Scheme 
35).44 The reported method also allows a self condensation of aldehydes.  
O
H
O
H
O
H
PhCOOH
CH2Cl2, reflux
91%
O
H
55%
formaldehydeaq
37%
PhCOOH
CH2Cl2, reflux
formaldehydeaq
37%
100e
100j
101
102
pyrrolidine
pyrrolidine
 
Scheme 35 
β- Substituted acrolein derivative 100g was synthesised using Horner-Wadsworth-Emmons 
chemistry by the procedure reported by Lee and coworkers (Scheme 36).45 The reaction of 
dihydrocinnamyl aldehyde 101 with (triphenylphosphoranylidene)acetaldehyde gave the 
desired product in good yield. 
 
Scheme 36 
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1.2.6 Allylation of α,β-unsaturated aldehydes 
To probe the potential of unsaturated aldehydes for the enantioselective allylation, we first 
carried out the reaction with cinnamaldehyde 100a, which is both an aromatic and α,β-
unsaturated aldehyde. This aldehyde also represents a breaking point in means of 
enantioselectivity in publications where reported, allylated either by chiral N-oxides and 
HMPA derivatives.28,30b,36b Allyl trichlorosilane was added to a mixture of cinnamyl aldehyde 
100a, DIPEA and 5% of Methox at –40 oC. The reaction was usually completed after 3 days 
(Scheme 37). The desired product 103a was isolated in good yield; and the HPLC analysis 
showed high enantioselectivity (88% ee). Encouraged by these results, we prepared a series of 
highly enantioenriched homoallylic alcohols and summarized the outcome in Table 2. 
 
 
Scheme 37 
 
Table 2.  Enantioselective allylation of α,β-unsaturated aldehydes.  
Entry 103 Alcohol Yield [%] ee [%] Chiral analysis 
1a a 
 
75 88 HPLC 
2ae 
 
b 
 
 
73 88 HPLC 
3ae c 
 
42 >86c Mosher’s ester 
19F NMR 
4ae d 
 
68 86 Mosher’s ester 
19F NMR 
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5bf e 
 
49 88 HPLC 
6bf f 
 
46 70 GC 
7ae g 
 
48d 89 GC 
8a h 
 
65 93 GC 
9ae i 
 
37 83 Mosher’s ester 
19F NMR 
 
a
 Reaction at –40 oC, b Reaction in –30 oC, cMinor enantiomer, signal overlapping with traces of stereoisomer, d 
Product extremely volatile. e Obtained by Yvonne Jewkes, f Obtained by Jiří Mikušek 
All the synthesised alcohols showed good to high enantioselectivity, the absolute values were 
only slightly lower than those obtained for aromatic aldehydes with the same catalyst.40 
Methox catalysed allylation is also tolerant to a variety of substitution pattern. Unexpected 
drop of enantioselectivity observed for alcohol 103e (entry 6) was further investigated.  
In order to bring enantioselectivity in line with the rest of the series, we optimised conditions 
for this aldehyde (Scheme 38). Lowering the reaction temperature to −45 oC for Methox 3 and 
also use of R-(+)-Quinox 86, another highly enantioselective Lewis base catalyst developed in 
our group, we obtained 88 and 80% ee respectively. Both enantiomers of the product were 
successfully prepared. Details are summarised in Table 3. 
 
 
Scheme 38 
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Table 3. Allylation – optimising conditions 
Entry Catalyst Catalyst 
loading [%] 
Solvent Temperature 
[oC] 
Yield 
[%]a 
ee  [%] 
1 Methox 10 CH3CN -30 46 70 (S) 
2 Methox 10 CH3CN -45 23 88 (S) 
3 R-Quinox 5 CH2Cl2 -30 20 80 (R) 
 
Methox exhibits high kinetic preference for E crotyl trichlorosilane, which allows the use of 
technical grade crotyl chloride as a starting material.40 The desired branched homoallylic 
alcohol was obtained in excellent ee and diastereoselectivity (Scheme 39).  
 
Scheme 39 
Finally, we decided to investigate the influence of chirality in the aliphatic side chain of the 
substrate aldehyde. Methylenated citronellal features a chiral centre proximal to the aldehyde. 
In the reaction catalysed by DMF the chirality present in the molecule had little effect on the 
newly formed stereogenic centre, giving an almost equimolar mixture of anti/syn 
diastereoisomers. Methox-catalysed allylation of the enantiomers of citronellal was expected 
to create two pairs of aldehyde-catalyst systems. Matching and mismatching pair should differ 
substantially in diastereoselectivity (Scheme 40). 
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Scheme 40  
The room temperature reaction, catalysed by DMF, produced both diastereoisomers in nearly 
equimolar ratio. The later experiment with Methox 3 only slightly improved the selectivity to 
2.5 : 1, revealing a mismatching relationship of the substrate-catalyst.  
In order to find the matching pair, the opposite enantiomer of citronellal was methylenated 
and submitted for Methox catalysed allylation. The S enantiomer of the methylenated 
citronellal gave substantially higher diastereoselectivity of allylation. The main product is 
assumed to have absolute configuration of S,S (anti) (Scheme 41). Overall low 
enantioselectivity is similar to aldehyde 6, Table 2 and can be assigned to the presence of a 
large substituent in α position. 
 
Scheme 41  
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1.3 Allyl transfer as a new method to synthesize linear homoallylic alcohols 
The project was completed under supervision and in collaboration with Dr. Mikhail 
Kabeshov. 
 
1.3.1 Introduction 
 
In 1998 Nokami and coworkers reported on a conceptually new method of allylation of 
aldehydes.46a Allylic functionality was transferred from homoallylic alcohol 105 to the 
aldehyde 101 in the presence of Sn(OTf)2 as catalyst. Initial experiments showed good results 
for allyl transfer from simple homoallylic alcohol. The same conditions applied to 
dihydrocinnamyl aldehyde 101 and branched alcohol 107 gave the desired linear product 108 
in excellent yield and E/Z ratio up to 12:1 (Scheme 42). 
 
 
Scheme 42 
 
Nokami suggested a mechanism according to which the Lewis acid catalyses reaction of 
chiral racemic homoallylic alcohol 109 with external aldehyde, to create hemiacetal 110.46b 
Oxycarbenium species 111 formed by displacement of hydroxyl undergoes 2-oxonia [3,3]-
sigmatropic rearrangement as shown on Scheme 43. The reaction is driven towards forming 
the most stable cationic intermediate, featuring less sterically hindered and 
thermodynamically more stable internal alkene 111b.46 
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Scheme 43 
 
Significant preference for the E isomer was rationalised by cyclic chairlike transition-state 
models (Scheme 44). Transition state 113 leading to E product is more favourable than 114 
due to minimisation of 1,3-diaxial repulsion between the methyl substituent and the hydrogen 
atom of the alkene.46a 
 
Scheme 44 
 
The first enantioselective version of this reaction was demonstrated by Sumida and Nokami 
two years later.46b Alcohol 115 was isolated as a pure 3R,4S enantiomer and submitted to the 
allyl transfer mediated by Sn(OTf)2. The desired product 116 was isolated as a pure S 
enantiomer in high yield (Scheme 45). The reaction proceeds with complete inversion of the 
stereogenic centre and exhibits kinetic preference for the anti diastereoisomer. 
 
 
Scheme 45 
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In 2001 Nokami reported on asymmetric crotylation reaction of aldehyde via acid-catalysed 
allyl-transfer reaction from the branched homoallylic alcohol 118.47a (−)-Menthone 117 
derived from natural (−)-menthol was used as a source of chirality. The reaction proceeded 
via the six-membered cyclic transition state 119 and gave E-alkene selectively 120, while 
preserving high enantiomeric purity of 99% (Scheme 46).  
 
Scheme 46 
 
This method was further optimised, allowing employment of various allylation reagents with 
multifunctionalised allyl moiety.47b The use of (-)-menthone allowed Nokami to prepare a 
series of enantiopure, E-configured alkenols.47c All the products obtained in this manner were 
isolated as single enantiomers. 
 
Loh and coworkers used In(OTf)3 as a Lewis acid catalyst and showed that the presence of an 
external aldehyde is not necessary for the formation of the linear homoallylic alcohol 122.48 
The indium salt catalysed a full conversion of the branched isomer 121 (Scheme 47). 
Monitoring the aldehyde proton by NMR of the crude mixture indicated generation of the free 
aldehyde in situ. When a mixture of syn/anti diastereoisomers was submitted to the reaction, 
their ratio was virtually mirrored by the E/Z ratio of the linear products.  
 
 
 
Scheme 47 
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1.3.2 Results and discussion 
 
The initial aim of the project was to develop a robust protocol for the synthesis of a series of 
linear homoallylic alcohols with an internal double bond and submit them to oxidation with 
singlet oxygen. In order to prepare racemic material, we used the procedure reported by Loh 
and coworkers utilising metallic indium.49 The first step is the metal-mediated Barbier-type 
crotylation of benzaldehyde 123 resulting in the branched  alcohol 125 as an intermediate. 
Alcohol 125 subsequently undergoes a Lewis acid allyl transfer reaction to yield the linear 
isomer as a single product (Scheme 48).  
 
 
Scheme 48 
 
Unfortunately, the linear alcohols were obtained almost quantitatively but as an equimolar, 
inseparable mixture of E 126a and Z 126b isomers as revealed by NMR spectroscopy. The 
result indicates that the syn and anti diastereoisomers of 125 were formed in an equimolar 
ratio due to the lack of control in the first step.  
 
To investigate the rearrangement, alcohols 127 and 129 were synthesized by the Methox-
catalysed allylation as single S,S enantiomer in excellent yields and selectivity (Scheme 49). 
 
Scheme 49 
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An equimolar mixture of 127 and benzaldehyde 123 was treated with Sn(OTf)2, and the 
reaction progress was monitored by 1H NMR. The reaction was complete after 20 minutes and 
the linear homoallylic alcohol 128 was isolated as a pure E isomer with complete inversion of 
the benzylic stereo centre (Scheme 50).   
 
 
Scheme 50 
 
During optimisation, we found Sn(OTf)2 to be the most effective Lewis acid, whereas the 
more electron-rich p-tolyl derivative 129 emerged as the best allyl donor. The high reactivity 
of 129 is assumed to result from its enhanced capability to stabilise the positive charge in 
transition state 133 compared to the phenyl analogue in 127 (Scheme 50), thus disfavouring 
the reverse reaction. As an additional benefit of 129, the reduced electrophilic character of p-
tolualdehyde, released during the reaction, makes it less competitive with the receptor 
aldehyde in the allyl-transfer process, thereby avoiding the formation of the corresponding α-
adduct. Herein we adopted the mechanism proposed by Nokami, where the driving force for 
the key oxonia-Cope rearrangement (131 → 133 via the transition state 132) is the formation 
of the more stable cation 133.46b Predicted chair-like transition state 132 with all equatorial 
substituents provides excellent E/Z ratio of >>50:1 of the product with a complete 
preservation of the stereochemical information (Scheme 51). 
 
 
Scheme 51 
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Alcohol 129 was employed in the crotylation of a wide range of receptor aldehydes (Scheme 
52, Table 4). The reaction proved to be very efficient in every instance, with good yields and 
high enantioselectivity, essentially irrespective of the nature of aldehyde. The only drawback 
observed was the inability to introduce an allyl group to pyridine- and furan-derived 
aldehydes. This was rationalised by high Lewis basisity of the heterocycles, competing for the 
Lewis acid catalyst with the substrate aldehyde. 
 
Scheme 52 
Table 4. The scope of the enantioselective allyl-transfer reaction. 
Entry 128 R1 Yield, 
%[b,c] 
ee,  
% 
Chiral 
analysis 
1 a Ph 85 96 GC 
2 b 4-NO2C6H4 75 98 HPLC 
3 c PhCH2 82 96 HPLC 
4 d tBu 60 93 Mosher’s 
ester 19F NMR 
5 e cC6H11 80 97 GC 
6 f Et2CH 83 ≥95 GC 
7 g nC6H11 85 ≥97 Mosher’s 
ester 19F NMR 
8 h MeS(CH2)2 72 ≥97 Mosher’s 
ester 19F NMR 
9 i PhCH2CH2 85 97 GC 
a
 The reactions were carried out with 1 mmol of 1 and 3 mmol of R1CHO in CHCl3 (15 mL),                      b 
Isolated yield. c In all cases the (E/Z) ratio was >100:1. 
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1.4. Kinetic resolution of chiral allyltrichlorosilanes 
 
Allylic silanes were shown to be useful synthetic reagents that readily react with electrophiles 
to give a wide variety of multifunctionalised compounds. When a chiral controller is used, the 
method becomes an excellent tool for the synthesis of enantiopure building blocks. Allyl 
trichlorosilanes used in previous sections were all non chiral and the chirality was introduced 
to the product by the catalyst. However, in the experiments with the chiral citronellal 
derivative (Scheme 40 and 41), we have demonstrated that selectivity in the formation of the 
new C-C bond depends on the matched/mismatched relationship in the pair aldehyde-catalyst. 
Development of chiral allylsilanes was pioneered by Hayashi and co-workers, who used the 
predefined stereogenic centre for the synthesis of enantioenriched alcohols.50a Initial 
investigation focused on the asymmetric synthesis of allyl TMS derivatives 137 and their 
further development.50 In one of the practical protocols, they used palladium-catalysed 
asymmetric Grignard cross-coupling of 135 and 136 in the presence of the 
ferrocenylphosphine ligand 138 (Scheme 53).51 
Scheme 53 
The transmetallation methodology was also applied to the synthesis of enantioenriched 
trichlorosilanes 140. These useful intermediates were obtained in high enantioselectivity from 
the corresponding alkenes 139 by palladium catalysed asymmetric S-MOP 142 catalysed 
hydrosilylation. These intermediates were converted into enantiopure aliphatic alcohols 141 
(Scheme 54).52 
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Scheme 54 
Synthesis of chiral allyltrichlorosilanes can also be considered as an alternative route to chiral 
homoallylic alcohols widely discussed in this chapter. The palladium-MOP complex has been 
identified as a successful catalyst for the enantioselective hydrosilylation of 1,3-dienes 143. 
Enantioenriched allyltrichlorosilanes 144 reacted with aldehydes in the presence of achiral 
DMF as a catalyst to yield the respective homoallylic alcohols 145. The best results were 
obtained with chiral triphenylphosphine ligand 146 featuring long aliphatic chains to 
overcome solubility issues (Scheme 55).53 
 
Scheme 55 
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1.4.1. Results and discussion 
To develop a more straightforward approach to linear homoallylic alcohols of type 15, we 
started an investigation on the use of chiral racemic allyltrichlorosilanes for the asymmetric 
allylation. We reasoned that chiral N-oxide catalysts34 developed in our group might be able 
to kinetically resolve the racemic allyltrichlorosilane 149.  
 
The simplest chiral trichlorosilane 149 was prepared from the corresponding halide 147 by 
first converting it into Grignard reagent 148 in ether followed by reaction with silicon 
tetrachloride (Scheme 56).54 It is worth noting that a commercially available solution of the 
Grignard reagent in THF was used initially, however, it proved extremely difficult to separate 
the resulting solution from MgCl2. Trichlorosilane 149 appears to be unusually stable for 
manipulation and storage but has to be distilled under low pressure. Attempts to use 
temperatures over 60 oC resulted in the formation of gel-like residues, probably due to 
polymerisation.  
 
 
Scheme 56 
With the chiral racemic silane 149 in hand, the initial experiments were conducted in the 
presence of DMF as a Lewis-basic catalyst to obtain a reference sample of two isomeric 
alcohols 126b and 126a (Scheme 57). The reaction was complete in just over 4 h to give a 3:2 
mixture of 126b and 126a as racemates in 75% isolated yield.    
 
Scheme 57 
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This result can be rationalised by considering transition structures 150 and 151 leading to Z 
and E isomers, respectively (Scheme 58). The sterically bulky Si moiety with coordinated 
Lewis base appears to favour the conformation, where the methyl group at the stereogenic 
centre is forced into axial position. We reasoned that use of chiral Lewis base may also 
provide a bias to discriminate between the enantiomers. 
 
Scheme 58 
As a proof of concept, three equivalents of racemic trichlorosilane 149 were reacted with 
benzaldehyde in the presence of Methox 3, chiral Lewis base, under various conditions 
(Scheme 59).  The results are summarised in Table 5. 
Scheme 59 
Table 5. Kinetic resolution of chiral racemic allyltrichlorosilane 149 with Methox. 
Entry Methox 
Loading 
(%) 
Reaction 
time 
(days) 
Solvent Temperature 
[oC] 
Isolated 
yield of 
152 (%) 
Z/E 
ratio 
ee (%)c 
 
1 10 14 a -30 35 6:1 56 
2 10 14 b -30 46 6:1 59 
3 10 5 CH3CN -40 14 9:1 68 
4 10 30 propionitrile -80 5 >20:1 82 
5 10 30 CH2Cl2 -80 5 >20:1 87 
a
 - CH3CN:DIPEA : 2 : 0.5, b - CH3CN:DIPEA : 0.5 : 2, c – ee confirmed by HPLC analysis 
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Reactions at sub-zero temperatures gave expected preference for allylation with one 
enantiomer of 152. Lowering temperature had a dramatic impact on the reaction rates:  at −80 
oC only small quantities of the product were isolated. Another drawback of the reactions at 
low temperatures is the formation of branched isomer of the desired alcohol in up to 
equimolar quantities with the product. Despite the yield, the good level of enantioselectivity 
in this reaction is encouraging. It is clear that further optimisation of the reaction conditions, 
including use of other chiral Lewis bases, is required.  
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2. Synthesis of β-Amino-δ-Hydroxy Esters via a Stereoselective Palladium-Catalysed 
Functionalisation of Homoallylic Alcohols.  
The project was completed with assistance of the Erasmus exchange student Lucie Potucká  
2.1 Abstract 
We report a practical procedure for synthesis of multifunctionalised enantioenriched 
heterocyclic compounds employing chiral homoallylic alcohols obtained by asymmetric 
allylation.  In a series of a few standard synthetic steps, we gain access to valuable β-amino-δ-
hydroxy esters 157 building blocks from readily available or commercial materials (Scheme 
60). High yields, excellent diastereoselectivity and simple purification protocols make this 
approach attractive from an industrial point of view.  
1. PPh3, DIAD,  
    N-hydroxyphthalimide
    THF 0o to RT
2. N2H4 H2O
R1
R2
ONH2
24h, RT
 Boc2O
CH2Cl2, H2O(1:1)
NaOH 2eq
R1
O
H
SiCl3
CH3CN, DiPEA
Methox, (5%),
 - 40 oC
R2
R1
R2
OH
Up to 98% ee 
up to 55 : 1 anti : syn
N
OMe
MeO OMe
O
(+) METHOX
R1
R2
OH
R1
R2
ONHBoc
R1
R2
ONHBoc CO, PdCl2 (10%), 
Cu(OAc)2 (3eq)
(MeO)3CH, MeOH (1:1)
40oC, 24-36h
R1
R2
O
CO2Me
N
Boc
up to 96% yield
up to >>50 : 1 syn : anti
Mo(CO)6
CH3CN : H2O
2h, reflux
R1
R2
OH
CO2Me
NHBoc
1
2
3
153 154 155
155 156 157
 
Scheme 60 
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In the course of the research, we developed several novel palladium catalysed 
transformations. A diverse range of products 160-163 was obtained from same starting 
materials 158, 159 by adjusting reactions conditions (Scheme 61).   
 
 
Scheme 61 
 
2.2 Literature review 
 
Transformations of unsaturated hydrocarbons catalysed by transition metal complexes 
continue to constitute a very important field of organic chemistry. The past 30 years have 
witnessed a considerable effort to achieve selective multiple C-C bond couplings by means of 
transition metal complexes. The activation of an unsaturated carbon-carbon bond can be 
induced by its coordination to the metal, which makes the bond susceptible to addition of a 
nucleophile. Many of these reactions are catalysed by palladium, perhaps the most versatile 
and widely used transition metal, which can exist in three easily interconvertible oxidation 
states: Pd(0), Pd(II), and Pd(IV).56  
 
The unique properties of palladium derive from its ability to form both d8 and d10 complexes 
at 0 and +2 oxidations states. The empty orbitals in the valence-shell provide Lewis acidic or 
electrophilic sites, one of which would serve as the LUMO (i.e., lowest unoccupied molecular 
orbital). Filled nonbonding orbitals provide Lewis basic or nucleophilic sites, one of which 
would act as HOMO.57 Palladium can therefore readily participate in a variety of concerted 
reactions of relatively low activation energies. Tunable coordination abilities make this metal 
a versatile vehicle. Palladium catalysis is well-established for named C-C cross couplings, a 
variety of C-O and C-N transformations, polymerisations, rearrangements and hydrogenation. 
The ability to form stable complexes with a variety of ligands makes palladium-based species 
also a powerful tool for modern asymmetric synthesis.57   
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2.2.1 Alkoxycarbonylation 
 
One of the undisputed milestones in palladium catalysed functionalisation of the double bond 
is the oxidation of ethylene to acetaldehyde in water called the Wacker process.59 Oxidative 
conditions of Pd2+/Pd0 reoxidised by the Cu2+/Cu+ system were successfully applied to a 
variety of organic processes.  
 
Carbon monoxide (CO) is a chemically reactive and inexpensive carbon source. It also 
provides versatile access to 13C labelled compounds.68 Therefore, oxidative carbonylations 
constitute an important class of Pd(II)-mediated reactions.63 Other transition metals like cobalt 
and molybdenum, which exhibit high affinity for carbon monoxide, are also known for 
carbonylation reactions.58 However, the high toxicity of Co2(CO)8  and Mo(CO)6 complexes 
and their stoichiometric use severely limit their application. Relatively stable acyl-palladium 
complexes were found to be versatile intermediates in the synthesis of a variety of 
heterocycles and carbonyl derivatives .56b,57  
 
There are two major pathways to generate C-Pd active species. The first one assumes 
oxidative insertion of a palladium complex into a carbon halogen bond followed by various 
C-C couplings, like Heck or Suzuki reactions. When organopalladium species are generated 
in the presence of carbon monoxide, it inserts into C-Pd bond to form an acyl palladium 
derivative, which can be further attacked by N or O nuclephiles.69 The second mechanism of 
oxidative carbonylation starts with electrophilic attack of Pd2+ on the olefinic double bond to 
form the active pi-Pd complex 164. An exchange of ligand for CO is followed by oxidative 
insertion to create a new C-C bond 166. Nucleophilic attack on the carbonyl causes 
displacement of palladium, releasing the stable carbonyl product 167 (e.g., ester or amide) 
(Scheme 62).56b This type of reaction is the main scope of this chapter and will be discussed 
in detail. 
 
 
 
Scheme 62 
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To avoid using stoichiometric amounts of palladium, the catalytic cycle is completed by 
excess of copper(II) salt or oxygen to regenerate Pd(II) species 168g (Scheme 63). 
 
Pd0 PdX2
Cu2+ Cu+
YH
YH
PdX2
PdXY HX
COPdXY
CO
NuH
CONuY
+ HX
168a
168b
168c
168d
168e 168f 168g
 
 
Scheme 63 
 
Although the general mechanism is known, there are two possible pathways describing the 
actual formation of an ester (or amide). In the majority of the literature data, the nucleophile 
attacks the acyl-palladium complex, displacing the Pd0 species.61a However, kinetic studies by 
Yamamoto’s group with trans-Pd(COPh)I(PPh)2 suggest that an alternative route is in 
operation,61b namely that the acetoxyester-palladium intermediate 172 undergoes subsequent 
reductive elimination of metal to form product 173 (Scheme 64).  
 
 
 
 
Scheme 64 
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When carbonylation is performed on unsaturated substrates having a nucleophilic function in 
a suitable position, an intramolecular nucleophilic attack on the alkene Pd(II) complex is 
favoured. This type of reaction was intensively studied in the 1970s by grups of Stille, Fenton 
and others to find similar results and form mechanistic conclusions.60 Semmelhack and co-
workers used this methodology for the total synthesis of naphthoquinone antibiotics: 
nanaomycin A (174) and desoxyfrenolicin (175). An intramolecular alkoxy-carbonylation 
reaction yielded the desired product but with poor diastereocontrol.62 (Scheme 65) 
 
 
Scheme 65 
 
Access to diastereoselective formation of substituted tetrahydrofurans and pyrans is vital for 
the total synthesis of many natural products. Palladium-catalysed 1,2-alkoxycarbonylation 
leading to these structures was further investigated by Semmelhack and coworkers.63 
 
Initial results showed a strong dependence of the six-membered ring geometry on the double 
bond substitution pattern. While the 1,2-substitued alkenes strongly prefer a cis arrangement 
177c, 177d, the selectivity generated by 1,1-disubstituted isomers remains poor 177a. It was 
explained by repulsive axial interactions experienced by the methyl substituent in the cyclic 
arrangement (Scheme 67). However, a methoxy group in that position has a stabilising 
influence driving cis ring closure exclusively to 177b. The latter stereoselectivity can be 
further aided by the substituent anomeric effect (Scheme 66).63b  
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Scheme 66 
 
Formation of the cis-2,6 arrangement of substituents was rationalised by pseudo chair 
conformations in the transition state for nucleophilic attack 179a and 180a. The trans 
stereochemistry 180b is disfavoured because it would require the alkene-Pd(II) moiety to 
adopt an energetically higher pseudoaxial position (Scheme 67).63b   
 
Scheme 67 
 
Palladium-catalysed intramolecular alkoxycarbonylation of analogous substituted 5-hydroxy-
l-pentenes 181 was also investigated by Semmmelhack.64 The reaction produces 2,5-
disubstituted tetrahydrofurans  in good yields with cis/trans ratio highly dependent on the 
substitution pattern. With a methyl group at C-4, 1:l or 2:l mixtures of cis:trans products 182a 
and 182b were obtained, depending on the relative configuration of the Me. With a methyl or 
phenyl group at C-3, the selectivity improved, producing either cis-2,5- or trans-2,5-
disubstituted furans in >9:1 selectivity (Scheme 68 and Table 6). 64 
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Scheme 68 
 
Table 6. Diastereoselectivity of THF ring formation. 
 
Entry R1 R2 R3 R4 cis : trans  
ratio 
1 Me H H H 38 : 62 
2 H Me H H 50 : 50 
3 H H Me H 10 : 90 
4 H H Ph H 0 : 100 
5 H H H Me 87 : 13 
6 H H H Ph 93 : 7 
 
 
The results were rationalised by steric interactions in the appropriate transition structures 
(Scheme 69). Two five-membered competing transition states 184a and 185a leading to the 
cis and the trans products 184b and 185b are assumed to be of comparable energy.57 
Therefore, the authors suggested that transition states arising from conformations with 
minimum nonbonded interactions would be more favoured. The effect is reinforced by the 
position, configuration and size of the substituent.64 
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Scheme 69 
 
When an additional hydroxyl group is appropriately placed as in the substrate 186, the Pd-acyl 
intermediates 187 can be trapped in an intramolecular fashion to furnish the cis-fused lactones 
188 (Scheme 70).65a  
 
Scheme 70 
 
Palladium catalysed cascade of double cyclisations was soon appreciated as a simple and a 
straightforward route toward pyran and tetrahydrofuran lactones. Fused heterocyclic γ-
lactones are important structural motifs in many natural products, such as kalafugin 189, 
granaticin 190, and frenolicin B 191 (Figure 4).63a,66 
 
 
 
Figure 4 
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This type of reaction was pioneered by Tamaru and coworkers.65a In the mid-1980s, the group 
investigated a cascade closure of fused cyclic tetrahydrofurans and γ-lactones, as well as 
double lactonisation (Scheme 71). Reactions reported by Yoshida and Tamaru proceed with 
high yields, regio- and stereo-selectivity.  
 
 
 
Scheme 71 
 
Cyclization of 3-hydroxy-2-pentenoic acids 194 to bis-lactones 196 also yielded products as 
single diastereoisomers. Formation of exclusively cis-lactones was attributed to the directing 
effect of the free allylic hydroxyl group (Scheme 72).65b     
 52 
R
CO2H
OH
Pd+2
O
R
O
O
Pd+2
H
O
R
O
CO
O
O
H
H
CO2H
OH
OO
O
OPh
H
H
CO2H
OH
OO
O OPh
H
CO2H
OH
OO
O
O
nPr
H
H
CO2H
OH
O
O
O OnPr
H
H
nPr
Ph
Ph
nPr
nPr
nPr
60%
84%
83%
nPr
88%
194 195 196
194a 196b
194b 196b
196c194c
194d 196d
nPr
 
Scheme 72 
 
Although the cascade ring closure, furnished by alkoxylation of metal-carbonyl intermediate, 
was the major aspect of the palladium-catalysed reactions discussed here, its scope is much 
broader. In 1976 Stille and coworkers reported the double carbonylations of the double bonds 
in a series of cyclic olefins 197 (Scheme 73).60c   
 
Scheme 73 
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Highly reactive allene derivatives 199 react at room temperature with carbon monoxide in the 
presence of palladium by 5-exo cyclisation to form THF derivatives 200 as mixtures of 
cis/trans isomers. (Scheme 74).67 
 
 
 
Scheme 74 
 
Yamamoto and coworkers examined carbonylation of various aryl iodides into α-keto esters 
and esters catalysed by palladium. Reaction with alcohols was carried out in the presence of 
Et3N and phosphine ligands. Adjusting the CO pressure, ligand types, basicity, and solvent 
allowed switching between the two products (Scheme 75).61b 
 
 
Scheme 75 
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2.2.2 Aminocarbonylation 
 
Palladium-catalysed ether ring closures, followed by lactonisation or furnishing methyl esters, 
were recognised as a powerful tool for synthesising many useful heterocycles. The reactions 
discussed in the previous paragraphs were also successfully employed in the synthesis of 
nitrogen analogues. Urethane and indole motifs appear commonly in natural products 
molecules.  Polyfunctionalised nitrogen heterocyclic intermediates for the syntheses of 
pyrrolidine alkaloids are easily available via Pd catalysed reactions.70,56b  
 
The first palladium-assisted aminocarbonylation of o-allylanilines was demonstrated by 
Hegedus et al.71 The desired dihydroindolacetates were obtained in good yields under mild 
conditions (Scheme 76).  
 
 
Scheme 76 
 
This approach was further extended to the synthesis of fully aromatic indole derivatives 207. 
The palladium-catalysed N,C-coupling/carbonylation sequence, as a route to 2-
carboxyindoles, required higher temperatures and 10 bar pressure (Scheme 77).72 
 
 
Scheme 77 
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Yoshida and Tamaru were investigating cyclisation of tosylamides 208, affording pyrrolidine 
and piperidine derivatives 209 in analogy to the formation of tetrahydrofurans 182 and pyrans 
177 discussed in earlier sections. Closures of five and six-membered rings under the Wacker 
conditions, similar to those presented in Scheme 77, were reported to proceed in good yields 
and selectivity (Scheme 78).75 
 
Scheme 78 
 
These reactions can be followed by intramolecular N or O nucleophilic attack. Thus, 
stereoselective, intramolecular aminocarbonylation of 3-hydroxypent-4-enylamides 210, 
catalysed by palladium, provides the cis-3-hydroxy pyrrolidine lactones 211 in good to 
excellent yields (Scheme 79).63a 
 
 
 
Scheme 79 
 
The scope of this reaction was further extended for cyclisation of N-protected amino hydroxy-
olefins 212 to produce cis-3-hydroxypiperidineacetic derivatives 213 with high 
diastereoselectively under the same conditions but in considerably lower yields (Scheme 
80).73b   
 56 
   
 
 
Scheme 80 
 
Intramolecular palladium catalysed aminocarbonylation was utilised as a key step in the total 
synthesis of racemic anatoxin 214d (Scheme 81),74 which mimics acetylcholine functions and 
is used for neurotransmission research.   
 
 
Scheme 81 
 
Tamaru, Yoshida, and co-workers expanded the scope of this methodology by employing urea 
and oxazolidinone derivatives, which are known as nucleophiles.75 These fragments are very 
common in modern drug structures (Befloxatone, Ritonavir, Toloxatone) and represent easily 
available intermediates for the synthesis of diamino and hydroxyaminoacids.76 Tandem 
cyclisation can be moderated by different types of urea or carbamate as well as by the choice 
of solvent. Depending on the conditions, formation of the first ring can be followed by 
amidation or esterification. Tamaru and coworkers found urea to be the most reactive towards 
the intramolecular aminopalladation reaction, whereas carbamate was more reactive than 
tosylamide. Benzamide was by far the least reactive. The best results for the double 
cyclisation were obtained with N-methylurea moiety. 
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Acetic acid with 3 equivalents of AcONa was the solvent of choice for the reaction. It was 
rationalised by proposed solvation of chloride ion of PdCl2, via hydrogen bonding, which 
results in the exposure of Pd2+ to the coordination to the olefin. Dichloromethane appeared to 
be the worst solvent for the reaction, resulting in low yields of 216 and 3 days reaction time 
(Scheme 82).75 
 
 
 
Scheme 82 
 
Under the optimised conditions, Tamaru and coworkers synthesised a series of cyclic ureas 
fused with another heterocycle (Scheme 83).75     
 
 
Scheme 83 
 
Further studies showed that nitrogen nucleophiles, depending on their structure, display 
completely different reaction behaviour in the Wacker-type intramolecular 
aminocarbonylation.77 Recognised differences in the reactivity towards ring closure were 
assigned to the type of the nitrogen nucleophile present and the size of the closing ring. 
(Scheme 84). Endo-6 ring closure of carbamates 217d proved to be most difficult, which was 
rationalised by molecular orbital overlapping models.77  
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Palladium-assisted ring closure of 219 proceeds chemoselectively in either direction, 
depending on whether acidic or buffered neutral conditions are applied. Methyl orthoacetate 
(MOA), methyl orthoformate (MOF), 2,2-dimethoxypropane, or propylene oxide were 
successfully used as HCl scavengers, producing methanol and ester as neutral byproducts. 
Only in the presence of orthoacetates do the cyclisations proceed in high trans-
stereoselectivity (Scheme 85).77   
 
 
Scheme 85 
 
The recent report by Sasai and coworkers78 shows that intramolecular exo-carbonylation of 
achiral urea 222 can be performed with good enantioselectivity. The use of a chiral spiro-
bis(isoxazoline) ligand (SPRIX) 224 furnished the desired product 223 in good yield and 
enantiopurity, opening an efficient synthetic method for the preparation of optically active 
cyclic β-aminoacid derivatives (Scheme 86).  
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Scheme 86 
 
When nucleophilic attack on the palladium pi-complex is followed by elimination of a leaving 
group instead of carbonylation, heterocycles with an allylic moiety 226 are formed. The use 
of chiral ferrocenyloxazoline palladacycles 227 as catalysts for enantioselective 
intramolecular aminopalladation of the double bond to form allylic amides was reported.79 A 
series of oxazolidinones, imidazolidinones, and pyrrolidinones were prepared by this 
methodology (Scheme 87).  
 
 
 
Scheme 87   
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2.2.3 Synthesis of isoxazolidines and their applications  
 
Nitrogen-containing heterocycles and their derivatives have a broad application in organic and 
biological chemistry and, as a result, their synthesis and reactivity is subject of considerable 
interest. The isoxazolidine structure is present in a number of naturally occurring molecules, 
such as pyrinodemins - potent cytotoxic alkaloids 228 isolated from the Okinawan marine 
sponge Amphimedon sp (Figure 5).80  
 
Figure 5 
 
Even more important are the commercial and pharmaceutical uses of these compounds as 
modern drugs or their precursors. The current trends for designing new drug molecules are 
largely based on mimicking naturally occurring structures (e. g., nucleosides). Alterations can 
take place in both the aglycon and carbohydrate moieties resulting in high anti-HIV (carbovir) 
and antifungal (polyoxins) activity.81 Demand for enantiopure N and O containing five-
membered heterocycles, isoxazolidines and isoxazolines, triggered rapid development of 
methods for their synthesis. Many recently described compounds containing this motif were 
recognized for their potential antiviral and antimicrobial properties 229a-c (Figure 6).82 
 
Figure 6 
 
Isoxazolines and isoxazolidines are typically generated via [3+2] cycloaddition of a nitrone 
230 to an alkene 231.83 Intramolecular nitrone-olefin cycloaddition leads to the formation of a 
new C-C bond and a new C-O bond. The [3+2] cycloaddition itself is a concerted, pericyclic 
process whose regiochemistry is controlled by steric factors and orbital interactions of the 
nitrone (the dipole) and the dipolarophile. The cycloaddition is stereospecific with respect to 
the configuration of the alkene (Scheme 88).84 
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Scheme 88 
 
Enantiomerically pure isoxazolidines are direct precursors to numerous biologically active 
compounds, such as chiral 1,3-amino alcohols and alkaloids, e.g., (+)-porantheridine 233a or 
(+)-hydroxycotinine 233b (Figure 7).188  
 
 
Figure 7 
 
 Effective methods for controlling up to three contiguous stereogenic centres were intensively 
studied in the last decade. There are known protocols for the enantioselective 1,3-dipolar 
cycloaddition reaction between nitrones 230 and alkenes 234 directed by either metal-based 
Lewis acids 236 (Scheme 89) or by organocatalysts 238 (Scheme 90).85 
 
 
Scheme 89 
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Scheme 90    
 
2.2.4 Formation of an isoxazolidine ring in the diastereoselective cyclization of N-
protected-O-alkoxyamines 
 
A conceptually new and straightforward strategy for a diastereoselective synthesis of 3,5- 
disubstituted isoxazolidines was developed by Bates and coworkers.86 Treatment of O-
homoallylhydroxylamines 239 with catalytic palladium(II) and co-oxidant, e.g., copper(II), in 
the presence of a strong base, methanol, and carbon monoxide results in the formation of 
isoxazolidines 240 in good yields. An electron-withdrawing group on the hydroxylamine 
nitrogen proved to be essential. Bates also observed that in the case of carbamate derivatives 
the products are exclusively formed as cis-isomers, which was confirmed by nOe experiments 
(Scheme 91). 
 
Scheme 91 
 
The predominant formation of the cis-isomer was explained by an envelope-like reactive 
conformation, similar to those shown in Schemes 68 and 70, in which 241a is favoured over 
241b due to the less crowded alkene-palladium moiety (Scheme 92).86 
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Scheme 92 
 
Enantiopure, multisubsituted isoxazolidnes are valuable intermediates in the total synthesis of 
natural products of Sedum alkaloid family. All these molecules possess either a 1,3-
aminoalcohol or a 1,3-diamine moiety in addition to nitrogen heterocycle and are interesting 
synthetic targets. Selected compounds, such as andrachamine 243, tetraponerine-8 244 and 
sedamine 245 presented on Figure 8, were all synthesised using isoxazolidine intermediates.87  
 
 
 
Figure 8 
 
Successful application of palladium-mediated ring-closure/carbonylation as the key step was 
reported for the synthesis of the alkaloid sedamine 245.88 This compound is the best known of 
a large group of piperidine alkaloids that have been isolated from Sedum and other species. 
The initial (S)-stereogenic centre was introduced in alcohol 246 via chiral Lewis acid 
catalysed asymmetric allylation of benzaldehyde to obtain homoallylic alcohol in 95% ee. 
Complete inversion of the stereogenic centre took place in the next Mitsunobu product 247. 
Cyclisation of the N-Boc protected alkoxyamine into five-membered isoxazolidine 248 was 
followed by five more steps to furnish the desired natural product 245 (Scheme 93).  
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Scheme 93 
 
This procedure was further explored by Dongol and co-workers who synthesised a series of 
aromatic isoxazolidines.89 Addition of TMG (1,1,3,3-tetramethylguanidine) and Na2HPO4 at 
room temperature were found optimal for the reaction. N-Boc protected derivative 250 of 
commercially available (S)-(+)-4-pentenol 249 was used in synthesis of the enantiopure 
isoxazolidine 251. GC analysis of the product confirmed complete inversion of the chiral 
centre and maintained 99% ee (Scheme 94). 
 
 
 
Scheme 94 
 
Another important aspect of this method is the reoxidation of the palladium species, which is 
being reduced during the catalytic process. Dongol and coworkers reported on complete 
formation of isoxazolidine under an atmosphere of CO and O2 as copper reoxidant.89 This 
modification introduced by Åkermark and coworkers reduces substantially the amount of the 
metal-based waste and makes the whole process more suitable for large scale operations 
(Scheme 95).90 
 
 
 
Scheme 95 
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2.3 Results and discussion 
 
2.3.1 Synthesis of starting materials 
 
Synthesis of chiral homoallylic alcohols similar to those shown in Schemes 93 and 94 is a 
well established process in our group.37,39,40 In this work we have demonstrated further 
development and synthetic applications of this class of compounds. Two top catalysts found 
in our laboratory, Methox and Quinox, provide access to enantiopure homoallylic alcohols 
with up to two stereogenic centres in either syn or anti configuration.39,40 These substrates 
with predefined chirality are ideal starting materials for the synthesis of more complex 
building blocks with multiple stereogenic centres. A series of enantiopure homoallylic 
alcohols with a wide range of electronic and steric properties was prepared (Table 7, Scheme 
96).  
 
 
Scheme 96 
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Table 7.  Synthesis of enantiopure homoallylic alcohols 
 
Entry alcohola yieldd  
% 
eeb 
% 
dec 
1 (±)-255a 93 racemicf n/a 
2 (S)-(–)-255b 70 96 n/a 
3 (S)-(–)-255c 75 95 n/a 
4 (S)-(–)-255d 91 91 n/a 
5 (S)-(–)-255e 72 92 n/a 
6 (S)-(–)-255f 82 94 n/a 
7 (1S,2S)-(–)-255g 87 95 55 : 1 
8 (1S,2S)-(–)-255h 52 98 35 : 1 
9 (S)-(–)-255i 75 88 n/a 
10 (R)-(+)-256 76 92 n/a 
 
a
 The absolute configuration of the starting alcohols 255 has either been established previously or is inferred by 
analogy, based on the fact that the allylation of aromatic aldehydes catalysed by (+)-METHOX (3) is known to 
produce (S)-alcohols40. b The enantiomeric purity of the starting alcohols was established by chiral HPLC or GC. 
c  Established by 1H NMR (or 19F NMR, where applicable) spectroscopy. d Isolated yield after purification; note 
that conversions were practically quantitative. f – racemic alcohol was prepared via DMF catalysed reaction. 
 
There are two different methods for the conversion of an alcohol into the corresponding 
alkoxyamine (R-ONH2), one involving the Mitsunobu substitution, in which a new C-O bond 
is formed with inversion of the original configuration,86,91,93 and another proceeding with net 
retention, where the O-N bond is constructed instead, leaving the chiral centre unaffected.92 
According to the former approach, alcohols 255a-i were treated with N-hydroxyphthalimide 
(NHPI) in the presence of diisopropyl diazodicarboxylate (DIAD) and triphenylphosphine 
under the standard Mitsunobu conditions86,91,93 and the resulting phthalimides were 
deprotected on reaction with hydrazine to afford the required alkoxyamines 257a-i in good 
yields (Scheme 97 and Table 8).  
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Scheme 97 
 
Table 8.  Synthesis of alkoxyamines 
 
Entry alkoxyamine yielda 
% 
eeb 
% 
dec 
1 (±)-257a 85 racemic n/a 
2 (R)-(+)-257b 74 ~10 n/a 
3 (R)-(+)-257c 78 90 n/a 
4 (R)-(+)-257d 86 90 n/a 
5 (R)-(+)-257e 84 92 n/a 
6 (R)-(+)-257f 91 88 n/a 
7 (1R,2S)-(+)-257g 89 95d 35 : 1e 
8 (1R,2S)-(+)-257h 54 98d 28 : 1f 
9 (S)-(–)-257i 64 ~40g n/a 
10 (S)-(–)-258 81 90 n/a 
 
a Isolated yield after purification; note that conversions were practically quantitative. b The enantiomeric purity 
was inferred from the 19F NMR spectra of the corresponding Mosher derivatives. c Established by 1H NMR 
spectroscopy for 257g (by integration of the signals of the benzylic protons of the crude products) and by 19F 
NMR for 257h. d The enantiomeric purity is assumed to be identical to that of the starting material, as the second 
chiral centre remained unchanged. e Increased to 55:1 purity by chromatography. f The conversion was ~70%. 
The syn/anti ratio could not be accurately established due to the overlap of the relevant signals in the 1H NMR 
spectrum of the crude product with those of the unreacted starting material; the 28:1 ratio corresponds to the 
product after purification. g Isolated as 2 : 1 ratio mixture with SN2’ product 260. 
 
 68 
In all cases, except two (entry 2 and 9), the inversion of configuration was almost perfect 
(with very little loss in the stereochemical integrity if any). All noted losses in the range of 3-
5% ee were assigned to insufficient accuracy of the Mosher amide detection method 
compared to the enantiopurity of alcohols confirmed by HPLC and GC. However, the p-
methoxy derivative 255b (96% ee) produced the corresponding alkoxyamine 257b, which 
turned out to be almost racemic (~10% ee). We assume this was a result of the strong electron 
donating effect 259 of the methoxy group at the p-position, which led to participation of 
cationic intermediate 259a stabilised by resonance. The strong SN1 component in this reaction 
renders the product 257b nearly racemic (Scheme 98).  
 
 
 
Scheme 98 
 
Another example where we have encountered a similar problem was Mitsunobu reaction of 
the alcohol 255i, derived from cinnamyl aldehyde. Product 260 was formed as a result of the 
competing SN2’ reaction in 1:2 ratio with the desired O-alkoxyamine 257i (Scheme 99).91b 
 
 
 
 
Scheme 99 
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Mosher amide analysis of the products revealed ca. 40% enantiopurity of 257i (loss from 
88%) and 260 was obtained as a racemate. This was again rationalised by the high stability of 
the cation in the conjugated system which enabled SN2, SN2’ and SN1 reactions to compete. 
This result represents a serious blow to the general belief in the Mitsunobu reaction93 as a 
means of clean inversion and will deserve further investigation.   
 
 
One of the possibilities to avoid racemisation is to install the alkoxyamine moiety without 
affecting the chiral centre. The retention pathway (Scheme 100) is based on the construction 
of the O-N bond via the reaction of the corresponding alkoxide (generated in situ) with 3,3’-
di-tert-butyloxaziridine, which involves a nucleophilic substitution at the oxaziridine 
nitrogen.94 According to this scenario, alcohols 255b,g,h were deprotonated with potassium 
hydride in the presence of the potassium-specific 18-crown-6 ether and the resulting alkoxides 
were allowed to react with 3,3’-di-tert-butyloxaziridine to produce 261b (88%), 261g (65%), 
and 261h (33%); these experiments were conducted by the Erasmus exchange student Lucie 
Potucká. 
 
 
 
Scheme 100 
 
The mechanism of oxaziridine 262b reaction proposed by Ellman resembles opening of the 
epoxide with an alkoxide 262a. When temperature is increased, a more stable alkoxide 262c 
is preferred and O-N bond is being formed. Protonation of the product 262c leads to the 
collapse of the molecule 262d and formation of alkoxyamine 262e and an unreactive 
byproduct 262f (Scheme 101). Bulky t-Bu groups prevent nucleophilic attack on carbonyl as 
well as it enolisation.92 
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Scheme 101 
 
Another approach (performed by the project student Colin Robinson) to prevent racemisation 
of the electron-rich starting alcohols in the Mitsunobu step was to decrease the electron 
donating effect of the substituents by replacing OMe with OAc. Alcohol 263 was synthesised 
in 96% ee and with 28:1 anti : syn diastereopurity using Methox crotylation under standard 
conditions. Mitsunobu reaction of the latter alcohol, followed by hydrazinolysis gave the 
product 264 with pure inversion with only minor decay of diastereopurity (25:1 syn : anti). 
The acetate group was then cleaved by hydrazine hydrate (Scheme 102).  
 
 
 
Scheme 102 
 
This result clearly indicates the existence of a borderline of the mechanism, which determines 
the scope of the Mitsuobu method. Computational analysis of the stability of benzylic cations 
and vulnerability of the respective alcohols to racemisation was carried out by Dr Mikhail 
Kabeshov (Table 9). DFT calculations were carried out at B3LYP{1}/6-31g(d,p) level with 
the CPCM{2} solvation model. 
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Table 9. Relative stability of benzylic cations  
 
Entry 
 
stability to 
racemisation 
1 4-NO2 11.5 
2 4-CN 9.3 
3 4-Ac 5.2 
4 4-F 0.2 
5 3-MeO 0.1 
6 Ph 0 
7 3-NHAc -0.3 
8 4-AcO -2.8 
9 4-Me -4.7 
10 4-NHAc -8.2 
11 4-MeO -10.5 
12 3,4-diMeO -12.1 
13 4-NH2 -20 
 
The results shown in Table 9 estimate the resistance of the selected homoallylic alcohols to 
racemisation during the Mitsunobu reaction. The greater the number the lower the stability of 
the benzylic cation and the more suppressed SN1 reaction. Simple phenyl group was set as a 
reference point. The results from Table 9 perfectly mirror the experimental data. With a 4-
MeO substituent, almost complete racemisation was observed while a 4-OAc group was 
sufficient to prevent it.   
 
A series of O-alkoxyamines were submitted to N-derivatisation with an electron withdrawing 
group. Derivatisation with EWG is crucial for the ring closing aminocarbonylation to occur, 
as free NH2 proved unreactive.86 tert-Butyloxycarbonyl (Boc) was employed as the group of 
choice, since it is much easier to remove than, e.g., acetate, and is beneficial to 
diastereoselectivity. Boc-derivatisation of 257, 258, and 261 was carried out under the 
standard Schotten-Bauman-type conditions using di-tert-butyl dicarbonate (Boc-anhydride) 
and NaOH in a two-phase system, and afforded the model alkoxycarbamates 265, 267, and 
266 in high isolated yields (Scheme 103, table 10). 
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Scheme 103 
 
Table 10.  Synthesis of N-Boc protection of alkoxyamines (Scheme 103). 
 
Entry N-Boc alkoxyamine yield  
% 
ee 
% 
de 
1 (R)-(+)-265a 99 racemic n/a 
2 (R)-(+)-265b 85 ~10 n/a 
3 (R)-(+)-265c 92 90 n/a 
4 (R)-(+)-265d 82 90 n/a 
5 (R)-(+)-265e 77 92 n/a 
6 (R)-(+)-265f 97 88 n/a 
7 (1R,2S)-(+)-265g 98 95 35 : 1 
8 (1R,2S)-(+)-265h 76 98 28 : 1 
9 (S)-(–)-266b 79 96 n/a 
10 (1S,2S)-(–)-266g 69 95 55 : 1 
11 (1S,2S)-(–)-266h 69 98 35 : 1 
12 (S)-(–)-267 91 90 n/a 
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2.3.2 Ring-Closing Carboamination of the Boc-Protected Alkoxyamines. 
 
Treatment of the unsaturated Boc protected alkoxycarbamates 265a-h with methanol and 
carbon monoxide at atmospheric pressure in the presence of PdCl2 as catalyst (10 mol%) and 
(AcO)2Cu (2-3 equiv) to reoxidise the palladium, was expected to result in the formation of 
isoxazolidines 268a-h (Scheme 104 and Table 11). However, the first attempts with just 
methanol as a solvent and reactant were rather disappointing: thus, at 0 oC or at room 
temperature, there was practically no reaction detected, whereas at 30 oC, especially in the 
presence of a base, such as K2CO3, Et3N, AcONa, PhCO2Na, or tetramethylguanidine, etc., 
precipitation of Pd-black was observed within ~10 min, apparently as a result of the 
stoichiometric oxidation of CO and/or MeOH at the expense of Pd(II).86 Finally, after much 
experimentation, we were able to identify a 1:1 mixture of methanol and methyl orthoacetate 
as the medium of choice, with no additional base required. Here, the role of the orthoacetate is 
to “mop up” the Brønsted acid generated during the reaction; the latter process also produces 
MeOH, which is present anyway, and one equivalent of the innocuous AcOMe. Significantly, 
under these neutral conditions, the reduction of Pd(II) by CO/MeOH was suppressed, so that 
the desired carboamination could proceed to completion. 
 
The cyclisation of 265a-f and 266b, i.e., terminal olefins lacking another substituent (R2 = H), 
proceeded with very high diastereoselectivity (24:1 to >50:1; Table 2, entries 1-6 and 9). The 
cyclisation of their homologues with an additional methyl (R2 = Me) exhibited dependence on 
the configuration. Thus, the syn-configured alkoxycarbamates 265g,h produced the less 
stereochemically pure syn,syn-isozaxolidines 268g,h (entries 7 and 8), whereas the anti-
configured analogues 266g,h afforded the anti,anti-isoxazolidines 269g,h of high 
diastereoisomeric purity (entries 10 and 11). 
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Table 11. Palladium-catalysed ring-closing carbonylation of N-Boc alkoxyamines. 
 
Entry N-Boc 
alkoxyamine 
ee 
% 
de isoxazolidine yielda 
(%) 
deb 
 1 (R)-(+)-265a racemic n/a 268a 93 >50 : 1 
 2 (R)-(+)-265b 10 n/a 268b 80 >50 : 1 
 3 (R)-(+)-265c 90 n/a 268c 76 20 : 1c,d 
 4 (R)-(+)-265d 90 n/a 268d 93 >50 : 1 
 5 (R)-(+)-265e 92 n/a 268e 73 25 : 1 
 6 (R)-(+)-265f 88 n/a 268f 96 >50 : 1 
 7 (1R,2S)-(+)-265g 95 35 : 1 268g 69 4.5 : 1e,f 
 8 (1R,2S)-(+)-265h 98   28 : 1 268h 60 5.7 : 1f 
 9 (S)-(–)266b 96 n/a 269b 54 >25 : 1e 
10 (1S,2S)-(–)-266g 95 55 : 1 269g 71 >20 : 1e,f 
11 (1S,2S)-(–)-266h 98 35 : 1 269h 66 17 : 1e,f 
12 (S)-(–)-267 90 n/a 270 55 22 : 2 : 1g 
 
a
 Isolated yield after purification; note that conversions were practically quantitative. b Established for the crude 
product by 1H NMR spectroscopy (by integrating the signals of the benzylic protons). c The 19F NMR spectrum 
of the crude product showed a 16:1 ratio. d Increased to ≥40:1 by chromatography. e Increased to >50:1 by 
chromatography. f In principle, three diastereoisomers could be formed here. However, the third isomer could 
not be detected, presumably because its concentration was below the detection limit of the NMR spectroscopy. g 
Increased to 40:2.5:1 by chromatography.   
 
It is frequently pointed out that the presence of another substituent at the olefinic double bond 
causes serious deterioration of the palladium(II)-catalysed cyclisation. Two main factors seem 
to contribute to this: one is the decrease of the stability of the intermediate olefin-palladium 
complex due to the increased steric hindrance. Another factor is the inhibition of an approach 
of a nucleophile to the sterically crowded electrophilic center.75 Homologue 267, with a more 
sterically hindered disubstituted double bond, required slightly higher temperature and 
extended reaction time to produce 270 as an almost pure diastereoisomer (entry 12). The 
relative configuration of 270 was established by NMR spectroscopy and confirmed by X-ray 
crystallography of the deprotected isoxazolidine (Scheme 105, Figure 9). 
 76 
 
Scheme 105 
 
Figure 9.  An ORTEP diagram for 271. 
 
There are two major mechanisms describing stereocontrolled electrophilic additions across a 
C=C bond.  When metals, such as Pd190 or Hg,190,191 are employed as the electrophilic triggers 
of the reaction, the initially formed organometallic product B can be utilized in a subsequent 
reaction that would allow the construction of a new C-C bond from the C-M bond. The 
overall result would then be the formation of a C-X and C-C bond, where X is introduced as a 
nucleophile, and the new C-substituent formally as an electrophile (C).57,63,190a,192 
 
In his seminal paper, Semmelhack63 had shown that olefinic alcohols can be readily cyclised 
in a stereocontrolled manner by Pd2+ (eq 1, X = O) and the resulting organopalladium 
intermediate B would then undergo carbonylation (with retention of configuration) to produce 
the corresponding ester (M = CO2Me).62-64,193 Semmelhack had also developed a catalytic 
cycle, in which the Pd(0) resulting from the reaction is re-oxidized by Cu(II).63,193 The latter 
reaction was formulated as an anti-addition of Pd2+ and the alkoxy group across the double 
bond (eq 1),63,193 which is in line with the mechanism of the Bäckvall oxidation, where the 
initially generated η4-Pd(II)-complex of a conjugated diene is attacked by a nucleophile from 
the face opposite to Pd,194 and with the mechanism of Pd(II)-catalysed amination of ethylene, 
thoroughly investigated by Åkermark.195 
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Aside from the anti-mechanism (eq 1), the syn-addition (eq 2) may also operate, especially if 
the XH group (-OH or -NHR) is deprotonated with a base prior to the reaction,196 so that it 
can easily pre-coordinate the metal and steer its approach to the C=C bond. Numerous 
examples of the latter mechanism have been reported for the catalytic cyclisations with 
nitrogen or oxygen as internal nucleophile and the Ar-[Pd] species by groups of Wolfe and 
others.196,197 In fact, Wolfe198a , Hartwig198b and collaborators have been able to prepare the N-
Pd complexes (D, X = NR) from the corresponding amines via deprotonation followed by 
treatment with Pd(II), and elucidate the mechanism with the aid of deuterium labelling. 
 
 
 Scheme 106 
 
The experiment with 267 was of key importance for establishing the stereochemistry of the 
Pd-catalysed cyclisation: here, the formation of diastereoisomer 270 corresponds to a syn-
addition (eq 2 in Scheme 106) of Pd and the nitrogen across the C=C bond. Apparently, the 
carbamate group is capable of coordinating the Pd(II) catalyst (Scheme 107), presumably by 
nitrogen upon its deprotonation (272), followed by a syn-addition across the neighbouring 
C=C bond, to generate the palladium species 273, whose carbonylation (with retention of 
configuration) gives rise to ester 270. This mechanism mirrors the findings by Wolfe95 and 
Hartwig,96 research groups who first deprotonated model amines with a strong base prior to 
the addition of a palladium complex (typically Ar-PdX). The syn-attack on the opposite face 
of the double bond, as in 274, would generate 1,3-strain, so that the corresponding Pd 
intermediate 275 is apparently not generated in any appreciable amount. By contrast, the anti-
pathway (276 → 277) would give rise to yet another diastereoisomer of 270, whose formation 
was not observed. These findings show that carbamates stand in stark contrast to alcohols, 
which prefer the anti-pathway in the carbonylative cyclisation (Scheme 108).63     
 
 78 
267
Pd2+
Me
Ph
O
N
Ot-BuO
PdX
H
Ph
PdX
Boc
* * *
H Me
270
CO
MeOH
272
273
*
O N
Ot-BuO
Ph H
PdX
*
Me
H
>>
274
Ph
PdX
Boc
* *
*
Me H
275
Me
Ph
O
NH
Boc
H
276
*
267
Pd2+
Ph
PdX
Boc
* *
*
Me H
277
Pd2+
NO N O
O N
 
 
Scheme 107 
 
Similar mechanistic arguments can be applied to the remaining members of the series, i.e., 
265 and 266 (Scheme 108). Thus, carbamates 265 apparently prefer the pathway involving the 
palladium complexes 278 and 279 to give 268; by analogy, carbamates 266 can be assumed to 
react via 282 and 283, giving rise to 269. In the case of the syn-configured carbamates 266, 
the reactive intermediate 278 is more congested than the analogous species 282 arising from 
the anti-configured carbamate 266, which can account for the clean formation of one 
diastereoisomer in the latter instance (269) and the less stereochemically homogeneous 
reaction in the former (268); compare entries 10 and 11 with 7 and 8 with in Table 10. 
 In the absence of the R2 substituent (i.e., R2 = H), the diastereoselectivity was high in all 
instances (Table 11, entries 1-6 and 9). 
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Scheme 108   
 
In order to expand the scope of the reaction, a nitrogen analogue of the N-Boc alkoxyamine 
was synthesised from homoallylic alcohol 255a by a modified Mitsunobu reaction.97 In the 
absence of a suitable reagent, azodicarboxylate serves as an N-nucleophile to furnish the 
hydrazine derivative 286 (Scheme 109) . 
 
 
Scheme 109 
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Product 286 was submitted to palladium-catalysed carbonylation under standard conditions 
with slightly increased temperature to cleanly furnish pyrazolidine 287 (Scheme 109). The 
product was obtained as a single diastereoisomer, presumably of syn configuration according 
to the proposed mechanism (Scheme 108). Attempts to close the pyrazolidine ring with Boc 
protected hydrazine failed and gave only 25% of impure product after 7 days at 60 oC. This 
reaction requires further investigation. To the best of our knowledge, this is the first example 
of asymmetric synthesis of pyrazolidines by aminocarbonylation.  
 
The reactions described above demonstrate the high level of diastereoselectivity in closing 5-
membered isoxazolidine rings. Closing six- and seven-membered ring was unsuccessful, as 
reported by Bates and Sa-Ei.86  
 
An inseparable 2:1 mixture of alkoxyamines 257i and 260 shown in Scheme 99, after 
protection with Boc, was carbonylated under standard conditions. Only alkoxyamine 
derivative 265i underwent cyclisation and the product 268i was easily isolated in 87% yield as 
a single diastereoisomer, while 288 was recovered unchanged (Scheme 110).  
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Scheme 110 
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2.3.3 Synthetic Application of Isoxazolidines  
 
During the last decade, synthesis of optically active β-amino acids attracted considerable 
attention due to their biologically important properties, their occurrence in natural products 
and as potential precursors to many other molecules, such as β-lactams.98 This structural motif 
is very common in nature and has been successfully reproduced by chemists (Figure 10). 
Furthermore, β-amino acids and their derivatives show interesting and useful pharmacological 
properties.99 
 
Figure 10 
 
Although methods for the synthesis of γ- and δ-substituted β-aminoacids are known, there is 
only a limited number of asymmetric variants.100 Therefore, the synthetic pathway presented 
here represents an important contribution to this methodology. The cleavage of the O-N bond 
in the N-Boc-protected isoxazolidines 268 and similarly in the related isoxazolidines 269 and 
270, would open an interesting access to β-amino-δ-hydroxy acids, with an optional 
substituent (R2) at the γ-position. Up to three stereogenic centres can be controlled using this 
methodology. Of the existing methods for the O-N bond cleavage, we chose the protocol of 
Cicchi and coworkers that employed Mo(CO)6, as this reagent appears to be tolerant to the 
N-Boc group.101 Indeed, on treatment with a stoichiometric amount of Mo(CO)6 at 90 oC 
(Scheme 111), the selected N-Boc protected isoxazolidines 268c,f,g afforded the expected N-
Boc-protected β-amino-δ-hydroxy acids 290c (65%), 290f (86%), and 290g (77%).   
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Scheme 111 
 
2.3.4 Unexpected Palladium Catalysed Transformations  
 
While optimising the conditions for the carbonylative cyclisation of 267 into 270 (Scheme 
105), the solvent composition of MeCN/(MeO)3CH/MeOH 8:1:1) gave a 1:1 mixture of 270 
and an unexpected unsaturated product 291 bearing an isoxazolidine moiety. Analysis of the 
isolated product 291 confirmed the structure shown in Scheme 112. 
 
 
 
Scheme 112 
 
Compound 291 has never been described in the literature. We assumed that products 270 and 
291 are formed by two different manifolds (Scheme 113). In the first pathway, 
organopalladium species 292 can be trapped with CO to give the expected ester 270. In the 
second route, acetonitrile is known as a good coordinating solvent which may trigger 
competing β-hydride elimination of the stabilised palladium species.102 This would produce 
intermediate 293. Next, addition of the palladium-acetonitrille complex across the double 
bond may result in the formation of the organopalladium species 294, which would then 
undergo carbonylation followed by elimination of acetonitrile to produce 291 (Scheme 113). 
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Scheme 113 
 
In order to confirm this hypothesis, N-Boc protected alkoxyamine 267 was submitted to the 
standard conditions used in the Pd-catalysed carbonylation (as in Scheme 112), except this 
time under argon atmosphere, i.e., lacking CO. As expected, the reaction resulted in a clean 
conversion of 267 into an inseparable 3:1 mixture of syn/anti vinyl isoxazolidines 293a and 
293b (Scheme 114). The mixture was then submitted to carbonylation under the carbon 
monoxide atmosphere to give a full conversion overnight into the corresponding α,β- 
unsaturated esters 295a and 295b in 75% isolated yield. 
 
 
Scheme 114 
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Further experiments showed that the 3-3.5:1 ratio of diastereoisomers remained constant for a 
variety of solvent compositions and temperatures and was accompanied by full conversions 
and 80-90% isolated yields. The best diastereoselectivity was obtained in the presence of 2 eq 
of PPh3 to give 11:1 syn/anti ratio but only in 25% isolated yield. A mixture of vinyl 
isoxazolidines was submitted to N-O bond cleavage by Mo(CO)6 and the diastereoisomeric N-
Boc protected amino alcohols 296a and 296b were isolated by chromatography in good yields 
(Scheme 115). 
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Scheme 115 
 
In order to expand the scope of this reaction, the nitrogen analogue 297 was synthesized and 
cyclised to afford the enantiopure pyrazolidine vinyl derivative 298 as a single 
diastereoisomer (Scheme 116).  
 
 
Scheme 116 
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Formation of the multisubstituted izoxazolidines, pyrazolidines, and imidazolidines 299 has 
been intensively investigated by White, Stahl and others (Figure 11).103 The methodology 
presented in this work provides a complementary contribution towards these highly sought 
after chiral heterocycles. 
 
Figure 11 
 
Other interesting developments were observed when the alcohol derivative cannot form five- 
or six-membered rings. When terminal olefin is heated to 60 oC in the presence of Pd2+ in a 
mixture of acetonitrile and methanol under an atmosphere carbon monoxide, formation of α,β- 
unsaturated esters took place. The product was identical to the one that can be obtained by 
ruthenium-catalysed cross metathesis with methyl acrylate. This reaction was attempted with 
several other substrates (Scheme 117). Boc protected alcohol appeared to be the best but the 
reaction is poorly reproducible at this stage and will require more research and optimisation. 
 
 
 
Scheme 117 
 
When substrates that are unable to cyclise were submitted to the reaction in methanol and 
methyl orthoacete, the double bond of the olefin was doubly carbonylated. This type of 
transformation was previously reported by Stille and Ishii, where the compounds were 
obtained as part of complex mixtures.60c,104 In our case, the products were formed as nearly 
equimolar mixtures of syn and anti diastereoisomers with no other by-products present 
(Scheme 118).     
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Scheme 118 
 
Palladium is well known for participating in a variety of complexes with phosphines, N-
heterocyclic carbenes, amines, DMF, carbon monoxide, nitriles and isocynanates. Application 
of these ligands leads to dramatic changes in the catalyst activity and may switch the reaction 
pathways.57 The initial results presented in Scheme 117 and 118 are encouraging and give 
warrant for further investigation.   
 
Conclusions 
 
An efficient, chemo- and diastereo-selective methodology for the synthesis of chiral 
isoxazolidines and β-amino-δ-hydroxy esters was developed. Optimised reaction conditions 
were applied to the synthesis of a series of enantiopure compounds in consistently high 
isolated yields. In the course of the experiments, mechanistic probes shed light on the 
probable mechanism of diastereoselective aminocarbonylation. The scope of the reaction was 
expanded to hydrazines and substrates with internal double bonds. We developed a 
convenient method for the synthesis of vinyl substituted isoxazolidines and pyrazolidines. In 
addition, we have accomplished some preliminary work on the synthesis of α,β-unsaturated 
esters from terminal olefins and double carbonylation of the terminal double bond.   
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3. Oxidation of linear homoallylic alcohols with singlet oxygen as a versatile route to 
diastereo and enantiopure 2-deoxypentose derivatives. 
 
3.1 Abstract 
 
Reported herein is a conceptually new synthetic route to enantiopure 2-deoxypentose 
derivatives using readily available non chiral starting materials and gaseous oxygen in the key 
step. Enantiopure alcohol 256 was prepared by the rearrangement developed by us and 
described in previous chapters, followed by TMS protection. The silyl ether 304 was then 
submitted to oxidation to yield hydroperoxide 305 as the main product. Further deprotection 
and reduction provided access to diastereopure diol 306, which was epoxidised in the next 
step. Treatment of 307 with a catalytic amount of a Lewis acid resulted in the epoxide 
opening to furnish 1-C substituted β-deoxyribose 308 (Scheme 119). 
 
 
 
Scheme 119 
 
The method developed by us has many advantages. The starting alcohol can be prepared in 
both enantiopure versions and the phenyl group can be replaced by most of the aliphatic and 
aromatic groups via an allyl transfer reaction. 
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3.2 Introduction (Literature Review) 
3.2.1 Physical Properties of Singlet Oxygen  
 
Singlet oxygen (1O2) is a higher energy state of molecular oxygen species. It is one of 
the most active intermediates involved in chemical and biochemical reactions.115 Singlet 
oxygen is an attractive oxidant due to its high reactivity, simple apparatus and procedures and 
that it grants an easy access to a variety of oxygen-containing products, e.g., alcohols, 
epoxides, etc. Allylic photo-oxygenation represents a useful and operationally simple process. 
Introduction of the oxygen functionality into alkenes by an ene reaction (Schenck reaction) 
may serve as a very useful, multi-purpose synthetic method.116 Increasing demand for 
stereoselective synthesis boosts its synthetic potential but the issues of stereo- and regio-
selectivity of singlet oxygen reactions require more detailed investigation.   
 
Oxygen is a triplet in its ground state, so it has two degenerated LUMOs containing 
one unpaired electron each. In this state oxygen exhibits diradical properties, however, is 
unreactive towards most organic compounds.117 The reason is that the substrates are usually in 
a singlet form, which makes the reaction with triplet oxygen spin-forbidden. That is why the 
reactions with oxygen in its ground form are kinetically blocked, despite having great 
thermodynamic potential.118 One way to make the oxygen react is to put it into an excited 
state. Oxygen has two major excited states and both are singlets. Table 12 shows the main 
physical properties of the singlet oxygen species. 
 
Table 12.  Molecular oxygen excited states and lifetimes 
 
States of the oxygen 
molecule 
Occupancy of 
highest orbitals 
 
Energy above 
ground state 
[kcal/mol] 
Lifetime 
Second excited state (1Σg+) ↑                      ↓ 37 10-12 s 
First excited state (1∆g) ↑↓ 22.4 10-4 s 
Ground state (3Σg−) ↑                      ↑ - stable 
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Briefly, the following processes are involved in the generation of singlet oxygen. 119  
 
Sen (S0) + hν  Sen (S1) 
Sen (S1)  Sen (T1) (intersystem crossing) 
Sen (T1) + 3O2  1O2 + Sen (S0) 
 
First, the photosensitiser (Sen) is excited from the ground singlet state to the excited singlet 
state. Then it undergoes an intersystem crossing to a longer-lived excited triplet state. When 
the photosensitiser and an oxygen molecule are in proximity, an energy transfer can take place 
that allows the photosensitiser to relax to its ground singlet state and create an excited singlet 
state oxygen molecule. The structures of dyes most commonly used as sensitisers are shown 
in Figure 12. 
 
 
Figure 12. Popular photosensitisers 
Most of the known photosensitisers are deeply coloured because their main absorption bands 
lie within the visible area. Visible light sources are convenient to apply and the energy of the 
photons is higher than for IR bands, which makes visible light more effective. On the other 
hand, it delivers considerably less energy than UV radiation, thus avoiding free radical side 
reactions in chlorinated solvents. Absorption spectra of the two commonly used 
photosensitisers are shown in Figure 13.131  
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Figure 13. Absorption bands for popular photosensitisers 
 
The key characteristic of a photosensitising agent is its quantum yield (Φ∆).122 The 
singlet oxygen quantum yield defines the number of molecules of 1O2 generated for each 
photon absorbed by the photosensitiser (Table 13). The higher the value of Φ∆  the more 
efficient the energy transfer. This is why not all of the compounds which exhibit an 
absorption in the desired area can be used as sensitisers in the singlet oxygen generation. 
 
Table 13. Quantum yields (Φ∆) and triplet state energies (ET) of the most common 
sensitisers.123 
Sensitiser Bengal rose Methylene blue TPP Fullerene 
Φ∆ 0.76 0.52 0.58 1.00 
ET (kJ/mol) 165 142 137 151 
 
The singlet oxygen molecule is relatively stable in the gas phase (up to several minutes) 
because its quenching is a slow, spin-forbidden radiative deactivation. Singlet oxygen 
luminescence was established in the gas and condensed phases where it decays to triplet 
state.124  
1O2  3O2 + hν    (1268 nm) 
 
2 1O2  2 3O2 + hν     (634 and 701 nm) 
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In the liquid phase, perturbations of the electronic structure of singlet oxygen caused by 
collisions with solvent molecules quench the 1O2 species. Radiationless process acquires 
partially allowed character, leading to enhancement of the variety of transitions in which 1O2 
decays. The decay rate constant increases exponentially with rising the vibration energy of the 
deactivating bond stretching in the solvent molecules in the series: C-Cl > C-D > O-D > C-H 
> O-H. 125 Dramatic change of quenching rate constants for different types of bonds in 
relation to the two exited oxygen states is illustrated in Table 14.  
 
Table 14.  Singlet oxygen quenching in           Table 15. Singlet oxygen quenching in                      
liquid phase                                                                                gas phase                                               
Type of bond 
 
1∆g 
quenching 
M-1s-1 
1Σg+ 
quenching 
M-1s-1 collider 
1Σg+ 
quenching 
M-1s-1 
O-H 2900 1.5×109 He <0.6 
N-H 1530 4.7×108 Ne ~ 0.6 
C-Haromatic 494 1.1×108 N2 7.8 
C-H 309 1.0×108 O2 9.0 
O-D 132 2.7×108 Ar 10.2 
C-Daromatic 21.7 5.3×107 Kr 21.6 
C-D 10.4 3.3×107 SF6 26.4 
C=S 0.35 1.6×106 SO2 31.8 
C-Faromatic 0.62 1.5×106 Xe 46.8 
C-F 0.05 5.6×105 PCl3 252 
C-Cl 0.18 1.6×105   
 
 By contrast, the quenching rate constants in the gas phase are up to eight folds lower (Table 
15).126  As a consequence, this results in an enormous solvent dependence, including a large 
isotope and heavy atom effect, on the lifetime of the O2 (1∆g) species. Variation in the lifetime 
for the typical solvents extends over five orders of magnitude, as illustrated in Table 16.127 
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Table 16.   Singlet oxygen lifetime in popular solvents 
 
Solvent 
 
Singlet oxygen 
lifetime (µs) 
Solvent 
 
Singlet oxygen 
lifetime  
H2O 3.1 Ethanol-D 230 µs 
Ethanol 12  CD3CN 600 µs 
Benzene 28  Acetone-D 690 µs 
Acetone 51 Benzene-D 700 µs 
CH3CN 56 (C2F2)2O 1.1 ms 
CH2Cl2 59 CDCl3 3.6 ms 
D2O 71 C6F6 9.4 ms 
CD2Cl2 120 CCl4 31 ms 
CHCl3 166 perfluorodecalin 300 ms 
 
3.2.2 Synthetic Applications of Singlet Oxygen – The Ene Reaction 
Most of the known reactions of singlet oxygen with alkenes can be divided into three 
main categories (Scheme 120).128 
- Conjugated dienes form 4+2 cycloaddiction products 310 
- Electron-rich olefins prefer 2+2 cycloaddition 311 
- Other alkenes undergo an ene reaction to give allylic hydroperoxides 312 
 
 
 
Scheme 120 
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Due to the direct relevance to our research programme, the chapter is mainly focused on the 
singlet oxygen ene reaction. It was first reported by Schenck in 1943129 and is generally called 
the Schenck reaction. In some sources it is also referred to as an indirect substitutive 
addition115 Allylic hydroperoxides 312 resulting from the ene reaction serve as versatile 
intermediates for further transformations (Scheme 121).  
 
Scheme 121. Application of the ene reaction products 
 
Alkene 313 reacts with singlet oxygen via the cyclic mechanism 314 and then forms allylic 
hydroperoxides 315 that can further undergo the following reactions: 
 
- Reduction of allylic peroxides leading to allylic alcohols 316a 
- Ti(IV) catalysed epoxidation furnishing epoxy alcohols 316b 
- Dehydration leading to enones 316c 
 
There are several hypotheses regarding the ene reaction mechanism involving 
different transition states and pathways of the transformation.115 Two major theories consider 
either a concerted pathway via a six-membered pericyclic transition state 322130 or a stepwise 
mechanism via perepoxide-like 321131 or biradical 319132 intermediates. Kinetic data133 clearly 
support the stepwise mechanism but the absence of the Markovnikov directing effect134 
contradicts the biradical or zwitterionic 320 intermediates (Scheme 122).   
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Scheme 122. Possible ene reaction mechanisms 
Since singlet oxygen is a highly reactive oxidant that easily undergoes reactions with a wide 
range of substrates, selectivity control in these transformations is essential for practical 
synthesis applications. The major problem of the Schenck reaction is its poor regioselectivity. 
When a given substrate has several allylic protons available, abstraction usually takes place at 
all possible sites leading to complex mixtures of isomeric products. This problem has been 
studied intensively over the past years and several empirical rules have been proposed to 
predict the regioselectivity of the reactions for a variety of substrates.115 
  
The preference for hydrogen abstraction from the cis-positioned groups in trisubstituted 
alkenes is usually called the “cis effect”. It was interpreted as a consequence of the concerted 
rather than the stepwise diradical mechanism.135 To understand the reasons for this behaviour, 
two possible transition structures for the attack of 1O2 on the substituted alkene should be 
considered. Mechanistic investigation by Singleton and co-workers136 suggested that the 
transition state leading to the reaction of one of the initially cis-methyl groups 325 is preferred 
over 326 for a number of reasons (Scheme 123). Attachment of the singlet oxygen to the 
olefinic carbons is synchronous with coordination to both methyl protons. The double bonds 
are perpendicular to each other and the transition state 325 is highly symmetric. By contrast, 
in the alternative TS structure 326 the oxygen interaction with the trans-methyl group is less 
favourable. The transition state 326 is an analogue to the later stage of cis-protons attack 
represented by structure 325. Lack of symmetry in structure 326 makes it eventually higher in 
energy by 2.8 kcal/mol compared to 325. 
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Scheme 123. ”Cis effect” rationalisation  
The simplest example of this “cis effect” is the reaction of deuterated alkene 328 (Scheme 
124), where 93% of the products result from the proton abstraction from the initially cis- 
methyl groups (329 and 330), while formation of 331 is clearly disfavoured (Note, that the 
H/D isotope effect in the singlet oxygen ene reaction is negligible because the rate limiting 
step is the formation of the intermediate peroxyepoxide).137 Scheme 124 also gives examples 
of how the structure of the substrate determines the site of hydrogen abstraction in more 
complex molecules.138 The percentage value indicates the position where protos is abstracted 
from, while peroxy group is formed on the opposite side of the double bond. 
 
 
 
Scheme 124. Examples of the ”cis effect”.  
 
Steric properties of the substrate are another important factor that affects the selectivity of the 
singlet oxygen ene reactions. Thus, Jefford and co-workers reported that the ratio of exo/endo 
hydroperoxides 334 and 336 formed by the photooxidation of 2-methylnorborn-2-ene 333 is 
reversed in the case of more bulky 7,7-dimethyl derivative 335 (Scheme 125).139 
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Scheme 125. Sterically controlled ene reaction 
The regioselectivity in the photooxygenation of trisubstituted alkenes 337 with large geminal 
groups in favour of hydroperoxide 339 suggests that the allylic protons next to the bulky alkyl 
substituent are more reactive. The regioselectivity was explained by examining the possible 
transition states 338 and 340 (Scheme 126).140 In the TS 340, which leads to the minor 
product, the repulsive non-bonding interactions between the oxygen atom and the large group 
also remain in the final structure 341. In the TS 338, where the hydrogen is removed from the 
carbon next to the large group, the repulsive interactions are weaker and product 339 is 
formed preferentially.  
 
 
 
Scheme 126. Large group effect - rationale 
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Several further examples of singlet oxygen ene reaction where regioselectivity is controlled 
by steric properties of the substituents are presented in Figure 14.138 
 
Figure 14. Large substituent effect – examples. 
 
The regiochemistry of the ene reaction is also influenced by the electronic properties of 
substituents. Thus, electrophilic heteroatoms favour hydrogen abstraction from the same side 
of the double bond (Figure 15).  
 
Figure 15. Directing effect of electrophilic heteroatoms.  
 
The regioselectivity in photooxygenation of vinylsilanes 345 and vinylstannanes 344 can be 
explained by the interaction between the negatively charged oxygen of the peroxyepoxide and 
the heteroatom bearing a partial positive charge.141 In the case of 344 and 345 the proton 
abstraction site is mainly influenced by the electronic factors (Figure 16), whereas the effect 
of the tert-butyl group in 343 is of steric origin (Scheme 126).  
 
 
 
Figure 16. Directing effect of silicon. 
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For the t-Bu, Me3Si-, and Me3Sn- substituents, steric and stereoelectronic effects are working 
in opposite directions, as follows:  
 
- Steric Effects: Me3Sn- < Me3Si- < t-Bu- 
- Electronic Effects: Me3Sn- > Me3Si- >> t-Bu- 
 
Further evidence of the electronic nature of the directing effect of the TMS group was 
obtained by reducing its steric influence by inserting an additional CH2 group (Figure 17). 
Thus, replacing t-butyl with TMS group led to the predicted reversal of regioselectivity in the 
ene reaction.116     
 
 
Figure 17. Directing effect of t-Bu and TMS groups in the allylic position. 
 
Stratakis and coworkers compared both the steric and electronic effects of the substituents in 
the homoallylic position.138 Increased distance between the double bond and the directing 
group dramatically diminished regioselectivity. The electronic influence of the hydroxy group 
in the remote position is rather weak, though some differences in the regioselectivity still 
remain compared with the corresponding alkenes (Figure 18).  
 
 
 
Figure 18. Directing effect in homoallylic position. 
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Thus, in the ene reaction of homoallylic alcohol 348 with singlet oxygen, the electronic 
repulsion between the hydroxyl group and the oxygen atom of the peroxyepoxide in the TS 
351 disfavours the formation of product 352.138 On the other hand, such a repulsive 
interaction is not present in the transition structure 349 leading to the major product 350 
(Scheme 127). 
 
Scheme 127. Ene reaction regioselectivity controlled by O-O repulsion. 
 
Diastereoselectivity is another important factor in the singlet oxygen ene reaction. In the 
allylic systems, the stereoelectronic effects of the substituent combined with the 1,3-allylic 
strain, e.g., in the case of a (Z)-methyl group, often gives rise to good anti 
diastereoselectivity.142 The repulsive effect can be either of steric or electronic origin. 
Diastereoselectivity controlled by steric effects is illustrated in Scheme 128.  
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Scheme 128. Ene reaction controlled by steric factors. 
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Figure 19. Steric interactions in the ene reaction. 
This selectivity can be rationalized in the Newman projection (Figure 17). The steric bias in 
the most favourable conformer blocks the oxygen approach from the upper face, resulting in 
the formation of the anti product. Nevertheless, steric control alone leads to only moderate 
disatereoselectivity. 
 
High diastereoselectivity was observed in the oxygenation of allylic alcohols. It was 
rationalised by the combined effect of hydrogen bonding and 1,3 allylic strain (Figure 20).115 
Here, the approach of the oxygen molecule is assisted by the OH group, while the steric strain 
determines the conformational preference.  
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Figure 20. Ene reaction controlled by hydrogen bond.   
 
Adam and coworkers investigated the photo-oxygenation of a series of chiral (Z)-allylic 
alcohols and amines in order to shed more light on the origin of the observed high syn 
selectivity. Thorough examination of all the steering factors led to a series of conclusions: 
The size of the aliphatic substituent at the stereogenic centre does not affect the reaction 
diastereoselctivity (Scheme 129).144 
 
 
 
Scheme 129. Syn-selectivity of ene reaction of allylic alcohols  
 
The presence of the 1,3-allylic strain is crucial for the selective oxidation of allylic alcohols. 
In the case of E double bond, as in substrate 363, where the strain is absent, both 
disatereoisomers are generated in the nearly equimolar ratio (Scheme 130).114b  
 
 
 
Scheme 130. Non-selective ene reaction of E allylic alcohols. 
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High syn preference applies also to other substituents capable of hydrogen-bonding with the 
approaching oxygen (Scheme 131).   
 
 
Scheme 131. Ene reaction controlled by hydrogen bonding. 
  
Removing the possibility of forming H-bonds by acetylation of both alcohol 367 and amine 
369 led to a dramatic loss of selectivity (Scheme 132). In the extreme case, when the amine 
was derivatised with two bulky groups 371, the pi-facial selectivity was reversed and the anti 
product 372b was isolated almost exclusively. In the absence of electronic interactions the 
stereoselectivity is controlled by steric factors (Figure 19). 
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Scheme 132. Impact of derivatisation on selectivity of the ene reaction of allylic amines and 
alcohols. 
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Solvent effect is another factor to influence the facial preference. High syn-selectivity for the 
allylic alcohols 373 is only achieved in the nonpolar chlorinated solvents (Table 17, entries 
1-3). However, in polar and protic solvents (entries 4 and 5), a significant loss of 
diastereoselectivity is observed. It is likely that the solvents capable of hydrogen bonding 
provide alternative stabilisation of the negatively charged oxygen atom in the intermediate 
peroxyepoxide, preventing the allylic hydroxyl group from the internal complexation.144 
 
Table 17.  Solvent effect. 
 
 
 
 
 
 
 
 
 
 
Taking into account the significant steering influence of the allylic hydroxyl group on the 
regio- and diastereo-selectivity of the ene reaction, the respective homoallylic analogues were 
also examined.138 However, the placing the extra carbon between the hydroxy group and the 
double bond had a negative effect on selectivity. Homoallylic alcohols 375 exhibited 
regioselectivities similar to simple alkenes in non-polar solvents (Figure 18). Substituent R at 
the stereogenic centre had little effect on the product distribution (Table 18).143,145 A similar 
drop of selectivity was observed for allylic hydroperoxides 378 (Scheme 133).143  
 
 
 
 
 
 
Entry Solvent Syn 374a Anti 374b 
1 CCl4 93 7 
2 CHCl3 92 8 
3 CH2Cl2 90 10 
4 CH3CN 76 24 
5 CH3OH 73 27 
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Table 18. Ene reaction of α-homoallylic alcohol  
 
 
 
R 
 
Diastereoselectivity 
376a : 376b 
Regioselectivity 
376 : 377 
Me 56 : 44 56 : 44 
Et 44 : 56 51 : 49 
t-Bu 49 : 51 58 : 42 
Ph 45 : 55 63 : 37 
 
 
Scheme 133 
 
The observed low regio- and diastereo-selectivities for homoallylic substrates can be 
explained by the lack of the allylic strain and loss of the directing effect typical for the allylic 
alcohols. The remote homoallylic position of the OH in both the homoallylic alcohols and 
allylic hydroperoxides, provides no appreciable bias in the pi-facial attack. The lack of 
stereocontrol can also be rationalised in terms of the reversible formation of perepoxide-like 
diastereoisomeric exciplexes 380-382 during the oxyfunctionalisation step (Figure 21).143 In 
these intermediates, formation of the 6-membered structure with the incoming singlet oxygen 
is essential for the high diastereoselectivity that is observed in the allylic systems (380, Figure 
21,), whereas in the exciplexes 381 and 382 coordination of the incoming oxygen proceeds 
via more flexible seven-membered transient species, thus reducing the steering control 
exercised by the OH group in hydroperoxides and homoallylic alcohols. This rationalisation is 
a direct analogy to the diastereoselectivity of the epoxidation process with use of both 
Sharpless and peroxyacids protocols (Scheme 148 and 149).   
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Figure 21 
 
The only known example of diastereoselective oxidation of homoallylic alcohols 383 with 
singlet oxygen was reported by Linker and Frohlich146 (Scheme 134). Exclusive formation of 
the anti-product 384b was possible in the case of sterically demanding substituents R. High 
selectivity was rationalised by the directing effect of the hydroxyl group supported by the 
repulsive steric interactions from the opposite face. 
 
 
 
Scheme 134 
 
Conclusion 
 
Singlet oxygen is regarded as powerful and versatile tool in organic synthesis. Numerous 
ways of controlling the selectivity of ene reaction of allylic systems were presented herein. 
Nevertheless its synthetic applications are severely limited when the directing group is in the 
more remote homoallylic position. Therefore development of a methodology for selective 
oxidation of homoallylic alcohols constitutes an interesting challenge. 
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3.3 Results and Discussion 
 
The aim of this project was to develop an efficient method for generating singlet oxygen and 
investigate stereoselective oxygenation of homochiral allylic and homoallylic alcohols by the 
Schenk ene reaction. As a secondary objective, we intended to employ the enantiopure 
intermediates obtained by this method in the synthesis of important carbohydrate analogues.   
 
3.3.1 Optimisation of the Ene Reaction  
 
According to the literature data,143 alcohols in both free and protected form, may serve as an 
efficient steering group to control regio- and stereo-selectivity of the singlet oxygen ene 
reaction. Therefore, chiral homoallylic alcohols with an (E)-internal double bond 256 were 
selected as model substrates for our investigation. They can be easily obtained in good yields 
and high enantioselectivity via the allyl-transfer reaction164 described in the previous chapters. 
This universal method provides access to a wide range of homoallylic alcohols with excellent 
enantiopurity (Scheme 135). Another advantage of this methodology is the possibility to 
synthesise both R and S alcohols selectively just by switching between Methox enantiomers. 
 
 
Scheme 135 
 
Alcohol 256 was subjected to an ene reaction with singlet oxygen. The experiment was 
conducted in dichloromethane with a 150W medium pressure mercury UV lamp as a light 
source and tetraphenylporphyrine (TPP) as photosensitiser.42 Irradiation for 36 h at room 
temperature afforded an inseparable mixture of all four possible peroxyalcohols 386a and 386b 
in equimolar quantities (Scheme 136). This outcome mirrored the results reported by Adam165 
for the analogous oxygenation of the isomeric (Z)-homoallylic alcohols.  
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Scheme 136 
 
In addition, we observed that UV irradiation was triggering numerous side reactions, resulting 
in the formation of unidentified by-products. It also led to an increased acidification of the 
reaction mixture over the time. The latter effect was manifested in the change of colour from 
purple to bright green, which could be rationalised by photodegradation of the chlorinated 
solvent under UV light to generate HCl.166 The green colour was assigned to the protonated 
form of the photosensitser, which appears to be inactive in this state. 
 
 
Therefore, to minimize decomposition, we switched to the generation of singlet oxygen under 
milder visible light irradiation.120 Importantly, the visible light sources are also safer and more 
convenient from the operational point of view. A sodium lamp, with the main band in the 
yellow light area (570-590 nm), was successfully used by Adam144b in various photooxidation 
reactions. Taking into account that TPP has its main absorption band in the blue and violet light 
area of the spectrum with wavelengths around 400-450 nm (Figure 11), a white light source 
should serve as a reasonable alternative to UV irradiation, delivering sufficient energy in the 
desired bandwidth. Indeed, irradiation of pinene, which was selected as a benchmark substrate, 
with a white light source under standard reaction conditions led to a quantitavive formation of 
pinocarvone (Scheme 34). Several different light sources were investigated and the results can 
be summarised as follows: 
 
- A sodium 400W lamp, a powerful light source, proved very efficient, however, it 
generated the amount of heat that was difficult to cope with. For this reason, it was not 
suitable for singlet oxygen reaction at sub-zero temperatures. However, it offered 
considerable advantages for large-scale preparations at ambient or elevated 
temperatures. 
- A high intensity discharge (HID) lamp benefits from very high luminous efficiency at 
low wattage. Low heat output makes it a perfect choice for low temperature 
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experiments. Reactions can be conducted at −20 oC, albeit at the expense of the reaction 
rate. Selectivity of the reaction shown in Scheme 137 remained poor even at −20 oC.   
- A portable 500W halogen lamp is a reliable, easy to use source of white light. It is 
characterised by a broad range of wavelengths emitted at high power output. This type 
of lamp is designed for continuous work avoiding overheating problems during long 
time irradiation without external cooling systems. 
- A panel of light-emitting diodes (LED), a light source presented by our collaborators 
from the University of Bath, exhibited superior performance in terms of reaction time, 
power efficiency and scaling up possibilities. At later stages, it was incorporated into 
the design of a flow reactor for generation of singlet oxygen.  
 
In further optimisation of the reaction conditions, the solvent was changed from 
dichloromethane to carbon tetrachloride. According to Table 16, in CCl4 the lifetime of singlet 
oxygen increased almost 500 times. Also, higher boiling point of CCl4 reduced solvent losses 
from the reaction vessel by evaporation, whereas its non-polar character does not disrupt any 
polar interactions that may develop between the reacting species (Table 16).  
 
The results shown in Scheme 136 indicate that the hydroxyl in the homoallylic position has 
little effect on product distribution. Therefore, we next considered derivatisation of the 
hydroxyl group to order to tune its directing effect. The choice of protecting group had to take 
into account the following factors: 
 
- Selectivity: The protecting group should favour a selective formation of 1,3 
peroxyalcohol isomer with preference for one diastereoisomer. 
- Separability: The resulting mixture of peroxyalcohol derivatives should be separable by 
standard laboratory techniques, e.g. flash chromatography.  
- Stability: The protecting group should be stable to oxidation under the reaction 
conditions and be a poor leaving group. 
- Solubility: As the reaction takes place in nonpolar solvents, ionic groups are excluded. 
- Easy protection/deprotection: The group must be easy to install and to remove, avoiding 
the use of any harsh conditions (temperature, acids) due to the presence of the benzylic 
stereogenic centre prone to racemisation. 
- Detectability: The group has to have a minimum footprint in 1H NMR spectroscopy to 
allow monitoring of the reaction and determining product ratios in crude product.  
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Taking into account a proven steering effect of the trimethylsilyl group (Figure 15, 16, 17, 
Scheme 127), we decided to investigate silyl ethers as possible protecting groups to improve 
the selectivity of the ene reaction. In the published examples, the ability of the silicon atom to 
direct singlet oxygen in the ene reaction is either of electronic origin163 or an interplay of steric 
and stereoelectronic factors.141b     
 
3.3.2 Oxygenation of TMS protected homoallylic alcohol 
 
We envisioned that the chiral silyl ether groups may enhance the regio- or diastereo-selectivity 
of the singlet oxygen reaction. Bulky protecting groups were expected to work in two different 
ways. Firstly, it may serve as a bulky substituent and, secondly, may interact via the 
electropositive silicon atom. Trimethylsilyl ether of the homoallylic alcohol 304 was obtained 
quantitatively by treatment of alcohol 256 with trimethylsilyl trifluoromethanesulfonate 
(Scheme 137).167 TMSCl can be also used but reaction is much slower and gives lower yields.  
 
 
Scheme 137. TMS protection of alcohol. 
 
An aliquot of TMS derivative 304 was deprotected with TBAF/THF and the resulting alcohol 
was analysed by chiral HPLC to confirm that no deterioration of enantiopurity was taking 
place. 
 
TMS derivative 304 was photooxidised at room temperature using a portable 500W halogen 
lamp (Scheme 138). A clean conversion was observed after 20-24h and the products were 
isolated in 85% overall yield. Analysis of the product mixture by 1H NMR spectroscopy 
revealed that regio and diastereoselectivity of the reaction improved substantially compared to 
the oxidation of the unprotected alcohol (Scheme 136). The product was identified as a mixture 
of 1,3- and 1,4-isomers, two diastereoisomers each, with a clear preference toward the anti 
product with the terminal double bond 387 (Scheme 138). The relative configuration of the 1,3-
regioisomers was later determined by the X-ray crystallographic analysis of their respective 
derivatives (vide infra).  
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Scheme 138. Oxygenation of TMS protected homoallylic alcohol. 
 
With the TMS protection in place, 1,3-diastereoisomers 387 and 388 were readily separable by 
flash chromatography on silica, whereas the pair of 1,4-diastereoisomers were eluted as an 
inseparable mixture of 389. The selectivity towards 1,3-regioisomers can be rationalised as 
follows (Scheme 139). A high degree of polarisation of the Si-O bond in the TMS protected 
alcohol places a large partial negative charge on the oxygen atom. As a result, repulsive 
interactions with the oxygen atom of peroxyepoxide 390 disfavour hydrogen abstraction from 
position 2 leading to a minor isomer. The same repulsion may also favour the approach of the 
singlet oxygen molecule from the opposite pi face leading to preference for the anti 
diastereoisomer 387. See also Schemes 126 and 127. 
 
 
Scheme 139. Mechanistic rationalisation of 1,3 –anti product preference.  
 
In order to assess the influence of the steric factor on the product ratio, we synthesised a series 
of silyl ethers with bulkier substituents 392 (dimethyltertbutylsilane) and 393 
(diphenyltertbutylsilane) (Scheme 140). 
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Scheme 140. Synthesis of sterically more demanding silyl ethers. 
 
However, the use of the more bulky substituents had little effect on the selectivity but led to 
substantial reduction in the rate of photooxygenation. These results may serve as evidence that 
it is the electronic rather than steric factors that play the major role in regio- and 
stereoselectivity.  In addition, synthesis of the two bulky silyl ethers also proved more difficult 
giving slow conversion and low yields 
 
In our initial experiments we aimed at exploring the atom-economic approach utilising the 
existing peroxyalcohol as a source of oxygen to form epoxyalcohol 394 diastereoselectively 
(Scheme 141). Intramolecular epoxidation of this type, mediated by complexes of Ti and V, 
was reported by Adam,178 who also observed high diastereoselectivity in the oxygen transfer. 
 
 
 
Scheme 141. Attempted intramolecular metal catalysed epoxidation. 
 
In our case, no reaction took place when VO(acac)2 was employed as a catalyst, whereas the 
use of VO(OiPr)3 gave a complex mixture with only traces of the desired product (Scheme 
141). 
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3.3.3 Synthesis and epoxidation of allylic diols 
 
As a potential synthetic application of the 1,3-allylic diols 396, we focused on the development 
of a synthetic approach towards a series of enantiomerically pure sugar derivatives 397 
(Scheme 142).   
 
 
Scheme 142. 
 
Asymmetric synthesis of unnatural C-nucleosides represents an interesting and timely 
challenge. There has been considerable interest in various analogues of C-nucleosides, because 
most of them show a broad spectrum of biological activity.105 Some of the naturally occurring 
C-nucleosides were recognized as antibiotic, antiviral and antitumor agents (Figure 22).106 
 
Figure 22 
 
These compounds mimic the action of regular nucleosides; however, the replacement of a C-N 
with a C-C linkage in C-nucleosides provides these compounds with impressive therapeutic 
lifetimes. C-Nucleosides appear to resemble their respective counterparts uridine or adenosine, 
which explains their activity. The C-C linkage, on the other hand, provides resistance towards 
the enzymatic degradation and therefore the half-life of these compounds is far greater than that 
of N-nucleosides.107 
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A large array of synthetic strategies toward C-nucleosides has been developed to date, and the 
compounds were used in a wide range of applications. In a recent review, Kočovský108 
summarised all synthetic approaches with their pros and cons, including an assessment of their 
applications and future prospects. According to this survey, the synthetic strategies fall in one 
of the five categories: 
 
(a) Connection of an appropriate functional group to the anomeric position of a preformed 
carbohydrate moiety, followed by construction of the aglycon unit;  
(b) connection of an appropriate functional group to a preformed aglycon, followed by 
construction of the carbohydrate moiety;  
(c) a direct coupling of a preformed carbohydrate moiety with an aglycon;  
(d) modification of an existing C-nucleoside; and  
(e) modular approaches.  
 
Synthesis of a carbohydrate moiety on the predefined aglycon, which is at the heart of our 
strategy (Scheme 143), clearly falls into the category (b) approach. These strategies are not very 
common, as they require construction of up to four contiguous stereogenic centres. Therefore, 
most of the known protocols describe synthesis of the racemic material or include a step where 
a chiral moiety is incorporated into the molecule.174 
 
An interesting carbene cycloaddition approach was developed recently by Fu and coworkers.112 
Asymmetric copper-catalysed cycloaddition of diazoester 399b to enone 399a leads to the 
dihydrofuran derivative 399d (Scheme 143). Reduction of the compound 399d affords sugar 
399f in 90% de  
 
 
Scheme 143 
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Stereoselective synthesis of tetrahydrofurans (and tetrahydropyrans) that can be regarded as a 
blueprint for the synthesis of dideoxy ribose derivative was developed by Carren (Scheme 
144).175 In this approach, succinic anhydride 400a was first opened with enantiopure (R)-
methyl-p-tolylsulfoxide, followed by esterification of the resulting acid. A highly 
diastereoselective reduction of 400b gave the hydroxysulfinyl ester in 98% de. Ester 400c was 
then transformed into ketone 400d via Weinreb amide, followed by reductive cyclization to 
afford the β-C-nucleoside structure 400f. 
 
 
 
Scheme 144 
Sharpless asymmetric epoxidation was successfully used in the synthesis of a series of 
unnatural L-hexoses.161 Sharples, Matsamune and coworkers used a reagent-controlled strategy 
employing four key reactions to obtain monosaccharides in eight possible configurations. The 
use of the opposite tartrate enantiomers and the presence of diverging intermediates provides a 
perfect control over all the stereogenic centres (Scheme 145).   
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Scheme 145 
 
A synthetic approach to carbohydrates using singlet oxygen chemistry was reported by Adam 
and co-workers: the ene reaction followed by epoxidation and opening of the epoxides 
furnished diastereoisomeric furans 402d and 402e (Scheme 146).164 The enantiopure starting 
homoallylic alcohol 402a was obtained by a lipase catalysed resolution of the racemates. 
Singlet oxygen reaction gave an equimolar mixture of diastereoisomers 402b and 402c, which 
were separated by chromatography at the diol stage.  
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Scheme 146 
 
In our strategy, removal of the TMS ether group in hydroperoxides 387 and 388 was followed 
by reduction of the peroxide moiety. Standard TBAF/THF deprotection of the silyl ether 
produced a mixture of peroxyalcohol 403 and reduced diol 404.168 The crude mixture was than 
treated with a triphenylphosphine (Scheme 147).165 Both reactions can be monitored by TLC 
and were found to proceed cleanly, without any by-product formation. 
 
 
Scheme 147 
 
Diols 404 and 406 were isolated in 76% and 70% yields over 2 steps as >20:1 and 16:1 dr, 
respectively. Discarding the mixed fractions after chromatography allowed us to substantially 
increase dr, compared with the starting compounds, with little loss of the product. 1H NMR data 
of these diols were in good agreement with the literature.165 
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Asymmetric epoxidation is a very useful methodology for introducing new stereogenic centres 
in the synthesis of chiral compounds. In our case, diols 404 and 406 already have a set of 
stereogenic centres. Therefore, we focused on a diastereoselective epoxidation employing non-
chiral reagents. For the allylic alcohols, the most widely used reagents are m-CPBA and 
complexes of transition metals (Ti, V) with an external oxidant. High diastereoselectivity in the 
epoxidation of allylic alcohols has been shown to be due to participation of the hydroxyl group 
in shaping up the transition structures, which ensure the epoxide is delivered from a single pi 
face.189  
 
For the organic peroxyacids, the selectivity is rationalised by a transition structure largely based 
on the "butterfly" mechanism proposed by Bartlett.151 The transition state involves the 
interaction of the electron-rich alkene 407 with an electrophilic peroxyacid. Formation of the 
hydrogen bond between the alcohol and the oxygen of the incoming oxidising reagent was 
proposed as the stereocontrolling factor. Peroxyacid is directed by the hydroxyl group and the 
six-memebered ring structure 408 provides its delivery to the syn face of the alkene (Scheme 
148). 
 
Scheme 148  
 
Numerous transition metals complexes were used as catalysts for epoxidations of a variety of 
alkenes by organic hydroperoxides. Very good results were also obtained with allylic 
alcohols.156 Transition metal catalysis exhibited exceptional reactivity combined with high 
regio- and diastereo-selectivity. It has been rationalised by coordination of the metal cation by 
both allylic alcohol and peroxide in the transition state. High reactivity towards an allylic 
moiety was demonstrated by Adam and Wirth in the epoxidation of 1-methylgeraniol.157 The 
metal catalysed epoxidation gave exclusively the 3,4-epoxide while m-CPBA resulted in almost 
equimolar mixture of the products from the reactions occurring at the both double bonds 
(Scheme 149).   
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Scheme 149 
 
In our project, both diols were epoxidised using the V(IV)/TBHP system and with m-CPBA in 
a toluene and dichloromethane respectively (Scheme 150). The best results of the epoxidation 
of the major anti diastereoisomer 404 are summarised in Table 19. 
 
 
 
Scheme 150 
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Table 19. Epoxidation of anti diol (404)a  
Entry Epoxidising 
reagent 
Solvent Crude 
product 
417:418 
Epoxide 
combined 
yield %a 
 419 
Yield %c 
1 VO(acac)2/TBHP Toluene 3 : 1 63 11 
2 VO(acac)2/TBHP CH2Cl2 4 : 1 58 10 
3 m-CPBA CH2Cl2 1 : 1 66 6 
aThe absolute configuration was deduced from the X-ray analysis of the cyclised products. bIsolated yield. cThe 
same ratio of diastereoisomers as for the epoxides. 
 
In all cases, epoxidation was complete overnight. The crude reaction mixture contained only 
traces of the cyclised THF products 419 but their amount increases during chromatographic 
purification on silica. Similar opening of epoxides by Lewis acidic silica gel was also observed 
by Adam and coworkers.163,169 
 
The results of the epoxidation of the syn diastereoisomer 406 (Scheme 151) are summarized in 
Table 20. 
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Scheme 151 
 
Table 20. Epoxidation of syn diola   
Entry Epoxidising  
agent 
Solvent Crude 
product 
420:421 
Epoxide 
combined 
Yield %b 
422 
Yield %c 
1 VO(acac)2/TBHP Toluene 3 : 1 38d 8 
2 m-CPBA CH2Cl2 1 : 2 48g 26 
 
a 
– absolute configuration deduced from the  X-ray analysis of the cyclised products; b – yield of the isolated 
product; c - the same ratio of diastereoisomers as for the epoxides, d – pure 420 was isolated in 10% yield, e – pure 
421 was isolated in 16% yield. 
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3.3.4 Intramolecular epoxide opening with a Lewis acid 
 
The epoxides were submitted to an intramolecular cyclisation mediated by a Lewis acid 
(Scheme 152, Table 21).170 The reaction proceeds smoothly and cleanly under mild conditions. 
The use of catalytic amount of BF3•Et2O as a Lewis acid in 30 minutes produced the desired 
products of 5-exo cyclisation. Desired product was obtained in good yields as mixtures of 1-
phenyl deoxyribose diastereoisomers.  Product composition reflected the ratio of the 
diastereoisomeric epoxydiols submitted for the reaction. We were able to isolate and identify all 
four configurational isomers of the 3-hydroxy-tetrahydrofurans (Scheme 152).  
 
 
Scheme 152 
 
Table 21.  Intramolecular cyclisation  
 
Entry Epoxide 
mixture  
Epoxides 
ratio 
Overall 
yield (%) 
Products after chromatography 
    Pure 
product 1 
(%) 
Pure 
product 2 
(%) 
Remaining 
mixture  
(%)b 
1 417 + 418 3 : 1 69 423 (49) - a  2 : 1 (20) 
2 417 + 418 1 : 1 71 423 (19) 424 (14) 1 : 1 (38) 
3 420 + 421 4 : 1 80 425 (20) 426 (7) 2.5 : 1 (53) 
4 420 + 421 1 : 3 68 425 (9) 426 (25) 1 : 3 (34) 
 
aTraces of 424 were detected but the isomer could not be isolated in a pure form. bSubmitted to further purification 
by recrystalisation. 
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In order to probe the suggested configurations for the products, we compared the 1H NMR 
pattern of our compounds with 3-hydroxy-tetrahydrofurans reported by Tamaru and 
coworkers.171 By recrystallisation from hexane and dichloromethane, we were also able to 
obtain X-ray quality crystals for the cyclic products 423 and 425. X-Ray crystallographic 
analysis, carried out by Dr Louis Farrugia, established the structures of 423 and 425 as (+)-
R,R,R (Figure 23) and (+)-R,S,S (Figure 24), respectively. These results also confirmed the 
structures of both starting diols. Diastereoisomer 426 (Scheme 152) was found to be identical to 
L-configured 1-phenyl-deoxyriboside, reported by Fu and co-workers,112 (Figures 25, 26), while 
the NMR spectra or the remaining structure 424 is considerably different (Figure 27). 
 
Figure 23. An ORTEP diagram for 423 
 
Figure 24. An ORTEP diagram for 425 
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Figure 23. L-deoxyribose derivative reported by Fu. 
 
 
Figure 24. D-deoxyribose derivative 426 – this work. 
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Figure 27. L-deoxyribose derivative 424 
 
3.3.5 Synthesis of 3-NHBoc THF derivative  
 
Unnatural C-nucleosides and sugars can be synthesised in a variety of configurations, as shown 
in the previous section. Herein, we report an alternative route to transform an α-homoallylic 
alcohol into 1,3-difunctionalised terminal alkenes, which can be further used to build a 3-
amino-tetrahydrofuran framework. 
 
In the previous chapter (Schemes 115 and 116), we described the palladium catalysed 
cyclisation of N-Boc alkoxyamines into the corresponding isoxazolidines, which can be 
formally viewed as a C-H activation (Scheme 115). Cleavage of the O-N bond in the 3.5:1 
mixture of 427a and 427b produced a mixture of the respective 1,3-aminoalcohols 428a and 
428b, which can be separated by flash chromatography (Scheme 154).  
 
 
Scheme 154 
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Epoxidation of the major syn isomer with the V(IV)/TBHP system proved unsuccessful, 
leading only to a small amount of conjugated ketone. On the other hand, epoxidation with m-
CPBA is known to be controlled by carbamate and amide groups.172 Desired product 430 was 
obtained in good yield and dr (Scheme 155). Only traces of the cyclised tetrahydrofuran were 
formed under the reaction conditions.   
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Scheme 155  
 
The mixture was then submitted to the standard Lewis acid catalysed cyclisation (Scheme 156). 
After flash chromatography on silica, the major diastereoisomer 431 was isolated in 43% yield 
along with 29% of a 1:1 mixture with the minor isomer. Its configuration was confirmed by 1H 
NMR spectroscopy.  
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Scheme 156   
Conclusions 
 
The singlet oxygen reagent was successfully applied to the oxidation of enantiopure 
homoallylic alcohols. A reasonable level of stereo and diasteroselectivity was achieved, 
accompanied by good yields and good separability of the products. Our initial studies showed a 
conceptually new route to highly enantioenriched, valuable 1-substituted sugars and possible C-
nucleosides. The simplicity of the method and the ability to produce all four possible 
diasteroisomers, deriving from a single chiral centre, are highly encouraging. Nevertheless 
some optimisations are clearly required.  
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4. Experimental 
 
General Methods. Melting points were determined on a Kofler block and are uncorrected. 
Optical rotations were recorded on automatic polarimeter RUDOLPH RESEARCH 
ANALYTICAL APV-6W, in CHCl3 at 25 °C unless otherwise indicated with an error of <±0.1. 
The [α]D values are given in 10-1 deg cm2 g-1. The NMR spectra were recorded on a BRUKER 
ULTRASHIELD 400 NMR spectrometer in CDCl3, 1H at 400 MHz, 13C at 100.6 MHz and 19F 
at 376 MHz with chloroform-d1 (δ 77.0, 13C), tetramethylsilane (δ 0.00, 1H), and 
trichlorofluoromethane (δ 0.00, 19F) as internal standards unless otherwise indicated. The IR 
spectra were recorded for CHCl3 solutions on a SHIMADZU FTIR-8400S spectrophotometer. 
The mass spectra (EI and/or CI) were measured on a dual sector JEOL JMS-700 mass 
spectrometer using direct inlet and the lowest temperature enabling evaporation. All reactions 
were performed under an atmosphere of dry, oxygen-free argon in oven-dried glassware twice 
evacuated and filled with the argon. Solvents and solutions were transferred by syringe-septum 
and cannula techniques. Solvents for the reactions were of reagent grade and were dried; 
acetonitrile was distilled immediately before use from calcium hydride, THF was obtained from 
Pure-Solv™ Solvent Purification System (Innovative Technology) and DMPU was dried with 
molecular sieves (4Å) which were activated at 300 °C. The enantiomeric purity was determined 
by using chiral HPLC (HP AGILENT 1100 SERIES) and GC (HP GC SYSTEM 6890 
SERIES) techniques (for alcohols) and by 19F or 1H NMR measurements of Mosher derivatives. 
 
Method A: Synthesis of β-substituted conjugated aldehydes.45 Water (2 mL) was added to a 
solution of (triphenylphosphoranylidene)acetaldehyde (1.33 g, 4.37 mmol) in THF (15 mL) and 
the solution was stirred at room temperature for 40 min. Dihydrocinnamaldehyde (418 mg, 3.12 
mmol) was then added dropwise and the solution was subsequently heated at 42 ºC and stirred 
for 18 h. The reaction was quenched with satd aqueous NaHCO3, the product was extracted 
with ethyl acetate (3 × 50 mL) and the organic solution was dried with Na2SO4 and evaporated. 
The crude product was purified by chromatography on a column of silica gel (15 × 2 cm) with a 
mixture of petroleum ether and ethyl acetate (97:3). 
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(E)-5-Phenylpent-2-enal (100g). Yellowish oil (326 mg, 64%): 1H NMR (400 MHz, CDCl3) δ 
2.56-2.62 (m, 2H), 2.75 (t, J = 7.6 Hz, 2H), 6.06 (ddt, J = 15.6, 7.9, 1.5 Hz, 1H), 6.77 (dt, J = 
15.6, 6.7 Hz, 1H), 7.10-7.25 (m, 5H), 9.41 (d, J = 7.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
34.1 (CH2), 34.2 (CH2), 126.4 (CH), 128.4 (CH), 128.6 (CH), 133.4 (CH), 140.3 (C), 157.3 
(CH), 194.0 (CH); MS (EI) m/z (%) 161 (M+, 22), 130 (17), 117 (87), 105 (18), 91 (100), 83 
(55), 65 (52); HRMS (EI) 160.0887 (C11H12O+ requires 160.0888). 
 
Method B: Synthesis of α-substituted conjugated aldehydes.44 A 37% aqueous solution of 
formaldehyde (5.47 mmol) and the appropriate aldehyde (6.02 mmol) were added 
consecutively to a solution of pyrrolidine (0.55 mmol) and benzoic acid (1.1 mmol) in CH2Cl2 
(4 mL) at room temperature. The mixture was then heated rapidly to 45 ºC and stirred for 2 h at 
this temperature. The reaction was quenched with satd aqueous NaHCO3, the product was 
extracted with ethyl acetate (3 × 20 mL), and the organic solution was dried with Na2SO4 and 
evaporated. The crude product was purified by chromatography on a column of silica gel (15 × 
2 cm) with a mixture of petroleum ether and ethyl acetate (99:1). 
 
 
 
2-Benzylacrylaldehyde (100e). Colourless oil (722.5 mg, 91%): 1H NMR (400 MHz, CDCl3) 
δ 3.49 (s, 2H), 5.99 (s, 1H), 6.03 (s, 1H), 7.10-7.24 (m, 5H), 9.53 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 34.2 (CH2), 126.5 (CH), 128.6 (CH), 129.2 (CH), 135.2 (CH2), 138.2 (C), 149.8 (C), 
194.0 (CH); IR ν 3055, 1689, 1427, 1265, 956, 705 cm-1; MS (CI/isobutane) m/z (%) 147 
[(M+H)+, 10], 113 (5), 89 (100), 85 (21), 69 (27); HRMS (CI/isobutane) 147.0807 (C10H10O + 
H+ requires 147.0810).  
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(R)-(-)-3,7-Dimethyl-2-methyleneoct-6-enal (100j). Colourless oil (164 mg, 55%): [α]D -5.9 
(c 2.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.99 (d, J = 6.9 Hz, 3H), 1.31 (ddt, J = 13.4, 9.0, 
6.9 Hz, 1H), 1.41-1.50 (m, 1H), 1.49 (s, 3H), 1.59 (s, 3H), 1.76-1.93 (m, 2H), 2.63 (sext, J = 
6.9 Hz, 1H), 5.03-5.7 (m, 1H), 5.91 (s, 1H), 6.15 (s, 1H), 9.50 (s, 1H); 13C NMR (100 MHz, 
CDCl3) δ 17.7 (CH3), 19.6 (CH3), 25.7 (CH2), 25.8 (CH3), 31.0 (CH), 35.6 (CH2), 124.2 (CH), 
131.7 (C), 133.1 (CH2), 155.5 (C), 194.7 (CH); MS (CI/isobutane) m/z (%) 167 [(M+H)+, 100], 
149 (30), 123 (26), 109 (42), 81 (39), 69 (59); HRMS (CI/isobutane) 167.1440 (C11H18O + H+ 
requires 167.1436) 
 
Method C: General Procedure for the Reaction of Allyltrichlorosilane and 
Crotyltrichlorosilane with Aldehydes.  An oven-dried flask was filled with argon and charged 
with (+)-Methox or (R)-(+)-Quinox (0.075 mmol), followed by acetonitrile (5 mL, in the case 
of Methox) or dichloromethane (5 mL in the case of Quinox), diisopropylethylamine (478 mg, 
3.7 mmol), and aldehyde (0.75 mmol). The mixture was then cooled to -45 ºC and 
allyltrichlorosilane or crotyltrichlorosilane (1.10 mmol) was added dropwise. The mixture was 
stirred at -45 ºC for 4 h and then it was kept in a freezer at -30 ºC for 5 days. The reaction was 
quenched with satd aqueous NaHCO3, the product was extracted with ethyl acetate and the 
organic solution was dried with MgSO4 and evaporated The crude product was purified by 
chromatography on a column of silica gel (15×1.5 cm) with a mixture of petroleum ether and 
ethyl acetate (95:5). In all cases the conversions were ≥95%, as revealed by GC and NMR 
analysis of the crude mixtures. The isolated yields of alcohols and ee are given in Table 7. The 
enantiopurity of the resulting alcohol was determined by chiral GC, or HPLC, or by Mosher 
derivatization (see below).  
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(S,E)-(-)-1-Phenylhexa-1,5-dien-3-ol (103a). Method C, starting from cinnamyl aldehyde, 
afforded 103a as a yellowish oil (445 mg, 75%): [α]D -25.6 (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 1.72 (br d, J = 4.0 Hz, 1H), 2.27-2.41 (m, 2H), 4.29 (m, 1H), 5.08-5.15 (m, 
2H), 5.74-5.84 (dddd, J = 17.1, 10.2, 7.4, 6.9 Hz, 1H), 6.17 (dd, J = 15.9 and 6.3 Hz, 1H), 6.54 
(d, J = 15.9 Hz, 1H), 7.15-7.33 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 42.0 (CH2), 71.7 (CH), 
118.5 (CH2), 126.5 (2 × CH), 127.7 (CH), 128.6 (2 × CH), 130.4 (CH), 131.6 (CH), 134.1 
(CH), 136.7C); IR ν 3371, 3070, 3026, 2926, 2850, 1495, 1449, 1217, 1030, 997, 966, 916, 
748 cm-1; MS (CI/isobutane) m/z (%) 157 (M - OH, 100), 133 (24); HRMS (CI/isobutane) 
157.1016 (C12H13 requires 157.1017), all identical to the data of an authentic sample of the (+)-
enantiomer;37a HPLC analysis (Chiralcel IB column, hexane/2-propanol = 97:3, 0.75 mL min-1) 
showed 88% ee (tR = 18.5 min, tS = 27.7 min). 
 
 
(4S,5E,7E)-(-)-8-Phenyl-1,5,7-octatrien-4-ol (103b). Method C, starting from (2E,4E)-5-
phenylpenta-2,4-dienal, afforded 103b as a yellowish oil (183.7 mg, 73%): [α]D -23.6 (c 1.0, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.65 (d, J = 4.0 Hz, 1H), 2.23-2.37 (m, 2H), 4.19-4.25 
(m, 1H), 5.08-5.14 (m, 2H), 5.72-5.82 (m, 2H), 6.35 (dd, J = 15.2, 10.5 Hz, 1H), 6.47 (d, J = 
15.7 Hz, 1H), 6.70 (dd, J = 15.5, 10.6 Hz, 1H), 7.13-7.36 (m, 5H); 13C NMR (100MHz, 
CDCl3) δ 42.0 (CH2), 71.4 (CH), 118.5 (CH2), 126.4 (2 × CH), 127.6 (CH), 128.2 (CH) 128.6 
(2 × CH), 130.8 (CH), 132.8 (CH), 134. 0 (CH), 135.6 (CH), 137.2 (C); IR ν 3364, 3078, 3024, 
2905, 1641, 1492, 1447, 1297, 1071, 1026, 986, 914, 746, 691 cm-1; MS (CI/isobutane) m/z 
(%) 183 (M – OH, 100), 159 (10), 107 (15), 81 (10), 73 (10); HRMS (CI/isobutane) 183.1172 
(C14H14 + H+ requires 183.1168), all in accordance with the literature data given for the 
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racemate;179 HPLC analysis (Chiralcel OD-H column, hexane/ 2-propanol 96:4, 0.75 mL min-
1) showed 88 % ee tR= 18.54 min, tS = 22.78 min).  
 
 
 
(4S,5E,7E)-(–)-1,5,7-Nonatrien-4-ol (103c). Method C, starting from (2E,4E)-hexa-2,4-dienal, 
afforded 103c  as a yellowish oil (151 mg, 42%): [α]D -7.7 (c 1.8, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 1.67 (d, J = 3.9, 1H), 1.76 (dd, J = 6.7, 1.2 Hz, 3H), 2.25-2.38 (m, 2H), 4.16-4.22 (m, 
1H), 5.11-5.17 (m, 2H), 5.57 (dd, J = 15.2, 6.6 Hz, 1H). 5.71 (dd, J = 15.0, 6.8 Hz, 1H), 5.80 
(dddd, J = 17.0, 10.3, 7.4, 6.8 Hz, 1H), 6.04 (ddd, J = 15.1, 10.5, 1.5 Hz, 1H), 6.20 (dd, J = 
15.1, 10.4 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 18.2 (CH3), 42.0 (CH2), 71.5 (CH), 118.3 
(CH2), 130.2 (CH), 130.7 (CH), 131.0 (CH), 132.3 (CH), 134.2 (CH); IR ν 3362, 3078, 3018, 
2916, 1435, 1261, 1025, 985, 913 cm-1; MS (EI+) m/z (%) 138 (M+, 23), 97 (100), 79 (41); 
HRMS (EI+) 138.1048 (C9H14O requires 138.1045), in agreement with the literature;181 19F 
NMR of the corresponding Mosher ester showed ≥86% ee (δR = -71.47, δS = -71.53). 
 
 
(4S,5E)-(-)-1,5-Nonadien-4-ol (103d). Method C, starting from (E)-hex-2-enal, afforded 103d 
as a yellowish oil (244 mg, 68%): [α]D -14.1 (c 1.00, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
0.90 (t, J = 7.4 Hz, 3H), 1.40 (sext, J = 7.4 Hz, 2H), 1.63 (br s 1H), 1.95 (q, J = 7.1 Hz, 2H), 
2.23-2.36 (m, 2H), 4.12 (q, J = 6.3 Hz, 1H), 5.10-5.16 (m, 2H), 5.48 (ddd, J = 15.4, 6.7, 1.4 Hz, 
1H), 5.61 (dt, J = 15.4, 6.7 Hz, 1H), 5.80 (dddd, J = 17.1, 10.4, 7.4, 6.8 Hz, 1H); 13C NMR 
(100MHz, CDCl3) δ 13.7 (CH3), 22.3 (CH2), 34.3 (CH2), 42.1 (CH2), 71.9 (CH), 118.0 (CH2), 
132.1 (CH), 132.2 (CH), 134.5 (CH); IR ν 3433, 3414, 3333, 2960, 2930, 2911, 2873, 1436, 
1261, 1027, 995, 968, 914 cm-1; MS (CI/isobutane) m/z (%) 123 (M - OH, 100), 113 (5), 99 
(45), 81 (20), 67 (10); HRMS (CI/isobutane) 123.1160 (C9H15 requires 123.1174), in 
agreement with the literature;180 19F NMR of the corresponding Mosher ester showed 87% ee 
(δR = -71.46, δS = -71.51). 
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(S,E)-(-)-8-Phenylocta-1,5-dien-4-ol (103e). Method C, starting from (E)-5-phenylpent-2-enal, 
afforded 103e as a light yellow oil (78 mg, 49%): [α]D -12.5 (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 2.13-2.25 (m, 2H), 2.24-2.31 (m, 2H), 2.62 (dd, J = 8.1, 7.4 Hz, 2H), 4.03 (br 
q, J = 6.3 Hz, 1H), 5.02-5.07 (m, 2H), 5.42 (tdd, J = 15.4, 6.7, 1.3 Hz, 1H), 5.63 (dtd, J = 15.4, 
6.7, 0.9 Hz, 1H), 5.70 (dddd, J = 18.0, 10.6, 7.3, 6.8 Hz, 1H), 7.09-7.13 (m, 3H), 7.17-7.22 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 32.9 (CH2), 34.5 (CH2), 40.9 (CH2), 70.7 (CH), 117.1 
(CH2), 124.8 (CH), 127.3 (2 × CH), 127.4 (2 × CH), 130.1 (CH), 131.8 (CH), 133.3 (CH), 
140.7 (C); IR ν 3315, 3055, 2932, 1435, 1265, 972, 918, 708 cm-1; MS (CI/isobutane) m/z (%) 
185 (M - OH, 100), 161 (43), 142 (81), 117 (19), 91 (16), 81 (9); HRMS (CI/isobutane) 
185.1327 (C14H17 requires 185.1330); HPLC analysis (Chiralcel OJ-H column, 
hexane/isopropanol 95:5, 0.75 mL min-1) showed 89% ee (tR = 14.8 min, tS = 17.1 min). 
 
 
(S)-(-)-2-Benzylhexa-1,5-dien-3-ol (103f). Method C, starting from 100e, afforded 103f as a 
colourless oil (68 mg, 46%): [α]D -3.2 (c 0.5, CHCl3);  1H NMR (400 MHz, CDCl3) δ 1.63 (d, J 
= 3.8 Hz, 1H), 2.23 (dt, J = 14.2, 7.7 Hz, 1H), 2.32-2.38 (m, 1H), 3.27 (d, J = 15.6 Hz, 1H), 
3.41 (d, J = 15.6 Hz, 1H), 4.04-4.08 (m, 1H), 4.73 (d, J = 1.2 Hz, 1H), 5.05 (d, J = 1.2 Hz, 1H), 
5.05 (br s, 1H), 5.07-5.10 (m, 1H), 5.09 (d, J = 1,2 Hz, 1H), 5.67-5.77 (m, 1H), 7.12-7.25 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ 39.2 (CH2), 40.4 (CH2), 73.2 (CH), 112.4 (CH2), 118.4 
(CH2), 126.4 (CH), 128.5 (2 × CH), 129.3 (2 × CH), 134.6 (CH), 139.3 (C), 150.6 (C); IR ν 
3321, 3055, 2924, 1435, 1265, 910, 740 cm-1; MS (CI/isobutane) m/z (%) 171 (M – OH, 47), 
129 (20), 113 (21), 97 (27); HRMS (CI/isobutane) 171.1177 (C13H15 requires 171.1174); chiral 
GC analysis (Supelco β-DEX 120 column, oven at 100 °C for 2 min then 1 oC min-1) showed 
88% ee for the Methox experiment carried out at -45 oC, 70% ee for the Methox experiment 
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carried out at -30 oC, and 80% ee (opposite enantiomer) for the (R)-(+)-Quinox experiment 
carried out at -30 oC (tR = 50.14 min, tS = 50.49 min).  
 
 
(S)-(-)-2-Ethyl-1,5-hexadien-3-ol (103g). Method C, starting from 2-methylenebutanal, 
afforded 103g as a yellowish oil (215 mg, 48%): [α]D -30.3 (c 1.0, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 1.08 (t, J = 7.4 Hz, 3H), 1.68 (d, J = 3.9 Hz, 1H), 2.02 (dq, J = 16.5, 7.4 Hz, 
1H), 2.13 (dq, J = 16.3, 7.5 Hz, 1H), 2.28 (dt, J = 14.2, 7.7 Hz, 1H), 2.37-2.44 (m, 1H), 4.12-
4.16 (m, 1H),  4.87 (d, J = 1.4 Hz, 1H), 5.05 (t, J = 1.1 Hz, 1H), 5.11-5.18 (m, 2H), 5.80 (dddd, 
J = 17.1, 10.2, 7.4, 6.8 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 12.2 (CH3), 24.4 (CH2), 40.4 
(CH2), 74.0 (CH), 108.5 (CH2), 118.1 (CH2), 134.7 (CH), 152.7 (C); IR ν 3380, 3078, 3025, 
2931, 1641, 1434, 1297, 989, 915, 748, 692 cm-1; MS (CI/isobutane) m/z (%) 1109 (M - OH, 
100), 95 (19), 85 (30); HRMS (CI/isobutane) 109.1019 (C8H13 requires 109.1017); GC 
analysis (Supelco γ-DEX 120 column, oven: 50 °C for 2 min, then 0.5 °C min-1 to 70 °C) 
showed 89% ee (tR = 36.06 min, tS = 36.44 min).  
 
 
(4S,5E)-(-)-5-Methyl-1,5-octadien-4-ol (103h). Method C, starting from (E)-2-methylpent-2-
enal, afforded 103h as a colourless oil (196 mg, 65%): [α]D -11.6 (c 0.9, CHCl3); 1H NMR (400 
MHz, CDCl3) δ 0.96 (t, J = 7.5 Hz, 3H), 1.61 (s, CH3 and OH), 2.03 (quintet, J = 7.4 Hz, 2H), 
1.99-2.38 (m, 2H), 4.01-4.05 (m, 1H), 5.07-5.15 (m, 2H), 5.40 (dt, J = 7.1, 1.1 Hz, 1H), 5.76 
(dddd, J = 17.2, 10.2, 7.3, 6.9 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 11.5 (CH3), 14.0 (CH3), 
20.8 (CH2), 39.9 (CH2), (CH), 117.6 (CH2), 128.5 (CH), 134.9 (CH), 135.7 (C); IR ν 3369, 
2963,2934, 2874, 1641, 1125, 1066 cm-1; MS (CI/isobutane) m/z (%) 123 (M - OH, 100), 99 
(15), 81 (10), 69 (10); HRMS (CI/isobutane) 123.1167 (C9H15 requires 123.1168); GC analysis 
(Supelco γ-DEX 120 column, oven: 70 °C, then 0.5 °C min-1 to 90 °C) showed 93% ee (tR = 
32.52 min, tS = 33.62 min).  
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(S)-(-)-(1’-Cyclohexen-1’-yl)but-3-en-1-ol (103i). Method C, starting from cyclohex-1-
enecarbaldehyde, afforded 103i as a colourless oil (73 mg, 37%): [α]D -17.5 (c 1.0, CHCl3); 1H 
NMR (400 MHz; CDCl3) δ 1.50-1.71 (m, 4H + 1H (OH)), 1.89–1.96 (m, 1H)], 1.98-2.11 (m, 
3H), 2.25-2.38 (m, 2H), 3.94 (t, J = 6.5 Hz, 1H), 5.02-5.08 (m, 2H), 5.61 (br s, 1H), 5.72 (dddd, 
J = 17.1, 10.2, 7.4, 6.8 Hz, 1H); 13C NMR (100MHz, CDCl3) δ 22.62 (CH2), 22.63 (CH2), 23.9 
(CH2), 25.0 (CH2), 39.9 (CH2), 75.2 (CH), 117.7 (CH2), 123.1 (CH), 135.0 (C), 139.2 (CH); IR 
ν 3347, 2926 2858, 2837, 1641, 1298, 1269, 1137, 1030 cm-1; MS (CI/isobutane) m/z (%) 135 
(M - OH, 35), 113 (57), 107 (90), 97 (40), in agreement with the literature;182 19F NMR of the 
corresponding Mosher’s ester showed 83 % ee (δR  = -71.32 ppm and δS = -71.57 ppm ). 
 
(4S,6S)-(+)-6,10-Dimethyl-5-methyleneundeca-1,9-dien-4-ol (103k). Method C, starting from 
(S)-3,7-dimethyl-2-methyleneoct-6-enal, afforded 103k as a colourless oil (55 mg, 57%): [α]D 
+7.5 (c 0.5, CHCl3); 1H NMR (400 MHz, CDCl3, main diastereoisomer) δ 1.08 (d, J = 6.9 Hz, 
3H), 1.30-1.40 (m, Hz, 1H), 1.49 (ddt, J = 15.7, 8.9, 6.7 Hz, 1H), 1.59 (s, 3H), 1.69 (br s, 4H), 
1.84-1.92 (m, 2H), 2.02 (sxt, J = 6.9 Hz, 1H), 2.18 (br pent,  J = 6.9 Hz, 1H), 2.31-2.38 (m, 
1H), 4.01-4.05 (m, 1H),  4.85 (s, 1H), 5.00-5.12 (m, 4H), 5.75 (dddd, J = 17.0, 10.3, 7.5, 6.8 
Hz, 1H); 13C NMR (100MHz, CDCl3; δ 17.7 (CH3), 20.7 (CH3), 25.7 (CH3), 25.9 (CH2), 35.4 
(CH), 37.4 (CH2), 40.8 (CH2), 73.3 (CH), 107.8 (CH2), 118.1 (CH2), 124.4 (CH), 131.6 (C), 
134.8 (CH), 157.1 (C); IR ν 3389, 3077, 2965, 2916, 2857, 1642, 1452, 1437, 1377, 1109, 
1047, 901 cm-1; MS (CI/isobutane) m/z (%) 209 [(M+H)+, 9], 191 (M-OH, 100), 167 (16) 149 
(24), 135 (58), 124 (15), 109 (31), 95 (41), 81 (28); HRMS (CI/isobutane) 209.1901 (C14H25O 
requires 209.1905).  
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(3S,4R,E)-(-)-3-Methylnona-1,5-dien-4-ol (104). Method C, starting from (E)-hex-2-enal, 
afforded 104 as a colourless oil (103 mg, 67%): [α]D -3.3 (c 1.0, CHCl3); 1H NMR (400 MHz, 
CDCl3) δ 0.90 (t, J = 7.4 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 1.34-1.47 (m, 2H), 1.73 (br s, 1H), 
1.96-2.10 (m, 2H), 2.17-2.26 (m, 1H), 3.79 (t, J = 7.3 Hz, 1H), 5.05-5.10 (m, 2H), 5.42 (tdd, J 
= 15.4, 7.5, 1.3 Hz, 1H), 5.60 (dt, J = 15.4, 6.7, 1H), 5.69 (ddd, J = 16.7, 10.8, 8.2 Hz, 1H); 13C 
NMR (100MHz, CDCl3) δ 13.8 (CH3), 16.3 (CH3), 22.4 (CH2), 34.5 (CH2), 44.7 (CH), 76.5 
(CH), 116.5 (CH2), 130.8 (CH), 133.8 (CH), 140.8 (CH); IR ν 3385, 2957, 2925, 2855, 
1639,1260, 1015 cm-1; MS (CI/isobutane) m/z (%) 137 (M - OH, 35), 91 (49), 69 (100); HRMS 
(CI/isobutane) 137.1307 (C10H17 requires 137.1330); GC analysis (Supelco α-DEX 120 
column, oven: 50 ºC, then 1 ºC min-1) showed 36:1 dr and 96% ee for the major enantiomer 
(t3S,4R = 43.21 min, t3R,4S = 43.62 min).  
 
 
(1S,2S)-(-)-2-Methyl-1-phenyl-but-3-en-1-ol (127). Method C, starting from benzaldehyde, 
afforded 127 as a yellowish liquid (146 mg, 90%): [α]D -120.3 (c 0.9, CHCl3); 1H NMR (400 
MHz; CDCl3) δ 0.79 (d, J = 6.8 Hz, 3H), 2.15 (br.s., 1H ), 2.35-2.45 (m, 1H), 4.26 (d, J = 7.8 
Hz, 1H), 5.07-5.14 (m, 2H), 5.72 (ddd, J = 17.2, 10.3, 8.2 Hz, 1H), 7.16-7.29 (m, 5H, Ph); 13C 
NMR (100 MHz, CDCl3) δ 16.5 (CH3), 46.2 (CH), 77.8 (CH), 116.7 (CH2), 126.8 (2 × CH), 
127.6 (CH), 128.2 (2 × CH), 140.6 (CH), 142.4 (C); MS (CI/isobutane) m/z (%) 145 (M – OH, 
100), 129 (11), 107 (13), 85 (24); HRMS (CI/isobutane) 145.1016 (C11H13 requires 145.1017), 
in agreement with the literature;183 IR ν 3684, 3422, 2975, 2875, 1455, 1260, 1019, 914, 799, 
761, 701 cm-1; GC analysis (Supelco γ-DEX 120 column, oven for 2 min at 100 oC, then 0.5 ºC 
min-1) showed 97% ee (tSS = 37.3 min, tRR = 37.0 min). 
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(1S,2S)-(-)-2-Methyl-1-p-tolyl but-3-en-1-ol (129). Method C, starting from 4-
methylbenzaldehyde, afforded 129 as a colourless oil (237 mg, 90%): [α]D -99.5 (c 0.6, CHCl3); 
1H NMR (400 MHz; CDCl3) δ 0.86 (d, J = 6.8 Hz, 3H), 2.11 (d, J = 2.6 Hz, 1H), 2.35 (s, 3H), 
2.42-2.52 (m, 1H), 4.32 (dd, J = 8.0, 2.6 Hz, 1H), 5.16-5.24 (m, 2H), 5.81 (ddd, J = 17.2, 10.3, 
8.2 Hz, 1H), 7.16 (d, J = 8.0 Hz, 2H), 7.22 (d, J = 8.0 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
16.6 (CH3), 21.1 (CH3), 46.2 (CH), 77.7 (CH), 116.7 (CH2), 126.7 (2 × CH), 128.9 (2 × CH), 
137.3 (C), 139.4 (C), 140.8 (CH); IR ν 3652, 3420, 2976, 2927, 2870, 1637, 1514, 1456, 1417, 
1374, 1261, 1179, 1103, 1017, 914, 813, 760, 722, 677 cm-1; MS (CI/isobutane) m/z (%) 159 
(M - OH, 100), 121 (40); HRMS (CI/isobutane) 159.1172 (C12H15 requires 159.1174); GC 
analysis (Supelco γ-DEX 120 column, oven for 2 min at 100 oC, then 0.5 ºC min-1) showed 
98% ee (tRR = 49.5 min, tSS = 50.0 min). 
 
 
Method D:  General Procedure for the (TfO)2Sn-Catalysed Allyl Transfer.  Tin(II) triflate  
(21 mg, 0.05 mmol) was added in one portion to a solution of the alcohol 129 (1 mmol) and 
respective aldehyde (3 mmol) in CHCl3 (15 mL; passed through a pad of basic Al2O3 before 
use) at room temperature. The reaction mixture was stirred at room temperature and monitored 
by TLC. After full consumption of the starting alcohol the mixture was diluted with ethyl 
acetate (150 mL) and washed with the saturated NaHCO3 solution (2×100 mL). The organic 
layer was dried over sodium sulfate and the solvents were removed in vacuum. The product 
was purified on a column of silica gel (2.5 × 15 cm) using a gradient of petroleum ether and 
ethyl acetate as eluent (100:0 to 80:20).   
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(R,E)-(+)-1-(4-nitrophenyl)-pent-3-en-1-ol (128b). Method D, starting from 4-
nitrobenzaldehyde, afforded 128b as a yellowish liquid (155 mg, 75%): [α]D +61.5 (c 0.5, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.68-1.72 (br d, J = 6.3 Hz, 3H), 2.25 (d, J = 3.2 Hz, 
1H), 2.30-2.40 (m, 2H), 2.45-2.54 (m, 1H), 4.76-4.82 (m, 1H), 5.35-5.45 (m, 1H), 5.57-5.67 
(m, 1H), 7.50-7.54 (m, 2H), 8.18 – 8.22 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 18.0 (CH3), 
42.9 (CH2), 72.3 (CH), 123.6 (2 × CH), 125.5 (CH), 126.5 (2 × CH), 130.9 (CH), 147.2 (C), 
151.3 (C); IR ν 3565, 2940, 2357, 1715, 1605, 1520, 1437, 1347, 1107, 1050, 1013, 969, 854, 
751, 701 cm-1; MS (CI) m/z (%) 208 [(M + H)+, 100], 190 (10), 152 (10); HRMS (CI) 
208.0972 (C11H14NO3 requires 208.0974); HPLC analysis (Chiracel OJ-H column, hexane/2-
propanol = 96:4, 0.75 mL min-1) showed 98% ee (tR = 39.7 min, tS = 36.9 min). 
 
 
 
(R,E)-(-)-1-phenyl hex-4-en-2-ol
 
(128c). Method D, starting from 2-phenylacetaldehyde, 
afforded 128c as a colourless liquid (144 mg, 82% yield): [α]D -4.5 (c 1.0, MeOH); 1H NMR 
(400 MHz; CDCl3) δ 1.60-1.67 (m, 4H, OH and CH3), 2.07 (dt, J = 14.7, 7.6 Hz, 1H), 2.15-2.25 
(m, 1H), 2.65 (dd, J
 
= 13.6, 7.8 Hz, 1H), 2.72 (dt, J = 13.6 Hz, 5.0 Hz, 1H), 3.72-3.82 (m, 1H), 
5.35-5.45 (m, 1H), 5.48-5.58 (m, 1H), 7.12-7.27 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 18.1 
(CH3), 40.0 (CH2), 43.2 (CH2), 72.0 (CH), 126.4 (CH), 126.9 (CH), 128.5 (2 × CH), 129.1 
(CH), 129.4 (2 × CH), 138.5 (C); MS (EI) m/z (%) 176 (M+, 7), 121 (80), 92 (100); HRMS (EI) 
176.1199 (C12H16O requires 176.1201), in agreement with the literature; 184 HPLC analysis 
(Chiracel IB column, hexane/2-propanol = 98:2, 0.75 mL min-1) showed 96% ee (tR = 11.9 min, 
tS = 10.3 min). 
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(R,E)-(+)-2,2-dimethylhept-5-en-3-ol (128d). Method D, starting from pivalaldehyde, 
afforded 128d as a yellowish liquid (85 mg, 60%): [α]D +12.0 (c 5.0, MeOH; 1H NMR (400 
MHz; CDCl3) δ 0.90 (s, 9H), 1.67-1.71 (br d, J = 6.5 Hz, 3H), 1.85-1.95 (m, 1H), 2.24-2.32 (m, 
1H), 3.17-3.21 (m, 1H), 5.39-5.62 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 18.0 (3 × CH3), 
25.7 (CH3), 34.5 (C), 35.2 (CH2), 78.3 (CH), 128.6 (CH), 128.7 (CH), in agreement with the 
literature;184  19F NMR of the corresponding Mosher ester showed 93% ee (δR = -71.51 ppm 
and δS = -71.15 ppm).  
 
 
(R,E)-(+)-1-cyclohexyl-pent-3-en-1-ol (128e). Method D, starting from 
cyclohexanecarbaldehyde, afforded 128e as a colourless liquid (134 mg, 80% yield): [α]D +7.6 
(c 2.5, CHCl3); 1H NMR (400 MHz; CDCl3) δ 0.80-1.35 (m, 6H, Cy and OH), 1.55-1.70 (m, 
7H, Cy and CH3), 1.75-1.82 (m, 1H), 1.92-2.02 (m, 1H), 2.15-2.25 (m, 1H), 3.22-3.28 (m, 1H), 
5.32-5.42 (m, 1H), 5.45-5.55 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 18.1 (CH3), 26.2 (CH2), 
26.3 (CH2), 26.5 (CH2), 28.2 (CH2), 29.1 (CH2), 37.5 (CH), 42.3 (CH2), 74.9 (CH), 127.6 (CH), 
128.9 (CH); IR ν 3362, 2925, 2857, 1449, 1261, 1027, 969 cm-1; MS (CI/isobutane) m/z (%) 
151 (M - OH, 100), 113 (15), 95 (25); HRMS (CI/isobutane) 151.1485 (C11H19 requires 
151.1487; GC analysis (Supelco α-DEX 120 column, oven for 30 min at 105 oC, then ºC min-1) 
showed 97% ee (tR = 30.1 min, tS = 31.0 min).  
 
 
 
(R,E)-(+)-3-ethyl oct-6-en-4-ol (128f). Method D, starting from 2-ethylbutanal, afforded 128f 
as a colourless liquid (130 mg, 83% yield): [α]D +4.0 (c 1.0, CHCl3); 1H NMR (400 MHz; 
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CDCl3) δ 0.90 (t, J = 7.4 Hz, 6H), 1.22-1.50 (m, 6H), 1.65-1.72 (br d, J = 6.6 Hz, 3H), 
2.01-2.11 (m, 1H), 2.18-2.26 (m, 1H), 3.52-3.60 (m, 1H), 5.38-5.48 (m, 1H), 5.51-5.61 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 11.6 (CH3), 11.7 (CH3), 18.1 (CH3), 21.3 (CH2), 21.9 
(CH2), 37.5 (CH), 46.0 (CH2), 72.1 (CH), 127.9 (CH), 128.8 (CH), in agreement with the 
literature;47a GC analysis (Supelco α-DEX 120 column, oven for 2 min at 65 oC, then 0.5 ºC 
min-1) showed 95% ee (tR = 36.0 min, tS = 36.6 min).  
 
 
 
(S,E)-(-)-undec-2-en-5-ol
 
(128g). Method D, starting from heptanal, afforded 128g as a 
colourless liquid (145 mg, 85% yield): [α]D -1.5 (c 1.1, CHCl3); 1H NMR (400 MHz; CDCl3) δ 
0.87 (t, J = 7.0 Hz, 3H), 1.22-1.45 (m, 10H, (CH2)5), 1.52 (d, J = 3.9 Hz, 1H), 1.65-1.72 (br. d, 
J = 6.4 Hz, 3H), 1.97-2.07 (m, 1H), 2.15-2.25 (m, 1H), 3.52-3.60 (m, 1H), 5.37-5.47 (m, 1H), 
5.50-5.60 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1 (CH3), 18.1 (CH3), 22.6 (CH2), 25.7 
(CH2), 29.4 (CH2), 31.8 (CH2), 36.8 (CH2), 40.7 (CH2), 71.0 (CH), 127.2 (CH), 128.9 (CH); IR 
ν 3360, 3021, 2957, 2928, 2857, 1456, 1378, 1260, 1034, 967, 800 cm-1; MS (CI) m/z (%) 153 
(M - OH, 100), 97 (50), 71 (60); HRMS (CI) 153.1642 (C11H21 requires 153.1643); 19F NMR 
of the corresponding Mosher ester showed 97% ee (δR = -71.31 ppm and δS = -71.35 ppm). 
 
 
 
(R,E)-(-)-1-(methylthio)-hept-5-en-3-ol (128h). Method D, starting from 3-
(methylthio)propanal, afforded 128h as a colourless liquid (115 mg, 72% yield): [α]D -14.5 (c 
0.5, CHCl3); ); 1H NMR (400 MHz; CDCl3) δ 1.67-1.77 (m, 5H), 1.92 (d, J = 3.9 Hz, 1H), 
2.05-2.15 (m, 4H), 2.17-2.27 (m, 1H), 2.57-2.67 (m, 2H), 3.67-3.77 (m, 1H), 5.37-5.47 (m, 
1H), 5.52-5.62 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 15.5 (CH3), 18.1 (CH3), 30.8 (CH2), 
35.6 (CH2), 40.7 (CH2), 70.1 (CH-O), 126.7 (CH), 129.2 (CH); IR ν 3734, 3375, 3025, 2915, 
1437, 1260, 1016, 968, 800 cm-1; MS (CI) m/z (%) 143 (M - OH, 100), 102 (40); HRMS (CI) 
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143.0892 (C8H15S requires 143.0894); 19F NMR of the corresponding Mosher ester  showed 
97% ee (δR = -71.24 ppm and δS = -71.22 ppm). 
 
(S,E)-(-)-1-phenylhept-5-en-3-ol (128i). Method D, starting from 3-phenylpropanal, afforded 
128i as a colourless liquid (162 mg, 85% yield): [α]D -15.7 (c 0.7, CHCl3); 1H NMR (400 
MHz; CDCl3) δ 1.57 (br s, 1H), 1.62 (br d, J = 6.3 Hz, 3H), 1.66-1.74 (m, 2H), 2.01-2.04 (m, 
1H), 2.13-2.22 (m, 1H), 2.61 (dt, J = 13.8, 8.0 Hz, 1H), 2.74 (dt, J 
 
= 13.8, 7.5 Hz, 1H), 
3.50-3.60 (m, 1H), 5.30-5.40 (m, 1H), 5.45-5.55 (m, 1H), 7.08-7.25 (m, 5H); 13C NMR (100 
MHz, CDCl3) δ 18.1 (CH3), 32.1 (CH2), 38.4 (CH2), 40.8 (CH2), 70.1 (CH), 125.7 (CH), 126.8 
(CH), 128.3 (2 × CH), 128.4 (2 × CH), 129.3 (CH), 142.1 (C); IR ν 3654, 3374, 3062, 3025, 
2929, 2856, 1603, 1495, 1454, 1377, 1261, 1045, 968, 746, 699 cm-1; MS (CI) m/z (%) 191 [(M 
+ H)+, 5], 173 (100), 134 (30), 117 (40); HRMS (CI) 191.1426 (C13H19O requires 191.1436), in 
agreement with the literature;47a GC analysis (Supelco γ-DEX 120 column, oven for 2 min at 
120 oC, then 0.5 oC min-1) showed 97% ee (tR = 40.9 min, tS = 41.3 min). 
 
SiCl3
 
But-3-en-2-yl-trichlorosilane (149).54 2-Butenyl chloride (14.3g, 0.159 mol) was added 
dropwise to magnesium turnings (11.6 g, 0.48 mol) in dry ether (10 mL) under an argon 
atmosphere. The resulting Grignard reagent was transferred to a syringe and added dropwise to 
a vigorously stirred solution of SiCl4 (30.4g (0.18 mol) in dry ether (100 mL). The mixture was 
stirred for 5 h, over which period a white precipitate was formed. The precipitated salts were 
removed by filtration under argon and the product was distilled under reduced pressure (45-50 
oC at 26 mm Hg) to afford 149 (11.2 g, 37% overall) as a colourless liquid: 1H NMR (400 
MHz; CDCl3) δ 1.33 (d, J = 7.3 Hz, 3H), 2.32-2.39 (m, 1H), 5.18 (dt, J = 17.1, 1.2Hz, 1H), 
5.22 (dt, J = 10.4, 1.0 Hz, 1H), 5.84 (ddd, J = 17.1, 10.4, 7.3 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 12.3 (CH3), 34.0 CH2), 117.2 (CH2), 134.0 (CH). 
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(1S,Z)-(-)-1-phenylpent-3-en-1-ol (151). Method C, starting from benzaldehyde and 149, 
afforded 151 as a colourless oil (9 mg, 14% yield): [α]D -44.7 (c 0.6, CHCl3 , for 68% ee, 9:1 
Z/E); 1H NMR (400 MHz; CDCl3) δ 1.62 (d, J = 6.3 Hz, 3H), 2.01 (br s, 1H), 2.25-2.40 (m, 
2H), 4.59-4.62 (m, 1H), 5.32-5.40 (m, 1H), 5.53 (dq, J = 15.2, 6.4 Hz, 1H), 7.17-7.29 (m, 5H); 
13C NMR (100 MHz, CDCl3) δ 13.0 (CH3), 36.9 (CH2), 73.8 (CH), 125.6 (CH), 125.8 (2 × 
CH), 127.5 (CH), 127.7 (CH), 128.4 (2 × CH), 144.1 (C); IR ν 3363, 3024, 2920, 2857, 1492, 
1452, 1325, 1255, 1197, 1115, 1045, 1015, 910, 874, 758 cm-1; MS (CI/isobutane) m/z (%) 145 
(M - OH, 60), 133 (13), 113 (23), 97 (24) ; HRMS (CI/isobutane) 145.1015 (C11H13 requires 
145.1017); HPLC analysis (Chiralcel OD-H column, hexane/2-propanol - 98:2, 0.75 mL min-1) 
showed 87 % ee (tR = 19.2 min, tS = 25.0 min). 
 
 
 
(S)-(–)-1-(4’-Methoxyphenyl)-3-buten-1-ol (255b). Method C, starting from 4-
methoxybenzaldehyde, afforded 255b as a pale yellow oil (636 mg, 70%): [α]D -32.5 (c, 1.3, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.97 (s, 1H), 2.43 (t, J = 6.4 Hz, 2H), 3.73 (s, 3H), 4.64 
(t, J = 5.6 Hz, 1H), 5.05-5.11 (m, 2H), 5.83 (ddt, J = 17.2, 10.1, and 7.1 Hz, 1H), 6.81 (d, J = 
8.8 Hz, 2H), 7.22 (d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 43.7 (CH2), 55.3 (CH3), 
73.0 (CH), 113.8 (2 × CH), 118.0 (CH2), 127.1 (2 × CH), 134.7 (CH), 136.1 (C), 159.0 (C); IR 
ν 3422, 2958, 2928, 2835, 1621, 1512 cm-1; MS (CI/isobutane) m/z (%) 179 [(M + H)+, 5], 161 
(M – OH, 100), 151 (20), 137 (15); HRMS (CI/isobutane) 161.0965 (C11H14O2 - OH requires 
161.0966), in agreement with the literature;39 HPLC analysis (Chiralcel OD-H column, 
hexane/2-propanol 97:3, 1 mL min-1) showed 96% ee (tR = 14.80 min, tS = 17.30 min). 
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(S)-(-)-1-(4’-fluorophenyl)-but-3-en-1-ol (255c). Method C, starting from 4-
fluorobenzaldehyde, afforded 255c as a yellowish oil (560 mg, 75% yield: [α]D -42.2 (c 0.9, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.05 (br s, 1H), 2.33-2.47 (m, 2H), 4.62-4.66 (m, 1H), 
5.08 (dd, J = 18.1, 10.9 Hz, 2H), 6.95 (t, J = 8.7 Hz, 2H), 7.24 (dd, J = 8.7, 5.6 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 44.0 (CH2), 72.6 (CH), {115.1 (CH), 115.3 (CH, J = 21.3 Hz), 
118.7 (CH2), 127.5 (2 x CH, JC,F = 8.0 Hz), 134.2 (CH), 139.5 (C, JC,F = 3.1Hz), 162.1 (C, JC,F 
= 245.2 Hz); 19F NMR (376.5 MHz, CDCl3) δ -115.14;  MS (CI/ISO)  m/z (%) 167 [(M + H)+, 
29], 149 (100), 125 (23), 107 (16), 85 (32); HRMS (CI/ISO) (M - OH) 149.0765 (C10H10F 
requires 149.0767); HPLC analysis (Chiralcel OD-H column , hexane/2-propanol 98.5:1.5, 
0.75 mL min-1) showed 95% ee (tR = 19.62 min, tS = 20.56 min). 
 
 
 
(S)-(-)-1-(4’-bromophenyl)-but-3-en-1-ol (255d). Method C, starting from 4-
bromobenzaldehyde, afforded 255d as a yellowish liquid (344 mg, 82%): [α]D -50.9 (c, 1.5, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.00 (br d, J = 2.4 Hz, 1H), 2.33-2.47 (m, 2H), 4.64 (dd, 
J = 7.2 and 5.2 Hz, 1H), 5.07-5.12 (m, 2H), 5.65-5.76 (dddd, J = 17.5, 10.9, 7.6, and 6.6 Hz, 
1H), 7.16 (d, J = 8.4 Hz, 2H), 7.40 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 43.9 
(CH2), 72.6 (CH), 119.0 (CH2), 121.3 (C), 127.6 (2 × CH), 131.5 (2 × CH), 133.9 (CH), 142.8 
(C); MS; IR ν 3374, 3077, 2932, 2907, 1641, 1593, 1489, 1431, 1404, 1070, 1011, 918, 826 
cm-1; (EI+) m/z (%) 226 (M+, 4), 187 (100), 157 (30), 77 (96); HRMS (EI+) 225.9989 
(C10H1179BrO requires 225.9993). HPLC analysis (Chiracel OJ-H column, hexane/2-propanol 
96:4, 0.5 mL min-1) showed 91% ee (tS = 27.29 min major, tR= 29.61 min minor).  
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 (S)-(-)-1-(4’-nitrophenyl)-but-3-en-1-ol (255e). Method C, starting from 4-
nitrobenzaldehyde, afforded 255e as a yellow oil (416 mg, 81% yield): [α]D -56.3 (c 1.9, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.19 (br s, 1H), 2.43-2.51 (m, 1H), 2.54-2.61 (m 1H), 
4.88 (dd, J = 7.7, 4.8 Hz, 1H), 5.21 (m, 2H), 5.80 (dddd, J = 17.0 , 10.4, 7.8, 6.5 Hz, 1H), 7.54 
(d, J = 8.8 Hz, 2H), 8.21 (d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 43.9 (CH2), 72.2 
(CH), 119.7 (CH2), 123.6 (2 × CH), 126.6 (2 × CH), 133.2 (CH), 147.3 (C), 151.1 (C); MS (CI) 
m/z (%) 194 [(M + H)+, 100], 178 (9), 164 (11), 146 (33), 113 (15); HRMS (CI) 194.0820 
(C10H11O3N + H+ requires 194.0817), in agreement with the literature;39 HPLC analysis 
(Chiralcel IB column, hexane/2-propanol 99:1, 0.75 mL min-1) showed 92% ee (tR = 81.21  
min, tS = 83.06 min). 
 
 
 
(S)-(-)-1-(3’-methoxyphenyl)-but-3-en-1-ol (255f). Method C, starting from 3-
methoxybenzaldehyde, afforded 255f as a colourless liquid (315 mg, 89%): [α]D -42.5 (c 1.5, 
CHCl3); 1H NMR (400 MHz CDCl3) δ 2.12 (br s, 1H), 2.47-2.59 (m, 2H), 3.84 (s, 3H), 4.73 
(dd, J = 7.0, 5.6 Hz, 1H), 5.16–5.22 (m, 2H), 5.79–5.89 (dddd, J = 17.2, 10.2, 7.4, 7.0 Hz, 1H), 
6.84 (dd, J = 8.1, 2,5 Hz, 1H), 6.96 (m, 2H), 7.29 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 43.8 
(CH2), 55.2 (CH3), 73.2 (CH), 111.3 (CH), 113.0 (CH), 118.1 (CH), 118.5 (CH), 129.5 (CH), 
134.4 (CH), 143.6 (C), 159.7 (C); MS (EI+) m/z (%) 178 (M+, 12), 137 (98), 109 (100), 94 (31); 
HRMS (EI+) 178.0993 (C11H14O2 requires 178.0994), all in agreement with the data for an 
authentic sample of the (R)-(+)-enantiomer;39 HPLC analysis (Chiracel OD-H column, 
hexane/2-propanol 96:4, 1 mL min-1) showed 94% ee (tR = 19.76  min, tS = 24.65 min).  
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 (1S,2S)-(–)-1-(4’-Fluorophenyl)-2-methyl-3-buten-1-ol (255h). Method C, starting from 4-
fluorobenzaldehyde, afforded 255f as a pale yellow liquid: (824 mg, 52%): [α]D -67.6 (c, 1.4, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.79 (d, J = 6.8 Hz, 3H), 2.05 (s, 1H), 2.31-2.41 (m, 
1H), 4.27 (d, J = 7.9 Hz, 1H), 5.11-5.16 (m, 2H), 5.71 (ddd, J = 17.0, 10.5, and 8.2 Hz, 1H), 
6.93-6.99 (m, 2H), 7.20-7.29 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 16.5 (CH3), 46.5 (CH), 
77.2 (CH), 115.0 (2 x CH, JC,F = 21.4 Hz), 117.15 (CH2), 128.41 (2 x CH, JC,F = 7.8 Hz), 
138.10 (C, JC,F = 2.9 Hz), 140.5 (CH), 161.0 (C, JC,F = 247.5 Hz); 19F NMR (376 MHz, CDCl3) 
δ -115.0 (1F); IR ν 3412, 2966, 2931, 2874, 1604, 1456 cm-1; MS (CI/isobutane) m/z (%) 163 
(M – OH, 100), 137 (28); HRMS (CI/isobutane) 163.0925 (C11H13F - OH requires 163.0917), 
in agreement with the literature;185 GC analysis (Supelco γ-DEX 120 column, oven for 2 min at 
80 °C, then 0.5 °C min-1) showed 98% ee (t1R,2R = 77.35 min, t1S,2S = 78.22 min) and the ratio of 
diastereoisomers 35:1.  
 
Method E: General Procedure for the Synthesis of Alkoxyamines with Inversion of 
Configuration via Mitsunobu Reaction.93 Triphenylphosphine (1.2 mmol) and N-hydroxy-
phthalimide (1.2 mmol) were added to a solution of the respective alcohol (1 mmol) in freshly 
distilled THF (10 mL) under argon at 0 °C and the mixture was stirred for 2 min. Diisopropyl 
azodicarboxylate (1.2 mmol) was then added dropwise over a period of 30 min and the 
resulting solution was stirred at room temperature under argon for 2 h. Hydrazine hydrate 
(100% N2H4●H2O, 0.1 mL) was then added and the reaction stirred at room temperature for 30 
min. The reaction was quenched with dematerialized water (5 mL) and the mixture was diluted 
with a mixture of ethyl acetate and petroleum ether (1:1; 10 mL). The organic layer was 
separated and the aqueous layer was extracted with a mixture of ethyl acetate and petroleum 
ether (1:1; 3×15 mL). The combined organic fractions were dried over Na2SO4 and the solvents 
were removed in vacuum. The product was purified on a column of silica gel (1.5×20 cm) using 
a gradient of petroleum ether and ethyl acetate as eluent (100:0 to 90:10). The enantiomeric and 
diastereoisomeric purity was established for both the crude product and the purified material 
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Method F: General Procedure for the Preparation of Mosher Amides from N-
Alkoxyamines.187 (R)-(+)-3,3,3-Trifluoro-2-methoxy-2-phenylpropionyl chloride (150 mg, 0.6 
mmol), prepared in situ from (R)-(+)-α-methoxy-α-trifluoromethylphenylacetic acid (99% ee 
from Sigma-Aldrich), was added to a solution of the alkoxyamine (0.5 mmol) and triethylamine 
(0.6 mmol) in CH3CN (1 mL) and the reaction mixture was stirred at room temperature for 1 h. 
The solvent was then removed in vacuo and the resulting oil was dissolved in ether (20 mL). 
The ethereal solution was washed with 1M HCl, saturated aqueous NaHCO3, and brine, dried 
(Na2SO4) and concentrated in vacuo to give an oil, which was analyzed by 19F and 1H NMR 
spectroscopy. 
 
 
 
(R)-(+)-O-(1-(4’-Methoxyphenyl)but-3-enyl)hydroxylamine (257b). Method E, starting from 
pure (S)-255b (96% ee), afforded 257b (314 mg, 74%) as a pale yellow oil: [α]D +2.8 (c, 1.4, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.28-2.36 (m, 1H), 2.48-2.56 (m, 1H), 3.74 (s, 3H), 
4.42 (t, J = 6.8 Hz, 1H), 4.93-5.01 (m, 2H), 5.11 (s, 2H), 5.67 (ddt, J = 17.3, 10.2, and 7.2 Hz, 
1H), 6.82 (br d, J = 8.7 Hz, 2H), 7.18 (br d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
40.3 (CH2), 55.3 (CH3), 86.2 (CH), 113.9 (2 × CH), 117.0 (CH2), 128.1 (2 × CH), 133.2 (C), 
134.6 (CH), 159.3 (C); IR ν 3319, 2933, 1607, 1585, 1509, 1247 cm-1; MS (CI/isobutane) m/z 
(%) 194 [(M + H)+, 37], 177 (100), 161 (98); HRMS (CI/isobutane) 194.1180 (C11H15NO2 + 
H+ requires 194.1181). The enantiopurity was not accurately determined but the optical rotation 
(+2.8) was rather low compared to that of the (S)-enantiomer 261b obtained via the oxaziridine 
method (Method G), which showed [α]D -33.7. Therefore, the enantiopurity of the product must 
be very low (5-10% ee). 
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(R)-(+)-O-[1-(4’-Fluorophenyl)-3-buten-1-yl]hydroxylamine (257c). Method E, starting from 
(S)-255c (95% ee), afforded 257c (316 mg, 78%) as a yellowish oil: [α]
 D +48.0 (c 1.0, CHCl3); 
1H NMR (400 MHz, CDCl3) δ 2.31 (ddd, J = 14.4, 7.8, and 6.7 Hz, 1H), 2.51 (m, 1H), 4.47 (t, 
J = 6.7 Hz, 1H), 4.89-5.09 (br m, 4H), 5.65 (ddd, J = 17.2, 10.2, and 7.0 Hz, 1H), 6.98 (t, J = 
8.7 Hz, 2H), 7.22 (dd, J = 8.7 and 5.5 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 40.5 (CH2), 
85.9 (CH), 115.4 (2 × CH, JC,F = 21.4 Hz), 117.3 (CH2), 128.4 (2 × CH, JC,F = 8.0 Hz), 134.1 
(CH), 137.1 (C, JC,F = 3.3 Hz), 162.4 (C, JC,F = 245.6 Hz); 19F NMR (376.5 MHz, CDCl3) δ -
114.7; IR ν 3321, 3078, 2908, 1641, 1604, 1510, 1418, 1223, 1157, 989, 912, 835 cm-1; MS 
(CI/isobutane) m/z (%) 182 [(M + H)+, 100], 165 (47), 149 (100), 137 (82), 121 (23); HRMS 
(CI/isobutane) 182.0979 (C10H12FNO + H+ requires 182.0981). 19F NMR of the corresponding 
Mosher amide (Method F) showed 90% ee [δR -69.17 (minor)  and δS -69.11 (major)]. 
 
 
 
(R)-(+)-O-[1-(4’-Bromophenyl)-3-buten-1-yl]hydroxylamine (257d). Method E, starting 
from (S)-255d (91% ee), afforded 257d (275 mg, 86%) as a colourless oil: [α]
 D +34.8 (c 1.2, 
CHCl3);  1H NMR (400 MHz, CDCl3) δ 2.30 (m, 1H), 2.48 (m, 1H), 4.54 (t, J = 6.8 Hz, 1H), 
4.97 (m, 2H), 5.19 (br s, 2H), 5.59-5.70 (dddd, J = 17.2, 10.2, 7.0, 6.8 Hz, 1H), 7.12 (d, J = 8.3 
Hz, 2H), 7.41 (d, J = 8.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 40.4 (CH2), 85.9 (CH), 117.5 
(CH2) 121.6 (C), 128.5 (2 × CH), 131.6 (2 × CH), 133.9 (CH), 140.6 (C); IR ν 3321, 3078, 
2920, 1643, 1589, 1485, 1431, 1404, 1342, 1296, 1265, 1180, 1069, 1007, 991, 952, 914, 817, 
779, 737 cm-1; MS (CI/isobutane) m/z (%) 242 [(M + H)+,100], 209 (42), 185 (8), 113 (13); 
HRMS (CI/isobutane) 242.0181 (C10H1279BrNO + H+ requires 242.0177). 19F NMR spectrum 
of the Mosher derivative (Method F) showed 90% ee [δS -69.02 (minor) and δR -69.14 (major)]. 
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(R)-(+)-O-[1-(4’-Nitrophenyl)-3-buten-1-yl]hydroxylamine (257e). Method E, starting from 
(S)-257e (92% ee), afforded 257e (236 mg, 84%) as a yellow oil: [α]D +34.8 (c, 1.1, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 2.34 (m, 1H), 2.50 (m, 1H), 4.63 (t, J = 6.7 Hz, 1H), 4.97 (m, 2H), 
5.32 (br s, 2H), 5.60-5.70 (dddd, J = 17.5, 10.5, 7.1, 6.9 Hz, 1H), 7.41 (d, J = 8.8 Hz, 2H), 8.16 
(d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 40.3 (CH2), 85.4 (CH), 118.0 (CH2), 123.7 
(2 × CH), 127.5 (2 × CH), 133.2 (CH), 147.5 (C), 149.4 (C); IR ν 3321, 3078, 2935, 2909, 
1642, 1601, 1518, 1344, 1282, 1080, 991, 918, 854 cm-1; MS (CI/isobutane) m/z (%) 209 [(M + 
H)+, 100], 194 (22), 146 (5); HRMS (CI/isobutene) 209.0923 [(C10H12N2O3 + H+) requires 
209.0926]. 19F NMR spectrum of the Mosher derivative (Method F) showed 92% ee [δS -69.01 
(minor), and δR -69.15 (major)]. 
 
 
 
(R)-(+)-O-[1-(3’-Methoxyphenyl)-3-buten-1-yl]hydroxylamine (257f). Method E, starting 
from (S)-255f (94% ee), afforded 257f (256 mg, 91%) as a colourless oil: [α]D +35.2 (c, 1.0, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.29-2.37 (m, 1H), 2.46-2.54 (m, 1H), 3.75 (s, 3H), 
4.46 (dd, J = 7.6, 6.0 Hz, 1H), 4.95-5.03 (m, 2H), 5.19 (br s, 2H), 5.64-5.75 (ddd, J = 17.1, 
10.2, 7.0 Hz, 1H), 6.75-6.85 (m, 2H), 7.21 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 40.6 (CH2), 
55.2 (CH3), 86.6 (CH), 112.1 (CH), 113.3 (CH), 117.1 (CH), 119.12 (CH), 129.6 (CH), 134.4 
(CH), 143.1 (C), 159.8 (C); IR ν 3316, 3074, 2936, 1641, 1599, 1586, 1489, 1454, 1435, 1286, 
1256, 1255, 1040, 993, 914, 872, 783 cm-1; MS (CI/isobutane) m/z (%) 194  [(M + H)+, 70], 
177 (22), 161 (100), 137 (24); HRMS  (CI//isobutene) 194.1178 (C10H11NO3 + H+ requires 
194.1181). 1H NMR spectrum of the Mosher derivative (Method F) showed ≥88% ee [δS 3.16 
(MeO, minor) and δR 3.10 (MeO, major); the 19F signals were poorly resolved, so that the 
analysis of the Mosher ester could only be done with the proton signals of the MeO group. 
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(1R,2S)-(+)-O-[1-Phenyl-2-methyl-3-buten-1-yl]hydroxylamine (257g). Method E, starting 
with (1S,2S)-255g (95% ee; 55:1 anti/syn ratio), afforded a crude product (35:1 syn/anti ratio as 
evidenced by 1H NMR), which was purified by chromatography on a column of silica gel 
(1.5×20 cm), using a gradient of petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to 
afford pure 257g (388 mg, 89%) (a 35:1 mixture of syn/anti diastereoisomers, as evidenced by 
1H NMR) as a colourless oil: [α]D +43.4 (c 0.93, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.10 
(d, J = 6.8 Hz, 3H), 2.61 (m, 1H), 4.38 (d, J = 6.8 Hz, 1H), 4.93 (m, 1H), 4.96 (m, 1H), 5.24 (br 
s, 2H), 5.63-5.71 (ddd, 17.5, 10.1, and 7.6 Hz, 1H), 7.28-7.40 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 15.8 (CH3), 42.8 (CH), 91.1 (CH), 114.8 (CH2), 127.5 (2 × CH), 127.7 (CH), 128.2 (2 
× CH), 140.01 (CH), 140.03 (C); IR ν 3318, 3082, 2967, 2928, 2882, 1640, 1582, 1493, 1454, 
1416, 1370, 1180, 1103, 1072, 991, 914, 756, 702 cm-1; MS (CI/isobutane) m/z (%) 178 [(M + 
H)+, 100], 161 (19), 145 (78), 122 (10), 107 (27); HRMS (CI/isobutane) 178.1230 (C11H15NO 
+ H+ requires 178.1232).  
 
 
 
(1R,2S)-(+)-O-[1-(4’-Fluorophenyl)-2-methyl-3-buten-1-yl]hydroxylamine (257h). Method 
E, starting with pure (1S,2S)-255h (98% ee; 35:1 anti/syn ratio), afforded a crude product at 
~80% conversion (≥20:1 syn/anti ratio as evidenced by 1H NMR),  which was purified by 
chromatography on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and 
ethyl acetate as eluent (100:0 to 90:10) to afford pure 257h (112 mg, 54%) as a pale yellow oil: 
[α]D +31.6 (c, 1.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.99 (d, J = 6.8 Hz, 3H), 2.41-2.56 
(m, 1H), 4.26 (d, J = 7.0 Hz, 1H), 4.80-4.89 (m, 2H), 5.53 (ddd, J = 17.2, 10.6, and 7.5 Hz, 
1H), 6.95-7.01 (m, 2H), 7.17-7.23 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 15.9 (CH3), 42.8 
(CH), 90.3 (CH), 114.5 (CH2), 115.1 (2 x CH, JC,F = 21.4 Hz), 129.5 (2 x CH, JC,F = 8.3 Hz), 
134.7 (C, JC,F = 3.4 Hz), 139.01 (CH), 162.60 (C, JC,F = 8.3 Hz); 19F NMR (376 MHz, CDCl3) 
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δ -114.9 (1F); IR ν 3500, 3018, 2965, 2916, 2849, 2359, 1602, 1508, 1222 cm-1; MS 
(CI/isobutane) m/z (%) 195 [(M + H)+, 70], 163 (100), 125 (28); HRMS (CI/isobutane) 
196.1142 [(C11H14FNO + H+)] requires 196.1132); 19F NMR spectrum showed ≥30:1 syn/anti 
ratio (δmajor -114.98, δminor -114.82). 
 
 
 
(S)-(–)-O-(1-Phenyl-3-penten-1-yl)hydroxylamine (258). Method E, starting from (R)-256 
(92% ee), afforded 258 (220 mg, 81%) as a colourless liquid: [α]D -30.9 (c 1.0, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 1.67 (dd, J = 6.1, 1.3 Hz, 3H, 2.32-2.39 (m, 1H), 2.49-2.57 (m, 
1H), 4.53 (dd, J = 7.6, 6.0 Hz, 1H), 5.24 (br s, 2H), 5.36-5.44 (m, 1H), 5.46-5.55 (m, 1H), 7.30-
7.42 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 18.1 (CH3), 39.5 (CH2), 87.2 (CH), 126.77 (2 × 
CH), 126.8 (CH), 127.72 (CH), 127.76 (CH), 128.5 (2 × CH), 141.6 (C); IR ν 3314, 3028, 
2916, 2855, 1581, 1495, 1452, 1362, 1175, 1001, 966, 914 cm-1; MS (CI/isobutane) m/z (%) 
178 [(M + H)+, 100], 161 (13), 145 (65); HRMS (CI//isobutene) 178.1231 (C10H15NO + H+ 
requires 178.1232). Mosher amide (Method F) 1H NMR showed 90% ee [δS = 3.14 (major), and 
δR = 3.08 (minor)].  
 
Method G: General Procedure for the Synthesis of Alkoxyamines with Retention of 
Configuration. The respective alcohol (1.0 mmol), 18-crown-6 ether (0.2 mmol), and KH (1.2 
mmol), obtained by rinsing its oil suspension with hexane, were added consecutively to 1,3-
dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMPU; 1.5 mmol) and the mixture was 
stirred at room temperature for 1 h under Ar. The resulting mixture was then added dropwise to 
a solution of 3,3-di-tert-butyl-oxaziridine (1.2 mmol) in DMPU (1.5 mL) at -40 °C and the 
resulting mixture was stirred first at –40 oC, then slowly allowed to warm to room temperature 
over a period 2 h (the reaction starts at ca –20 oC; if heated too fast, the mixture tends to 
overflow from the flask). The reaction was quenched with brine (5 mL) and the mixture was 
diluted with a mixture of ethyl acetate and petroleum ether (1:1; 10 mL). The organic layer was 
separated and the aqueous layer was extracted with an ethyl acetate-petroleum ether mixture 
(1:1; 3×15 mL). The combined organic fractions were dried over Na2SO4 and the solvent was 
removed in vacuum. The product was purified on a column of silica gel (1.5×20 cm), using a 
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gradient of petroleum ether and ethyl acetate as eluent (100:0 to 90:10). The enantiomeric and 
diastereoisomeric purity was established for both the crude product and the purified material. 
 
 
 
(S)-(–)-O-[1-(4’-Methoxyphenyl)-3-buten-1-yl]hydroxylamine (261b). Method G, starting 
with pure (S)-255b (96% ee) afforded 261b (236 mg, 88%) as a pale yellow oil: [α]D -33.7 (c, 
1.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 2.28-2.35 (m, 1H), 2.48-2.56 (m, 1H), 3.73 (s, 3H), 
4.41 (t, J = 7.1 Hz, 1H), 4.92-5.01 (m, 2H), 5.67 (ddt, J = 17.1, 10.2, and 7.0 Hz, 1H), 6.83 (br 
d, J = 8.7 Hz, 2H), 7.18 (br d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 40.4 (CH2), 55.3 
(CH3), 86.3 (CH), 113.9 (2 × CH), 117.0 (CH2), 128.1 (2 × CH), 133.2 (C), 134.5 (CH), 159.3 
(C); IR ν 3318, 2936, 1611, 1585, 1512, 1245 cm-1; MS (CI/isobutane) m/z (%) 194 [(M + H)+, 
37], 177 (100), 161 (98); HRMS (CI/isobutane) 194.1185 (C11H15NO2 + H+ requires 
194.1181); the enantiomeric purity should correspond to that of the starting alcohol i.e., 96% 
ee. The product was identical with its almost racemic version 257b (except for the optical 
rotation).  
 
 
 (1S,2S)-(–)-O-[2-Methyl-1-phenyl-3-buten-1-yl]hydroxylamine (261g). Method G, starting 
with pure (1S,2S)-255g (95% ee; 55:1 anti/syn ratio), afforded 261g (169 mg, 65%) as a pale 
yellow oil: [α]D -88.3 (c, 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.77 (d, J = 6.8 Hz, 3H), 
2.41-2.51 (m, 1H), 4.25 (d, J = 7.8 Hz, 1H), 4.95-5.00 (m, 2H), 5.81 (ddt, J = 17.6, 10.0, and 
7.7 Hz, 1H), 7.18-7.31 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 16.5 (CH3), 43.1 (CH), 90.2 
(CH), 114.4 (CH2), 127.4 (2 × CH), 127.7 (CH), 128.3 (2 × CH), 140.2 (C), 141.0 (CH); IR ν 
3318, 3028, 2966, 2881, 1639, 1581, 1454 cm-1; MS (CI/isobutane) m/z (%) 178 [(M + H)+, 
22], 161 (20), 145 (50), 137 (100), 121 (80); HRMS (CI/isobutane) 178.1228 (C11H15NO + H+ 
requires 178.1232); the stereochemical purity corresponds to that of the starting alcohol, i.e., 
95% ee and ~40:1 dr (by 1H NMR).  
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(1S,2S)-(–)-O-[1-(4’-Fluorophenyl)-2-methyl-3-buten-1-yl]hydroxylamine (261h). Method 
G, starting with pure (1S,2S)-255h (98% ee; 35:1 anti/syn ratio), afforded 261h (97 mg, 33%) 
as a colourless oil: [α]D -49.6 (c, 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.76 (d, J = 6.7 
Hz, 3H), 2.30-2.40 (m, 1H), 4.25 (d, J = 7.7 Hz, 1H), 5.10-5.14 (m, 2H), 5.74-5.82 (m, 1H), 
6.93-6.99 (m, 2H), 7.14-7.20 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 16.5 (CH3), 43.1 (CH), 
90.4 (CH), 115.0 (CH2), 115.2 (2 x CH, JC,F = 21.4 Hz), 129.31 (2 x CH, JC,F = 8.3 Hz), 134.8 
(C, JC,F = 2.9 Hz), 140.8 (CH), 162.6 (C, JC,F = 245.4 Hz); 19F NMR (376 MHz, CDCl3) δ 
-114.8 (1F); IR ν 3500, 3017, 2970, 2360, 2330, 1604, 1512, 1219 cm-1; MS (CI/isobutane) m/z 
(%) 195 [(M + H)+, 70], 163 (100), 125 (28); HRMS (CI/isobutane) 196.1145 (C11H14FNO + 
H+ requires 196.1132); ee and de correspond to those of the starting alcohol (vide supra): 98% 
ee and >30:1 dr by 1H NMR.  
 
Method H: General Procedure for the Synthesis of N-Boc Derivatives of Alkoxyamines  
A solution of the respective alkoxyamine (1.0 mmol) and (Boc)2O (2.0 mmol) in CH2Cl2 (15 
mL) was added to a solution of NaOH (2.0 mmol) in deionized water (5 mL) and the resulting 
two-phase mixture was stirred at room temperature for 24 h. The organic layer was separated 
and the aqueous layer was extracted with CH2Cl2 (3×25 mL). The combined organic extracts 
were dried over Na2SO4 and the solvent was removed in vacuum. The product was purified on 
a column of silica gel (1.5×20 cm) using a gradient of petroleum ether and ethyl acetate as 
eluent (100:0 to 85:15). 
 
 
 
tert-Butyl (±)-{[1-(4’-Methoxyphenyl)-3-buten-1-yl]oxy}carbamate (265b). Method H, 
starting with racemic 257b, afforded (±)-265b (193 mg, 85%) as a colourless oil: 1H NMR 
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(400 MHz, CDCl3) δ 1.38 (s, 9H), 2,37-2.44 (m, 1H), 2.63-2.70 (m, 1H), 3.74 (s, 3H), 4.67 (t, J 
= 6.9 Hz, 1H), 4.95-5.05 (m, 2H), 5.71 (ddd, J = 17.0, 10.0, and 6.9 Hz, 1H), 6.83 (d, J = 8.5 
Hz, 2H), 7.18 (d, J = 7.3 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 39.5 (CH2), 
55.3 (CH3), 81.6 (C), 86.6 (CH), 113.9 (2 × CH), 117.4 (CH2), 128.6 (2 × CH), 131.7 (C), 
134.0 (CH), 156.4 (C), 159.6 (C); IR ν 3372, 2978, 2254, 1735, 1697, 1612, 1512, 1250 cm-1; 
MS (CI/isobutane) m/z (%) 161 [(M-ONHBoc)+, 100]; HRMS (CI/isobutene) 161.0963 
[(C11H13O)+ requires 161.0966]; note that the MS could only detect the benzylic cation, which 
is much more stable than the molecular peak. The product was identical with its almost 
enantiopure version (-)-261b (except for the optical rotation).  
    
 
 
tert-Butyl (R)-(+)-{[1-(4’-Fluorophenyl)-3-buten-1-yl]oxy}carbamate (265c).  Method H, 
starting with (S)-257c (90% ee), afforded 265c (329 mg, 92%) as a colourless oil: [α]D +108.6 
(c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.38 (s, 9H), 2.40 (ddd J = 14.2, 6.9, 6.8 Hz, 
1H), 2.66 (ddd, J = 14.2, 7.2, 7.0 Hz, 1H), 4.71 (t, J = 7.0 Hz, 1H), 4.96-5.04 (dd, J = 17.1, 10.2 
Hz, 2H), 5.69 (dddd, J = 17.1, 10.2, 7.0, 6.9 Hz, 1H), 6.81 (br s, 1H), 6.98 (t, J = 8.7 Hz, 2H), 
7.23 ( dd, J = 8.7, 5.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 39.6 (CH2), 
81.8 (C), 86.4 (CH), 115.4 (2 × CH, JC,F = 21.4 Hz), 117.74 (CH2), 129.0 (2 × CH, J = 8.1 Hz), 
133.5 (CH), 135.6 (C, JC,F = 3.2 Hz), 156.5 (C), 162.6 (C, JC,F = 246.4 Hz); 19F NMR (376.5 
MHz, CDCl3) δ -113.9 (1F); IR ν 3302, 2978, 2931, 1736, 1705, 1604, 1512, 1443, 1366, 1227, 
1165, 1103, 1003, 918, 833 cm-1; MS (FAB/NOBA) m/z (%) 282 [(M + H)+, 16], 226 (29), 150 
(100), 138 (14), 110 (12); HRMS (FAB+) 282; (C15H20FNO3 + H+ requires 282.1505). 
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tert-Butyl (R)-(+)-{[1-(4’-Bromophenyl)-3-buten-1-yl]oxy}carbamate (265d). Method H, 
starting with (S)-257d (90% ee), afforded 265d (246 mg, 82%) as a colourless oil: [α]D +124.5 
(c 0.83, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.47 (s, 9H), 2.48 (m, 1H), 2.73 (m, 1H), 4.79 
(t, J = 6.9 Hz, 1H), 5.09 (m, 2H), 5.73-5.83 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 6.91 (br s, 1H), 
7.23 (d, J = 8.4 Hz, 2H), 7.51 (d, J = 8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × 
CH3), 39.5 (CH2), 81.8 (C), 86.4 (CH), 117.9 (CH2), 122.2 (C), 129.0 (2 × CH), 131.6 (2 × 
CH), 133.3 (CH), 138.9 (C), 156.4 (C); IR ν 3289, 2980, 2924, 1743, 1697, 1604, 1490, 1368, 
1250, 1163, 1100, 1011, 920, 820 cm-1; MS (FAB/NOBA) m/z (%) 342 [(M + H)+ 15], 286 
(22), 209 (100), 131 (38), 130 (18); HRMS (FAB+) 342.0709 (C15H2279BrO3N + H+  requires 
342.0705). 
 
 
 
tert-Butyl (R)-(+)-{[1-(4’-Nitrophenyl)-3-buten-1-yl]oxy}carbamate (265e). Method H, 
starting with (S)-257e (92% ee), afforded 265e (248 mg, 77%) as a yellowish oil: [α]D +113.4 
(c 1.2, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.37 (s, 9H), 2.42 (m, 1H), 2.65 (m, 1H), 4.85 (t, 
J = 6.8 Hz, 1H), 4.99 (m, 2H), 5.63-5.73 (ddd, J = 16.7, 9.7, 7.0 Hz, 1H), 7.10 (br s, 1H), 7.44 
(d, J = 8.7 Hz, 2H), 8.14 ( d, J = 8.7 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.1 (3 × CH3), 
39.6 (CH2), 82.1 (C), 86.1 (CH), 118.4 (CH2), 123.6 (2 × CH), 128.0 (2 × CH), 132.6 (CH), 
147.6 (C), 147.7 (C), 156.6 (C); IR ν 3306, 3080, 2980, 2930, 1719, 1697, 1607, 1520, 1456, 
1368, 1344, 1248, 1161, 1103, 1013, 920, 854, 799, 775 cm-1; MS (CI/isobutane) m/z (%) 309 
[(M + H)+, 7], 253 (88), 194 (37), 176 (100), 162 (22), 146 (82), 134 (41), 118 (28) ; HRMS 
(CI/isobutene) 309.1454 (C15H20N2O5 + H+ requires 309.1450). 
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tert-Butyl (R)-(+)-{[1-(3’-Methoxyphenyl)-3-buten-1-yl]oxy}carbamate (265f). Method H, 
starting with (S)-257f (88% ee), afforded 265f (294 mg, 97%) as a colourless oil: [α]D +142.9 (c 
0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.38 (s, 9H), 2.40 (m, 1H), 2.63 (m, 1H), 3.75 (s, 
3H), 4.70 (t, J = 6.9 Hz, 1H), 4.96|-5.06 (m, 2H), 5.68-5.80 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 
6.77-6.86 (m, 4H), 7.21 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 39.8 (CH2), 
55.2 (CH3), 81.6 (C), 87.0 (CH), 112.6 (CH), 113.6 (CH), 117.5 (CH2), 119.5 (CH), 129.6 
(CH), 133.8 (CH), 141.6 (CH), 156.4 (C), 159.8 (C); IR ν 3310, 2980, 2926, 1740, 1701, 1605, 
1456, 1437, 1368, 1258, 1248, 1161, 1103, 1043, 1013, 918, cm-1; MS (FAB/NOBA) m/z (%) 
294 [(M + H)+, 11], 238 (27), 162 (100); HRMS (FAB+) 294.1710 [(C16H23NO4 + H+) requires 
294.1705]. 
 
ONHBoc
 
 
tert-Butyl (1R,2S)-(+)-[(1-Phenyl-2-methyl-3-buten-1-yl)oxy)carbamate (265g). Method H, 
starting with pure (1R,2S)-257g (95% ee; 35:1 syn/anti ratio), afforded 265g  (521 mg, 98%) as 
a colourless oil: [α]D +165.2 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.13 (d, J = 6.8 Hz, 
3H), 1.37 (s, 9H), 2.60 (dd, J = 7.4, 6.8 Hz, 1H), 4.49 (d, J = 7.4 Hz, 1H), 4.85 (m, 2H), 5.54 
(ddd, J = 17.2, 10.2, 7.4 Hz, 1H), 6.80 (br s, 1H), 7.17-7.30 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 16.1 (CH3), 28.2 (3 × CH3), 42.5 (CH), 81.5 (C), 91.3 (CH), 115.2 (CH2), 127.8 (2 × 
CH), 128.0 (CH), 128.2 (2 × CH), 138.9 (C), 139.3 (CH), 159.3 (C); IR ν 3302, 2978, 2932, 
1705, 1451, 1437, 1366, 1250, 1165, 1096, 1003, 918, 849, 756, 702 cm-1; MS (FAB/NOBA) 
m/z (%) 278 [(M + H)+, 6], 222 (15), 145 (100); HRMS (FAB) 278.1755 (C16H23NO3 + H+) 
requires 278.1756).  
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tert-Butyl (1R,2S)-(+)-{[1-(4’-Fluorophenyl)-2-methyl-3-buten-1-yl]oxy}carbamate (265h). 
Method H, starting with pure (1R,2S)-257h (98% ee; 28:1 syn/anti ratio), afforded 265h (140 
mg, 76%,) as a pale yellow oil: [α]D +138.5 (c, 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.12 
(d, J = 6.8 Hz, 3H), 1.38 (s, 9H), 2.53-2.63 (m, 1H), 4.47 (d, J = 7.5 Hz, 1H), 4.82-4.86 (m, 
2H), 5.51 (ddt, J = 17.1, 10.5, and 7.5 Hz, 1H), 6.77 (s, 1H), 6.94-6.99 (m, 2H), 7.14-7.19 (m, 
2H); 13C NMR (100 MHz, CDCl3) δ 15.2 (CH3), 27.2 (3 × CH3), 41.4 (CH), 80.7 (C), 89.6 
(CH), 115.1 (2 x CH, JC,F = 21.9 Hz), 115.9 (CH2), 129.5 (2 x CH, JC,F = 7.8 Hz), 134.7 (C, JC,F 
= 3.4 Hz), 138.0 (CH), 156.3 (C), 162.5 (C, JC,F = 246.4 Hz); 19F NMR (376 MHz, CDCl3) δ 
-114.2 (1F); IR ν 3300, 3020, 2980, 2361, 2343, 1734, 1701, 1602, 1510, 1224 cm-1; MS 
(FAB/NOBA) m/z (%) 296 [(M + H)+, 5], 240 (15), 163 (100); HRMS (FAB+) 296.1664 
(C16H22FNO3 + H+ requires 296.1656).  
 
 
 
tert-Butyl (S)-(–)-{[1-(4’-Methoxyphenyl)-3-buten-1-yl]oxy}carbamate (266b). Method H, 
starting with pure (S)-261b (96% ee), afforded 266b  (215 mg, 79%,) as a colourless oil: [α]D 
-139.1 (c, 1.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.37 (s, 9H), 2.36-2.44 (m, 1H), 2.62-
2.70 (m, 1H), 3.73 (s, 3H), 4.67 (t, J = 7.1 Hz, 1H), 4.94-5.04 (m, 2H), 5.71 (ddt, J = 17.1, 10.2, 
and 7.0 Hz, 1H), 6.79 (s, 1H), 6.82 (br d, J = 8.7 Hz, 2H), 7.18 (br d, J = 8.7 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 39.5 (CH2), 55.3 (CH3), 81.5 (C), 86.3 (CH), 113.9 
(2 × CH), 117.4 (CH2), 128.6 (2 × CH), 131.7 (C), 133.9 (CH), 156.4 (C), 159.6 (C); IR ν 
3372, 2978, 2254, 1735, 1697, 1612, 1512, 1250 cm-1; MS (CI/isobutane) m/z (%) 161 [(M-
ONHBoc)+, 100]; HRMS (CI/isobutene) 161.0963 [(C11H13O+ requires 161.0966]; The product 
was identical with its racemic version 265b (except for the optical rotation). 
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tert-Butyl (1S,2S)-(–)-{[2-Methyl-1-phenyl-3-buten-1-yl]oxy}carbamate (266g). Method H, 
starting with pure (1S,2S)-261g (95% ee; 55:1 anti/syn ratio), afforded 266g (185 mg, 69%,) as 
a colourless oil: [α]D -149.4 (c, 1.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.80 (d, J = 7.0 Hz, 
3H), 1.36 (s, 9H), 2.49-2.58 (m, 1H), 4.50 (d, J = 7.8 Hz, 1H), 4.98-5.03 (m, 2H), 5.90-5.99 (m, 
1H), 6.81 (s, 1H), 7.19-7.30 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 16.4 (CH3), 28.2 (3 × 
CH3), 42.5 (CH), 81.4 (C), 91.3 (CH), 114.7 (CH2), 127.6 (2 × CH), 128.1 (CH), 128.3 (2 × 
CH), 138.9 (C), 140.4 (CH), 156.2 (C); IR ν 3300, 3019, 2982, 1740, 1695, 1635, 1215 cm-1; 
MS (FAB/NOBA) m/z (%) 278 [(M+H)+, 8], 222 (18), 145 (100); HRMS (FAB) 278.1753 
(CB16BHB23NO3 + H+) requires 278.1756). 
 
 
 
 
 
tert-Butyl (1S,2S)-(–)-{[1-(4’-Fluorophenyl)-2-methylbut-3-en-1-yl]oxy}carbamate (266h). 
Method H, starting with pure (1S,2S)-261h (98% ee; 35:1 anti/syn ratio), afforded 266h (185 
mg, 69%) as a colourless oil: [α]D -150.6 (c, 1.3, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.80 
(d, J = 7.0 Hz, 3H), 1.36 (s, 9H), 2.49-2.58 (m, 1H), 4.50 (d, J = 7.8 Hz, 1H), 4.98-5.03 (m, 
2H), 5.87-5.96 (m, 1H), 6.78 (s, 1H), 6.95-7.00 (m, 2H), 7.16-7.21 (m, 2H); 13C NMR (100 
MHz, CDCl3) δ 16.4 (CH3), 28.2 (3 × CH3), 42.6 (CH), 81.7 (C), 90.7 (CH), 116.0 (CH2), 115.2 
(2 x CH, JC,F = 21.4 Hz), 129.3 (2 x CH, JC,F = 8.3 Hz), 134.8 (C, JC,F = 8.3 Hz), 140.3 (CH), 
156.3 (C), 162.5 (C, JC,F = 8.3 Hz); 19F NMR (376 MHz, CDCl3) δ -114.1 (1F); IR ν 3300, 
3021, 2980, 2365, 1740, 1694, 1606, 1511cm-1; MS (FAB+) m/z (%) 296 [(M+H)+, 6], 240 
(16), 163 (100); HRMS (FAB+) 296.1665 (C16H22FNO3 + H+ requires 296.1662). 
 155 
 
 
tert-Butyl (S,E)-(–)-[(1-Phenyl-3-penten-1-yl)oxy]carbamate (267). Method H, starting from 
(R)-256 (90% ee), afforded 267 (285 mg, 91%) as a colourless oil: [α]D -155.5 (c 0.75, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.38 (s, 9H), 1.54 (d, J = 6.2 Hz, 3H), 2.35 (m, 1H), 
2.59 (m, 1H), 4.67 (t, J = 6.9 Hz, 1H), 5.27-5.47 (m, 2H), 6.79 (br s, 1H), 7.22-7.31 (m, 5H); 
13C NMR (100 MHz, CDCl3) δ 18.0 (CH3), 28.2 (3 × CH3), 38.5 (CH2), 81.5 (C), 87.6 (CH), 
126.1 (CH), 127.3 (2 × CH), 128.1 (CH), 128.2 (CH), 128.5 (2 × CH), 140.0 (C), 156.4 (C); IR 
ν 3322, 2982, 2932, 1740, 1709, 1454, 1393, 1370, 1265, 1246, 1161, 1103, 1011, 968, 849, 
799, 733, 698 cm-1; MS (FAB+) m/z (%) 278 [(M+H)+ 18], 254 (37), 222 (53), 146 (100), 118 
(17); HRMS (FAB+) 278.1753 (C16H23NO3 + H+ requires 278.1756). 
 
Method I: General Procedure for the Palladium-Catalysed Cyclization/Carbonylation 
A round-bottom flask was charged with PdCl2 (0.1 mmol) and (AcO)2Cu.2H2O (3.0 mmol) and 
flushed with CO. The flask was then connected to a CO balloon (atmospheric pressure). Methyl 
orthoacetate (10 mL) was added and the resulting solution was stirred at room temperature for 
30 min. A solution of the respective Boc-protected alkoxyamine (1.0 mmol) in MeOH (10 mL) 
was added in one portion and the mixture was stirred at 40 oC until completion of the reaction 
(monitored by TLC), typically 48 h. The reaction was quenched with a saturated solution of 
NaHCO3 (5 mL), the mixture was diluted with deionized water (5 mL) and extracted with ethyl 
acetate (4×10 mL). The combined organic phase was dried over Na2SO4 and the solvent was 
evaporated in vacuum. The product was purified by chromatography on a column of silica gel 
(1.5×10 cm) using a gradient of petroleum ether and ethyl acetate (100:0 to 90:10). 
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(3S*,5R*)-(±)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-phenylisoxazolidine 
(268a). Method I, starting with (±)-265a,86 afforded a crude product (a >50:1 mixture of 
syn/anti diastereoisomers, as evidenced by 1H NMR), which was purified by chromatography 
on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and ethyl acetate as 
eluent (100:0 to 90:10) to afford pure 268a (108 mg, 93%) as a colourless dense oil, in which 
the opposite diastereoisomer could not be detected by NMR: 1H NMR (400 MHz, CDCl3) δ 
1.54 (s, 9H), 2.04 (ddd, J = 12.6, 9.0, and 6.1 Hz, 1H), 2.64 (dd, J = 15.9 and 8.8 Hz, 1H), 
2.94-3.0 (m, 2H), 3.71 (s, 3H), 4.72 (m, 1H), 4.92 (dd, J = 9.9 and 6.6 Hz, 1H), 7.32-7.45 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 40.7 (CH2), 43.2 (CH2), 51.8 (CH3), 57.4 
(CH), 82.2 (CH), 82.8 (CH), 126.6 (CH), 128.5 (CH), 128.6 (CH), 137.1 (C), 157.4 (C), 171.2 
(C) in accordance with the literature data;86 IR ν 2978, 1735, 1707, 1740, 1709, 1437, 1367, 
1318, 1255,  1161, 1064. 968 cm-1; MS (CI/isobutane) m/z (%) 322 [(M + H)+, 5], 266 (100), 
222 (45); HRMS (CI/isobutane) 322.1652 (C17H23NO5 + H+ requires 322.1654).  
 
 
 
(3S*,5R*)-(±)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(4’-methoxyphenyl) 
isoxazolidine (268b). Method I, starting with (±)-265b, afforded a crude product (a 22:1 
mixture of syn/anti diastereoisomers, as evidenced by 1H NMR), which was purified by 
chromatography on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and 
ethyl acetate as eluent (100:0 to 90:10) to afford pure 268b (149 mg, 80%) as a pale yellow oil: 
1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 1.94 (ddd, J = 12.6, 10.1, and 6.3 Hz, 1H), 2.56 
(dd, J = 15.8 and 8.8 Hz, 1H), 2.83 (ddd, J = 12.6, 8.2, and 6.4 Hz, 1H), 2.88 (dd, J = 15.8 and 
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5.5 Hz, 1H), 3.62 (s, 3H), 3.73 (s, 3H), 4.58-4.65 (m, 1H), 4.77 (dd, J = 10.1, 6.4 Hz, 1H), 6.82 
(d, J = 8.8 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H); 13C NMR (100.6 MHz, CDCl3) δ 28.2 (3 × CH3), 
40.7 (CH2), 42.9 (CH2), 51.8 (CH), 55.3 (CH3), 57.5 (CH3), 82.2 (C), 82.7 (CH), 113.9 (2 × 
CH), 128.2 (2 × CH), 128.7 (C), 157.4 (C), 159.8 (C), 171.3 (C); MS (CI/isobutane) m/z (%) 
352 [(M+H)+, 8], 296 (100), 252 (94), 219 (76), 137 (92); HRMS (CI/isobutane) 352.1758 
(C18H25NO6 + H+ requires 352.1760). The diastereoisomeric purity was >50:1 as the anti-
isomer could not be detected 1H NMR spectroscopy. The product was identical with its 
enantiopure version (-)-269b (except for the optical rotation). 
 
 
 
(3S,5R)-(–)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(4’-fluorophenyl) 
isoxazolidine (268c). Method I, starting with (R)-265c (90% ee), afforded a crude product (a 
16:1 mixture of diastereoisomers, as evidenced by 19F NMR) (20:1 by 1H NMR), which was 
purified by chromatography on a column of silica gel (1.5×20 cm), using a gradient of 
petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to furnish pure 268c (128 mg, 76%) 
(>40:1 by both 1H and 19F NMR), followed by a 3:1 mixture of 268c and the anti-
diastereoisomer (15 mg, 9%). 268c: viscous, colourless oil: [α]D -4.2 (c 1.1, CHCl3); 1H NMR 
(400 MHz, CDCl3) δ 1.45 (s, 9H), 1.93 (ddd, J = 12.6, 10.0, and 6.2 Hz, 1H), 2.56 (dd, J = 15.8 
and 8.8 Hz, 1H), 2.83-2.90 (m, 2H), 3.63 (s, 3H), 4.58-4.65 (m, 1H), 4.80 (dd, J = 10.0 and 6.4 
Hz, 1H), 6.98 (t, J = 8.7 Hz, 2H), 7.29 (dd, J = 8.7 and 5.4 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 28.2 (3 × CH), 40.7 (CH2), 43.2 (CH2), 51.8 (CH), 57.5 (CH3), 82.2 (CH), 82.4 (C), 
115.5, (2 × CH, JC,F = 21.6 Hz), 128.5 (2 × CH, JC,F = 8.3 Hz), 132.8 (C, JC,F = 3.1 Hz), 157.3 
(C), 163.3 (C, JC,F = 247.0 Hz), 171.2 (C); 19F NMR (376.5 MHz, CDCl3) δ -113.2; IR ν 2954, 
2923, 2853, 1734, 1608, 1514, 1457, 1438, 1369, 1327, 1301, 1258, 1227, 1157, 1064, 834, 
758 cm-1; MS (CI/isobutane) m/z (%) 340 [(M + H)+, 46], 284 (100) 240 (90), 239 (71), 207 
(21), 155 (17), 119 (37); HRMS (CI/isobutane) 340.1559 [(C17H22FNO5 + H+) requires 
340.1560). 
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(3S,5R)-(+)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(4’-bromophenyl) 
isoxazolidine (268d). Method I, starting with (R)-265d (90% ee), afforded a crude product (a 
>50:1 mixture of diastereoisomers, as evidenced by 1H NMR), which was purified by 
chromatography on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and 
ethyl acetate as eluent (100:0 to 90:10) to furnish pure 268d (229 mg, 93%) as a colourless 
dense oil: [α]D +8.5 (c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 1.89 (ddd,  J = 
12.6, 9.9, and 6.1 Hz, 1H), 2.52 (dd, J = 15.9 and 8.8 Hz, 1H), 2.86 (m, 2H), 3.61 (s, 3H), 4.60 
(m, 1H), 4.79 (dd, J = 9.8 and 6.6 Hz, 1H), 7.18 (d, J = 8.3 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 28.1 (3 × CH3), 40.6 (CH2), 43.1 (CH2), 51.8 (CH3), 57.5 (CH), 82.0 (CH), 82.4 (C) 
122.4 (CH), 128.2 (2 × CH), 131.7 (2 × CH), 136.3 (C), 157.2 (C), 171.1 (C); IR ν 2978, 1732, 
1593, 1489, 1438, 1370, 1300, 1254, 1200, 1157, 1069, 1011, 953, 899, 845, 818, 752 cm-1; 
MS (CI/isobutane) m/z (%) 400 [(M+H)+, 17], 344 (100) 300 (16), 266 (13); HRMS 
(CI/isobutane) 400.0753 [(C17H2279BrNO5 +  H+) requires 400.0760].  
 
 
 
(3S,5R)-(+)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(4’-nitrophenyl) 
isoxazolidine (268e). Method I, starting with (R)-265e (92% ee), afforded a crude product (a 
25:1 mixture of diastereoisomers, as evidenced by 1H NMR), which was purified by 
chromatography on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and 
ethyl acetate as eluent (100:0 to 90:10) to furnish pure 268e (160 mg, 73%) as a yellowish oil 
(>50:1 dr): [α]D +14.8 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.45 (s, 9H), 1.93 (ddd, J 
= 12., 9.7, 6.0 Hz, 1H), 2.52 (dd, J = 15.9 and 8.8 Hz, 1H), 2.87 (dd, J = 15.9 and 5.4 Hz, 1H), 
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2.97 (ddd, J = 12.6, 8.2, and 6.8 Hz, 1H), 3.62 (s, 3H), 4.63 (m, 1H), 4.95 (dd, J = 9.7 and 6.8 
Hz, 1H), 7.49 (d, J = 8.4 Hz, 2H), 8.15 (d, J = 8.8 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 
28.2 (3 × CH3), 40.5 (CH2), 43.3 (CH2), 51.8 (CH3), 57.6 (CH), 81.2 (CH), 82.8 (C), 123.8 (2 × 
CH), 127.1 (2 × CH), 144.8 (C), 147.8 (C), 157.1 (C), 170.9 (C); IR ν 2982, 1732, 1604, 1524, 
1454, 1439, 1370, 1346, 1300 1254, 1200, 1157, 1107, 1015, 853, 748 cm-1; MS (CI/isobutane) 
m/z (%) 367 [(M + H)+,  9], 337 (19), 311 (100), 281 (96), 267 (35), 237 (22), 204 (20), 160 
(27), 122 (36), 113 (38); HRMS (CI/isobutane) 367.1510 (C17H22N2O7 + H+ requires 
367.1505).  
 
CO2Me
Boc
O N
MeO
 
 
(3S,5R)-(–)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(3’-methoxyphenyl) 
isoxazolidine (268f). Method I, starting with (R)-265f (88% ee), afforded a crude product (as a 
pure diastereoisomer; the anti-diastereoisomer could not be detect by 1H NMR), which was 
further purified by chromatography on a column of silica gel (1.5×20 cm), using a gradient of 
petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to furnish pure 268f (182 mg, 96%) 
as a colourless oil: [α]D -1.8 (c 1.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.45 (s, 9H), 1.93 
(ddd, J = 12.6, 9.8, 6.0 Hz, 1H), 2.54 (dd, J =  15.8, 8.8 Hz, 1H), 2.87 (m, 2H), 3.62 (s, 3H), 
3.74 (s, 3H), 4.62 (m, 1H), 4.81 (dd, J = 9.8, 6.6 Hz, 1H), 6.79 (m, 1H), 6.88 (m, 2H), 7.20 (m, 
1H); 13C NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 40.7 (CH2), 43.2 (CH2), 51.8 (CH3), 55.3 
(CH3), 57.4 (CH), 82.3 (C), 82.6 (CH), 111.9 (CH), 114.1 (CH), 118.8 (CH), 129.6 (CH), 138.8 
(C), 157.4 (C), 159.8 (C), 171.2 (C); IR ν 2978, 2955, 2931, 1734, 1703, 1605, 1587, 1456, 
1437, 1370, 1321, 1258, 1159, 1064, 850 cm-1; MS (CI/isobutane) m/z (%) 352 [(M + H)+, 7], 
296 (100), 252 (49), 154 (17), 137 (22), 124 (19),113 (15); HRMS (CI/isobutane) 352.1761 
(C18H25NO6 + H+ requires 352.1760). 
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(3R,4S,5R)-(+)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-4-methyl-5-
phenylisoxazolidine (268g) (syn,syn). Method I, starting with (1R,2S)-265g (95% ee; 55:1 
syn/anti ratio), afforded a crude product (a 4.5:1 mixture of syn,syn and syn,anti 
diastereoisomers, as evidenced by 1H NMR), which was purified by chromatography on a 
column of silica gel (1.5×20 cm), using a gradient of petroleum ether and ethyl acetate as eluent 
(100:0 to 90:10) to furnish pure 268g (89 mg, 69%) as a lipophilic component and its syn,anti-
diastereoisomer (21 mg, 16%) as a more polar component. Pure (+)-268g (50:1 
syn,syn/syn,anti): a colourless oil; [α]D +11.2 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
0.56 (d, J = 7.3 Hz, 3H), 1.45 (s, 9H), 2.54 (dd, J = 16.6 and 9.2 Hz, 1H), 2.86-2.99 (m, 2H), 
3.63 (s, 3H), 4.61 (ddd, J = 9.2, 7.0, and 6.0 Hz, 1H), 5.07 (d, J = 5.9 Hz, 1H), 7.19-7.33 (m, 
5H); 13C NMR (100 MHz, CDCl3) δ 10.8 (CH3), 28.2 (3 × CH3), 35.6 (CH2), 42.6 (CH), 51.8 
(CH3), 61.0 (CH), 82.2 (C), 84.7 (CH), 126.2 (2 × CH), 127.7 (CH), 128.2 (2 × CH), 135.6 (C), 
158.0 (C), 171.7 (C); IR ν 2978, 2951, 1736, 1701, 1454, 1439, 1370, 1330, 1292, 1254, 1169, 
1092, 1030, 991, 960, 852, 702 cm-1; MS (CI/isobutane) m/z (%) 336 [(M + H)+, 11], 280 (100), 
236 (77); HRMS (CI/isobutane) 336.1812 (C18H25NO5 + H+ requires 336.1811).  
 
 
 
Pure syn,anti-diastereoisomer 268g’ (27:1 dr by 1H NMR). Obtained by chromatography 
along with 268g as the more polar component (29 mg, 23%): a colourless oil; [α]D +34.2 (c 1.6, 
CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.65 (d, J = 7.2 Hz, 3H), 1.47 (s, 9H), 2.59 (m, 1H), 
2.64 (dd, J = 15.8 and 9.2 Hz, 1H), 2.88 (dd, J = 15.8 and 4.9 Hz, 1H), 3.66 (s, 3H), 4.28 (ddd, 
J = 9.2, 4.9, and 2.3 Hz, 1H), 5.26 (d, J = 5.9 Hz, 1H), 7.18-7.31 (m, 5H); 13C NMR (100 MHz, 
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CDCl3) δ 14.9 (CH3), 28.3 (3 × CH3), 38.7 (CH2), 45.2 (CH), 51.8 (CH3), 63.6 (CH), 82.1 (C), 
83.1 (CH), 126.3 (2 × CH), 127.7 (CH), 128.2 (2 × CH), 136.1 (C), 155.9 (C), 171.2 (C); IR ν 
2970, 2931, 2859, 1736, 1705, 1605, 1454, 1370, 1343, 1312, 1261, 1169, 1088, 1022, 752  
cm-1; MS (CI/isobutane) m/z (%) 336 [(M + H)+, 32], 280 (61), 236 (100), 118 (55); HRMS 
(FAB) 336.1807 [(C18H25NO5 + H+) requires 336.1811].  
 
 
 
(3R,4S,5R)-(+)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-4-methyl-5-(4’-
fluorophenyl)isoxazolidine (268h). Method I, starting with (1R,2S)-265hh (98% ee; 28:1 
syn/anti ratio),), afforded a crude product (a 5.7:1 mixture of diastereoisomers, as evidenced by 
19F NMR), which was purified by chromatography on a column of silica gel (1.5×20 cm), using 
a gradient of petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to furnish pure 268h 
(116 mg, 60%) as a pale yellow oil: [α]D +10.9 (c, 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 
0.55 (d, J = 7.3 Hz, 3H), 1.44 (s, 9H), 2.54 (dd, J = 16.4 and 9.2 Hz, 1H), 2.87 (dd, J = 16.5 and 
5.9 Hz, 1H), 2.88-2.96 (m, 1H), 3.63 (s, 3H), 4.59 (ddd, J = 9.1, 7.0, and 6.1 Hz, 1H), 5.05 (d, J 
= 6.1 Hz, 1H), 6.94-7.00 (m, 2H), 7.16-7.21 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 10.2 
(CH3), 28.2 (3 × CH3), 35.5 (CH2), 42.6 (CH), 51.8 (CH3), 61.0 (CH), 82.4 (C), 83.1 (CH), 
115.2 (2 × CH, JC,F = 21.9 Hz), 127.9 (2 × CH, JC,F = 7.8 Hz), 131.3 (C, JC,F = 2.9 Hz), 157.8 
(C), 162.2 (C, JC,F = 245.93 Hz), 171.5 (C); 19F NMR (376 MHz, CDCl3) δ -114.3 (1F); IR ν 
3020, 2981, 2354, 1733, 1712sh, 1513 cm-1; MS (CI/isobutane) m/z (%) 354 [(M + H)+, 12], 
298 (100), 254 (100); HRMS (CI/isobutane) 354.1721 (C18H24FNO5 + H+ requires 354.1711); 
19F NMR showed 37:1 dr.  
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(3R,5S)-(–)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(4’-methoxyphenyl) 
isoxazolidine (269b). Method I, starting with (S)-266b (96% ee), afforded a crude product (a 
≥25:1 mixture of diastereoisomers, as revealed by the 1H NMR spectrum), which was purified 
by chromatography on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether 
and ethyl acetate as eluent (100:0 to 90:10) to furnish pure 269b (193 mg, 78%) as a colourless 
oil: [α]D -2.7 (c, 1.6, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 1.94 (ddd, J = 12.6, 
10.1, and 6.2 Hz, 1H), 2.56 (dd, J = 15.8 and 8.8 Hz, 1H), 2.82 (ddd, J = 12.6, 8.3, and 6.3 Hz, 
1H), 2.88 (dd, J = 15.7 and 5.5 Hz, 1H), 3.62 (s, 3H), 3.73 (s, 3H), 4.58-4.64 (m, 1H), 4.77 (dd, 
J = 10.1 and  6.4 Hz, 1H), 6.82 (br d, J = 8.8 Hz, 2H), 7.24 (br d, J = 8.7 Hz, 2H); 13C NMR 
(100 MHz, CDCl3) δ 28.2 (3×CH3), 40.7 (CH2), 42.9 (CH2), 51.7 (CH3), 55.3 (CH3), 57.4 (CH), 
82.2 (C), 82.7 (CH), 114.0 (2×CH), 128.2 (2×CH), 128.8 (C), 157.8 (C), 159.9 (C), 171.2 (C); 
IR ν 2979, 2358, 2336, 1736, 1702sh, 1517 cm-1; MS (FAB+) m/z (%) 352 [(M+H)+, 40], 296 
(100), 252 (70), 219 (100); HRMS (CI/isobutane) 352.1763 (C18H25NO6 + H+ requires 
352.1755); 1H NMR showed >50:1 dr. The product was identical with its racemic version 268b 
(except for the optical rotation).  
 
CO2Me
Boc
O N
 
 
(3S,4S,5S)-(+)-N-tert-Butoxycarbonyl-3-(Methoxycarbonylmethyl)-4-methyl-5-phenyl-
isoxazolidine (269g). Method I, starting with (1S,2S)-266g (95% ee; 55:1 anti/syn ratio), 
afforded a crude product (a >20:1 mixture of diastereoisomers, as evidenced by 1H NMR), 
which was purified by chromatography on a column of silica gel (1.5×20 cm), using a gradient 
of petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to furnish pure 269g (193 mg, 
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71%) as a colourless oil: [α]D +12.2 (c, 1.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.09 (d, J = 
6.8 Hz, 3H), 1.45 (s, 9H), 2.22-2.31 (m, 1H), 2.62 (dd, J = 15.3 and 8.1 Hz, 1H), 2.83 (dd, J = 
15.3 and 5.6 Hz, 1H), 3.62 (s, 3H), 4.20 (ddd, J1 = 8.1 Hz,  J2 = J3 = 5.6 Hz, 1H), 4.35 (d, J = 
8.8 Hz, 1H), 7.24-7.31 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 15.8 (CH3), 28.2 (3×CH3), 
39.9 (CH2), 51.8 (CH), 51.9 (CH), 64.6 (CH3), 82.2 (C), 89.9 (CH), 126.8 (2×CH), 128.6 
(2×CH), 128.7 (CH), 136.5 (C), 157.4 (C), 171.2 (C); IR ν 3020, 2984, 2364, 2337, 1734, 1516 
cm-1; MS (CI/isobutane) m/z (%) 336 [(M + H)+, 5], 280 (100), 236 (53); HRMS 
(CI/isobutane) 336.1821 (C18H26NO5 + H+ requires 336.1805); 1H NMR showed >50:1 dr. 
 
 
 
(3S,4S,5S)-(+)-N-tert-Butoxycarbonyl-3-(Methoxycarbonylmethyl)-4-methyl-5-(4’-
fluorophenyl)isoxazolidine (269h). Method I, starting with (1S,2S)-266h (98% ee; 35:1 
anti/syn ratio), afforded a crude product (a 17:1 mixture of diastereoisomers, as evidenced by 
19F NMR), which was purified by chromatography on a column of silica gel (1.5×20 cm), using 
a gradient of petroleum ether and ethyl acetate as eluent (100:0 to 90:10) to furnish 269h (98 
mg, 66%) as a colourless oil: [α]D +12.1 (c, 1.4, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.08 (d, 
J = 6.8 Hz, 3H), 1.45 (s, 9H), 2.21-2.29 (m, 1H), 2.62 (dd, J = 15.3 and 8.1 Hz, 1H), 2.82 (dd, J 
= 15.3 and 5.6 Hz, 1H), 3.62 (s, 3H), 4.18 (ddd, J = 8.0, 5.7, and 5.7 Hz, 1H), 4.34 (d, J = 9.1, 
1H), 6.95-7.01 (m, CH), 7.27-7.31 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 15.5 (CH3), 28.2 
(3×CH3), 39.9 (CH2), 51.69 (CH), 51.73 (CH), 64.5 (CH3), 82.3 (C), 89.1 (CH), 115.5 (2 × CH, 
JC,F = 21.9 Hz), 128.6 (2 × CH, JC,F = 8.3 Hz), 132.1 (C, JC,F = 3.4 Hz), 157.2 (C), 162.9 (C, 
JC,F = 245.9 Hz), 171.0 (C); 19F NMR (376 MHz, CDCl3) δ -114.1 (1F); IR ν 3020, 2984, 
2358, 2340, 1735, 1707sh, 1515 cm-1; MS (CI/isobutane) m/z (%) 354 [(M + H)+, 12], 298 
(100), 254 (100); HRMS (CI/isobutane) 354.1714 (C18H24FNO5 + H+ requires 354.1711); 19F 
NMR showed 50:1 dr.  
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(3R,5S,1’R)-(–)-N-tert-Butoxycarbonyl-3-{[2’-(Methoxycarbonyl)-1’-methyl]-1’-ethyl}-5-
phenyl-isoxazolidine (3R,5S,1’R)-(-)-(270). Method I, starting with (S)-267 (90% ee) and 
heating at 55 oC for 96 h, afforded a crude product (a 22:2:1 mixture of diastereoisomers, as 
evidenced by 1H NMR) as a viscous oil, which was purified by chromatography on a column of 
silica gel (1×10 cm), using a gradient of petroleum ether and ethyl acetate as eluent (20:1 to 
10:1) to afford pure 270 (33 mg, 55%) as a dense colourless oil: [α]D -18.5 (c 1.3, CHCl3); 1H 
NMR (400 MHz, CDCl3) δ 1.18 (d, J = 7.0 Hz, 3H), 1.45 (s, 9H), 2.05 (ddd, J = 12.6, 10.4, and 
6.8 Hz, 1H), 2.66 (ddd, J = 12.6, 8.5, and 6.2 Hz, 1H), 2.88 (t, J = 6.8 Hz, 1H), 4.57 (ddd, J = 
8.5, 6.7, and 6.6 Hz, 1H), 4.76 (J = 10.4 and 6.2 Hz, 1H), 7.23-7.34 (m, 5H); 13C NMR (100 
MHz, CDCl3) δ 11.8 (CH3), 28.2 (3×CH3), 39.5 (CH2), 43.6 (CH), 51.8 (CH3), 62.2 (CH), 82.2 
(C), 83.0 (CH), 126.6 (2×CH), 128.5 (CH), 128.6 (2×CH), 137.0 (C), 157.8 (C), 174.2 (C); IR 
ν 2978, 1736, 1458, 1327, 1258, 1165, 1072, 756 cm-1; MS (FAB/NOBA) m/z (%) 336 [(M + 
H)+, 58], 280 (89), 236 (100), 203 (33), 149 (75), 133 (75) ; HRMS (FAB+) 336.1808 
(C18H25NO5 + H+ requires 336.1811); 1H NMR showed 40:2.5:1 dr.  
 
 
 
(3S,5R)-(+)-N-tert-Butoxycarbonyl-3-(methoxycarbonylmethyl)-5-(2’-phenylethen-
1’yl)isoxazolidine (268i). Method I, starting with (S)-265i [40% ee, as revealed by the analysis 
of the alkoxyamine 257i), contaminated by 288 (2:1 ratio), afforded a crude product (a >20:1 
mixture of diastereoisomers, as evidenced by 1H NMR), which was purified by chromatography 
on a column of silica gel (1.5×20 cm), using a gradient of petroleum ether and ethyl acetate as 
eluent (100:0 to 90:10) to furnish 268i (211 mg, 87%) as a colourless oil (with de >>50:1 – 
opposite not visible on HNMR) unreacted 288 as less polar compound was isolated completely 
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on the collumn: [α]D + 5.9 (c 1.1, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.44 (s, 9H), 1.82 
(ddd, J = 12.6, 9.4, and 5.2 Hz, 1H), 2.51 (dd, J = 15.8 and 8.8 Hz, 1H), 2.69 (ddd, J = 12.6, 
8.1, and 6.8 Hz, 1H), 2.84 (dd, J = 15.8 and 5.5 Hz, 1H), 3.63 (s, 3H), 4.48 (m, 1H), 4.57 (m, 
1H), 6.08 (dd, J = 16.0 and 7.3 Hz, 1H), 6.63 (d, J = 16.0 Hz, 1H), 7.17-7.37 (m, 5H); 13C 
NMR (100 MHz, CDCl3) δ 28.2 (3 × CH3), 40.5 (CH2), 41.3 (CH2), 51.8 (CH3), 57.3 (CH), 
81.9 (CH), 82.2 (C), 124.9 (CH), 126.7 (2 × CH), 128.3 (CH), 128.6 (2 × CH), 134.8 (CH), 
136.0 (C), 157.3(C), 171.2 (C); MS (CI/isobutene) m/z (%) 348 [(M + H)+, 12], 292 (100), 248 
(44), 215 (43), 134 (56), 113 (46). HRMS (CI/isobutane) 348.1815 (C19H25NO5 + H+ requires 
348.1811).  
 
Method J: General Procedure for the Reduction of the Cyclization Products with 
Mo(CO)6.101 A solution of the respective isoxazolidine (0.1 mmol) in a 9:1 mixture of CH3CN 
and H2O (2.5 mL) was added to Mo(CO)6 (0.5 mmol) and the resulting solution was heated to 
reflux (~90 oC) for 2 h, during which time the colour had changed from white to black. The 
mixture was then cooled to room temperature, filtered through Celite, and the filtrate was 
evaporated. The residue was purified by chromatography on a column of silica gel (1×7 cm), 
using a gradient of petroleum ether and ethyl acetate from 9:1 to 2:1. 
 
 
 
Methyl-(3S,5R)-(+)-3-(tert-Butoxycarbamoyl)-5-hydroxy-5-(4’-fluorophenyl)valerate 
(290c). Method J, starting with 268c, produced 290c (53 mg, 65%) as a viscous colourless oil: 
[α]D +15.0 (c 2.5, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.36 (s, 9H), 1.79 (dt, J = 14.2, 5.3 
Hz, 1H), 1.97 (dt, J = 14.2, 8.1 Hz, 1H), 2.46-2.56 (m, 2H), 2.95 (br s, 1H), 3.60 (s, 3H), 3.93 
(br s, 1H), 4.68-4.70 (m, 1H), 5.20 (br d, J = 7.2 Hz, 1H),  6.95 (t, J = 8.7 Hz, 2H), 7.25 (dd, J = 
8.6, 5.4 Hz, 2H); 13C NMR (100 MHz, CDCl3) δ 28.3  (3 × CH3), 39.0 (CH2), 43.7 (CH2), 45.6 
(CH), 51.8 (CH3), 55.2 (CH3), 72.3 (CH), 115.3 (2 × CH, JC,F = 21.3 Hz), 127.5 (2 × CH, JC,F = 
8.1 Hz), 139.9 (C), 155.5 (C), 162.2 (C, JC,F = 245.4 Hz), 172.1 (C); MS (FAB+) m/z (%) 342 
[(M + H)+, 74], 286 (12), 268 (100), 207 (67), 176 (16), 147 (18); HRMS (FAB+) 342.1719 
(C18H24FNO5 + H+ requires 342.1717).  
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Methyl (3S,5R)-(+)-3-(tert-Butoxycarbamoyl)-5-hydroxy-5-(3’-methoxyphenyl)valerate 
(290f).  Method J, starting with 268f, produced 290f (39 mg, 86%) as a viscous colourless oil: 
[α]D +10.1 (c 1.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.36 (s, 9H), 1.82 (dt, J = 14.2, 5.1 
Hz, 1H), 1.97 (dt, J = 14.2, 8.1 Hz, 1H), 2.43-2.58 (m, 2H), 2.74 (br s, 1H), 3.60 (s, 3H), 3.73 
(s, 3H), 3.97 (br s, 1H), 4.68 (dd, J = 8.0, 5.0 Hz, 1H), 5.20 (br d, J = 5.6 Hz, 1H), 6.72-6.75 
(m, 1H), 6.84-6.86 (m 2H), 7.15-7.20 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 28.4  (3 × CH3), 
39.1 (CH2), 43.5 (CH2), 45.8 (CH), 51.7 (CH3), 55.2 (CH3), 72.3 (CH), 79.6 (C), 111.2 (CH), 
113.2 (CH), 118.1 (CH), 129.6 (CH), 145.9 (C), 155.5 (C), 159.8 (C), 172.1 (C); IR ν 3360, 
2974, 2931, 1709, 1690, 1601, 1508, 1493, 1454, 1439, 1366, 1316, 1254, 1211, 1165, 1045, 
860, 787 cm-1; MS (FAB+) m/z (%) 354 [(M + H)+, 38], 280 (76), 219 (62), 188 (24), 146 (31). 
HRMS (FAB+) 354.1919 (C18H27NO6 + H+ requires 354.1917). 
 
 
 
Methyl (3S,4S,5R)-(+)-3-(tert-Butoxycarbamoyl)-5-hydroxy-3-methyl-5-(phenyl)valerate 
(290g). Method J, starting with 268g, produced 290g (31 mg, 77%) as a viscous colourless oil: 
[α]D +26.0 (c 1.7, CHCl3); 1H NMR (400 MHz, CDCl3) δ 0.76 (d, J = 6.5 Hz, 3H), 1.37 (s, 
9H), 1.88-1.97 (m, 1H), 2.51 (dd, J = 15.6, 6.5. Hz 1H), 2.58–2.64 (m, 2H), 3.60 (s, 3H), 4.02 
(br s, 1H), 4.79 (br s, 1H), 4.95 (br d, J = 5.8 Hz, 1H), 7.16-7.28 (m, 5H); 13C NMR (100 MHz, 
CDCl3) δ 8.2 (CH3), 28.4 (3 × CH3), 38.2 (CH2), 43.7 (CH), 50.7 (CH), 51.8 (CH3), 75.1 (CH), 
79.7 (C), 125.8 (2 × CH), 127.2 (CH), 128.2 (2 × CH), 143.4 (C), 155.8 (C), 172.2 (C); IR ν 
3430, 3380 2978, 1694, 1504, 1454, 1439, 1366, 1250, 1165, 1018, 995, 856, 737, 702 cm-1; 
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MS (CI/isobutane) m/z (%) 338 [(M + H)+, 60], 282 (74), 264 (54), 250 (100), 189 (23), 132 
(31); HRMS (CI/isobutane) 338.1971 (C18H27NO5 + H+ requires 338.1967).  
 
 
 
(3S*,5R*)-(±)-3-(Methoxycarbonylmethyl)-5-(phenyl)isoxazolidine (432). Trifluoroacetic 
acid (2 mL) was added slowly to a solution of (±)-268a (279 mg, 0.87 mmol) in CH2Cl2 (2 mL) 
at 0 oC and reaction mixture was stirred in this temperature for 1 h. The reaction was quenched 
slowly with a cold saturated aqueous NaHCO3 until basic pH and the product was extracted 
with CH2Cl2 (3×5 mL). The organic layers were combined, dried over Na2SO4, and the solvent 
was evaporated. The crude product was practically pure but was further purified by flash 
chromatography on a column of silica gel (5×1 cm) with a mixture of petroleum ether and 
AcOEt (80:20 to 70:30) to afford (±)-432 (174 mg, 90%) as white crystals: mp 73-74 oC 
(AcOEt-petroleum ether); 1H NMR (400 MHz, CDCl3) δ 1.80 (ddd, J = 12.6, 8.7, 5.7 Hz, 1H), 
2.46 (dd, J = 16.0, 6.5 Hz, 1H), 2.70 (dd, J = 16.0, 7.6 Hz, 1H),  2.81 (dt, J = 12.6, 7.8 Hz, 1H), 
3.61 (s, 3H), 3.92-3.99 (m, 1H), 4.82 (t, J = 8.2 Hz 1H), 5.30 (br s, 1H), 7.19 – 7.34 (m, 5H); 
13C NMR (100 MHz, CDCl3) δ 39.7 (CH2), 43.9 (CH2), 51.8 (CH3), 57.6 (CH), 84.7 (CH), 
126.2 (2 × CH), 127.0 (CH), 128.6 (2 × CH), 139.5 (C), 171.9 (C); IR ν 3250, 3032, 2953, 
1732, 1495, 1437, 1375, 1263, 1206, 1157, 1045, 910, 758, 731 cm-1; MS (CI/isobutane) m/z 
(%) 222 [(M + H)+ 100], 107 (13); HRMS (CI/isobutane) 222.1127 (C12H15NO3 + H+ requires 
222.1130). 
 
 
 
(3R,5S,1’R)-(-)-3-{[2’-(Methoxycarbonyl)-1’-methyl]-eth-1’-yl}-5-phenyl-isoxazolidine 
(271).  Treatment of 270 (30 mg) under the same conditions as described for the preparation of 
432, afforded 271 (18 mg, 88%) as long colourless needles: mp 73-74 oC (from hexane); [α]D -
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47.9 (c 0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.19 (d, J = 7.1 Hz, 3H), 1.90 (ddd, J = 
12.5, 9.3, 6.7, 1H), 2.68 (dq, J = 9.2, 7.2 Hz, 1H), 2.77 (ddd, J = 12.5, 7.8, 7.2 Hz, 1H), 3.70 (s, 
3H), 3.80-3.86 (m, 1H), 4.87 (br s, 1H), 5.79 (br s, 1H), 7.27-7.41 (m, 5H); 13C NMR (100 
MHz, CDCl3) δ 13.4 (CH3), 28.7 (CH2), 40.9 (CH2), 50.8 (CH3), 62.2 (CH), 84.0 (CH), 125.17 
(2 × CH), 127.0 (CH), 127.5 (2 × CH), 138.3 (C), 174.6 (C); MS (FAB+) m/z (%) 236 [(M + 
H)+, 12], 233 (9), 268 (100), 207 (22), 147 (27); HRMS (FAB+) 236.1284 [(C13H17NO3 + H+) 
requires 236.1287].  
 
 
 
(3S*,5R*)-(±)-N,N’-Biisopropoxycarbonyl-3-(Methoxycarbonylmethyl)-5-
phenylpyrazolidine (287). Method I, starting with 286, produced 287 (85 mg, 73%) as a 
viscous colourless oil; 1H NMR (400 MHz, CDCl3) δ 1.15 (d, J = 6.3 Hz, 3H), 1.17 (d, J = 6.4 
Hz, 3H), 1.19 (d, J = 3.9 Hz, 3H), 1.20 (d, J = 3.8 Hz, 3H), 2.30-2.47 (m, 3H), 2.78 (dd, J = 
15.9, 5.3 Hz, 1H), 3.63 (s, 3H), 4.54-4.60 (br. m, 1H), 4.84-4.99 (m, 2H), 5.34 (dd, J = 8.0, 5.1 
Hz, 1H), 7.15-7.32 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 21.91 (CH3), 21.94 (CH3), 21.95 
(CH3), 21.98 (CH3), 38.4 (CH2) 39.9 (CH2), 51.8 (CH3), 55.5 (CH),  61.9 (CH), 70.0 (CH), 70.2 
(CH), 125.9 (2 × CH), 127.3 (CH), 128.5 (2 × CH), 140.3 (C), 156.0 (C), 157.1 (C), 170.9 (C); 
MS (FAB/NOBA) m/z (%) 393 [(M + H)+, 100], 307 (48), 306 (67), 261 (10), 219 (31), 189 
(10), 154 (10), 145 (17), 117 (20), HRMS (FAB+) 393.2022 (C20H28O6N2 + H+) requires 
393.2026. 
 
 
 
(3R,5S,E)-(–)-N-tert-Butoxycarbonyl-3-[1’-(Methoxycarbonyl)-ethen-2’-yl]-5-phenyl-
isoxazolidine (291). Modified Method I, starting with 267, produced 291 (36 mg, 45%)  as a 
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viscous colourless oil: [α]D -6.8 (c 0.8, CHCl3); 1H NMR (400 MHz, CDCl3) δ 1.51 (s, 9H), 
2.06 (ddd, J = 12.4, 10.0, 6.9 Hz, 1H), 2.94 (ddd, J = 12.4, 8.8, 6.2 Hz, 1H), 3.76 (s, 3H), 4.90 
(dd, J = 10.0, 6.2 Hz, 1H), 4.92-4.98 (m, 1H), 6.13 (dd, J = 15.5, 1.4 Hz, 1H), 6.95 (dd, J = 
15.5, 6.0 Hz, 1H), 7.30-7.41 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 28.2 (CH3), 43.2 (CH2), 
51.7 (CH3), 60.9 (CH), 82.6 (C), 82.9 (CH), 121.0 (CH), 126.8 (2 × CH), 128.6 (2 × CH), 128.8 
(CH), 136.4 (C), 146.5 (CH), 157.3 (C), 166.7 (C); IR ν 2956, 2923, 2854, 1723, 1459, 1369, 
1308, 1260 cm-1;  MS (FAB/NOBA) m/z (%) 334 [(M + H)+, 20], 307 (31), 278 (100), 233 
(41), 201 (22), 174 (32), 155 (39), 139 (41), 105 (15); HRMS (FAB) 334.1658 (C18H24NO5 
requires 334.1654). 
 
OH NHBoc
 
 
tert-Butyl (3R,5S)-(-)-5-Hydroxy-5-phenylpent-1-en-3-ylcarbamate (296a). Method J, 
starting with 293a, produced 296a (92 mg, 61% yield) as a viscous colourless oil: [α]D -23.8 (c 
1.0, CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.43 (s, 9H), 1.80-1.92 (br. m, 1H), 1.98 (dt, J = 
14.1, 8.1 Hz, 1H), 2.67 (br. s, 1H), 4.25 (br. s, 1H), 4.65-4.75 (br. m, 1H), 4.78 (dd, J = 8.4, 4.8 
Hz, 1H), 5.12 (d, J = 10.4 Hz, 1H), 5.20 (d, J = 17.2 Hz, 1H), 5.74-5.82 (m, 1H), 7.23-7.40 (m, 
5H); 13C NMR (100.6 MHz, CDCl3) δ  28.4 (3 × CH3), 44.3 (CH2), 51.3 (CH), 72.2 (CH), 79.6 
(C), 115.0 (CH2), 125.8 (2 × CH2), 127.7 (CH), 128.6 (2 × CH2), 138.6 (CH), 144.4 (C), 155.5 
(C); IR ν  3404, 3339, 2977, 2927, 1692, 1504, 1250, 1170 cm-1; MS (FAB/NOBA) m/z (%) 
278 [(M + H)+, 32], 204 (84), 148 (23), 144 (22); HRMS (FAB+) 278.1754; (C16H23NO3 + H+ 
requires 278.1756). 
 
 
 
tert-Butyl (3S,5S)-(+)-5-Hydroxy-5-phenylpent-1-en-3-ylcarbamate (296b). Method J, 
starting with 293b, produced 296b (32 mg, 21% yield) as a viscous colourless oil: [α]D +0.7 (c 
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1.7, CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.41 (s, 9H), 1.63 (ddd, J = 14.0, 10.3, 2.6 Hz, 
1H), 1.89 (ddd, J = 14.1, 10.9, 3.3 Hz, 1H), 3.82 (br. s, 1H), 4.45 (br. s, 1H), 4.69 (br. d, J = 
10.7 Hz, 1H), 4.83 (br. d, J = 8.7 Hz, 1H), 5.08 (d, J = 10.5 Hz, 1H), 5.15 (d, J = 17.3 Hz, 1H), 
5.80 (ddd, J = 17.3, 10.5, 6.7 Hz, 1H), 7.16-7.21 (m, 1H), 7.25-7.32 (m, 4H); 13C NMR (100 
MHz, CDCl3) δ 28.4 (3 × CH3), 45.4 (CH2), 49.7 (CH), 70.2 (CH), 80.1 (C), 114.8 (CH2), 125.6 
(2 × CH), 127.3 (CH), 128.4 (2 × CH), 138,1 (CH), 144.1 (C), 156.7 (C); IR ν  3400, 3342, 
3064, 2924, 2854, 1691, 1502, 1454, 1365, 1250, 1168, 1024, 996, 758 cm-1; MS 
(FAB/NOBA) m/z (%) 278 [(M + H)+, 57], 222 (16), 204 (100), 144 (14), 101 (90); HRMS 
(FAB+) 278.1761; (C16H23NO3 + H+ requires 278.1756). 
 
 
 
(3S,5R)-(-)-N,N’-Bisisopropoxycarbonyl-3-vinyl-5-phenylpyrazolidine (298). Modified 
Method I, starting with 297, produced 298 (31.5 mg, 65%) as a viscous colourless oil: [α]D 
-19.3 (c 1.1, CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.22 (d, J = 6.2 Hz, 3H), 1.26 (d, J = 6.3 
Hz, 3H), 1.263 (d, J = 6.3 Hz, 3H), 1.29 (d, J = 6.3 Hz, 3H), 2.33 (ddd, J = 12.7, 7.5, 6.6 Hz, 
1H), 2.37 (ddd, J = 12.7, 7.9, 4.0 Hz, 1H), 4.78 (br. s, 1H), 4.93 (septet, J = 6.3 Hz, 2H), 5.10 
(dt, J = 10.4, 1.4 Hz, 1H). 5.19 (t, J = 7.2 Hz, 1H), 5.35 (dt, J = 17.2, 1.5 Hz), 5.71 (ddd, J = 
17.2, 10.4, 4.6 Hz, 1H), 7.15-7.30 (m, 5H); 13C NMR (100.6 MHz, CDCl3) δ 21.96 (CH3), 
21.98 (2 ×  CH3), 22.02 (CH3), 40.7 (CH2), 60.7 (CH), 62.0 (CH), 69.98 (CH), 70.05 (CH), 
115.9 (CH2), 125.9 (2 ×  CH), 127.2 (CH), 128.5 (2 × CH), 135.6 (CH), 140.8 (C); IR ν  2980, 
2936, 1697, 1373, 1303, 1103, 920, 756 cm-1 ; MS (EI) m/z (%) 346 (M+, 9), 260 (37), 218 
(54), 215 (13), 173 (100), 129 (21), 104 (13), 83 (22); HRMS (EI) 346.1896; (C19H26O4N2+ 
requires 346.1893). 
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OH
 
 
(R,E)-(+)-1-Phenylpent-3-en-1-ol (256). Method D, starting with benzalehyde, produced 256 
(131 mg, 81% yield) as colourless oil: [α]D +64.9 (c 1.1, CHCl3); 1H NMR (400 MHz; CDCl3) 
δ 1.57 (br d, J = 6.4 Hz,, 3H,), 2.23-2.37 (m, 3H,), 4.52 (dd, J =5.1 Hz, J = 7.8 Hz, 1H), 
5.25-5.35 (m, 1H), 5.41-5.52 (m, 1H), 7.12-7.26 (m, 5H); 13C NMR (100.6 MHz, CDCl3) δ 
18.0 (CH3), 42.6 (CH2), 73.4 (CH), 125.7 (2 × CH), 126.7 (CH), 127.2 (CH), 128.2 (2 ×CH), 
129.1 (CH), 144.0 (C); IR ν 3650, 3360, 3027, 2963, 2916, 1493, 1453, 1270, 1026, 912, 872, 
799, 758, 700 cm-1; MS (CI/isobutane) m/z (%) 145 (M - OH, 100), 107 (93); HRMS 
(CI//isobutene) 145.1022 (C11H12 + H+) requires 145.1017, in agreement with literature;173 
HPLC analysis (Chiralcel OD-H column, hexane/2-propanol 98:2, 0.75 mL/min) showed 94% 
ee (tR = 17.43min, tS = 24.59 min).  
 
OTMS
 
 
(R,E)-(+)-1-Phenyl-1-trimethylsilyloxy-pent-2-ene (304).199 Trimethylsilyl 
trifluoromethanesulfonate (880 mg, 3.96 mmol) was added dropwise to a solution of the 
alcohol 256 (584 mg, 3.6 mmol) and triethylamine (550 mg, 5.4 mmol) in dry dichloromethane 
(10 mL) at room temperature and the resulting mixture was stirred at this temperature for 1 h. 
The reaction was quenched with a saturated aqueous solution of sodium hydrogen solution (10 
mL) and the product was extracted into dichloromethane (3 × 10 mL). The organic solution was 
dried over magnesium sulfate and the solvent was evaporated in vacuo. The residue was 
purified by chromatography on a column of silica gel (3 × 10 cm), using a mixture of petroleum 
ether and ethyl acetate (99:1) to afford 304 as a colourless oil (888 mg, 95%): [α]D +33.4 (c 1.5, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 0.0 (s, 9H), 1.60 (d, J = 5.7 Hz, 3H), 2.34-2.39 (m, 
2H), 4.58 (dd, J = 7.6, 5.4 Hz, 1H), 5.21-5.48 (m, 2H), 7.17-7.31 (m, 5H); 13C NMR (100 
MHz, CDCl3) δ 0.0 (3 × CH3), 17.4 (CH3), 43.7 (CH2), 75.1 (CH), 125.7 (2 × CH), 126.7 (CH), 
 172 
127.2 (CH), 127.7 (CH), 127.9 (2 × CH), 144.9 (C); MS (FAB) m/z (%) 145 (M - OTMS, 100) 
(as with alcohol 256, no molecular peak could be observed). 
 
Method K: Singlet oxygen ene reaction.145 A pink solution of the TMS ether 304 (888 mg, 
3.8 mmol) and TPP (Tetraphenylporphyrin) (0.6 mg, 10-3 mmol) in CCl4 (10 mL) were added 
to a transparent glass reaction vessel fitted with an oxygen diffuser and a stirrer. The reaction 
flask was placed in a water cooling jacket and a moderate stream of dry oxygen was run 
through the system, while stirring vigorously for the best oxygen dispersion. A portable 500W 
halogen lamp was used to irradiate the reaction mixture, and the reaction was monitored by H1 
NMR every 4 h. The reaction takes typically 20-24 h. After completion, CCl4 was evaporated 
and the oily residue analysed by NMR spectroscopy. In optimised condions a mixture of 2 : 1 
of  1,3 and 1,4 diols was obtained. 2 : 1 ratio of anti/syn 1,3 diols was observed. The mixture 
was purified by chromatography on a column of silica gel (2.5 × 25 cm) using a gradient of 
petroleum ether and ethyl acetate as eluent (100:0 to 90:10). Syn and anti 1,3 diols were 
isolated in low yields of 17 and 27% respectively followed by an inseparable mixture of 1,4 
diols (21%).  
 
TMSO OOH
 
 
(1R,3R)-(+)-3-Hydroperoxy-1-phenyl-1-trimethylsilyloxy-pent-4-ene (387). Method K, 
starting with 304, produced 387 (254 mg, 27%) as a viscous colourless oil: [α]D + 33.9 (c 0.9, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 0.0 (s, 9H), 1.82 (ddd, J = 14.8, 8.7, 3.1 Hz, 1H), 1.92 
(ddd, J = 14.8, 9.2, 3.9 Hz, 1H), 4.48-4.53 (m, 1H), 4.85 (dd, 9.2, 3.1 Hz, 1H), 5.21 (dd, J = 
10.5, 1.2 Hz, 1H), 5.27 (dd, J = 17.4, 1.2 Hz, 1H), 5.79 (ddd, J = 17.4, 10.5, 6.9 Hz, 1H), 7.11-
7.27 (m, 5H), 8.42 (s, 1H); 13C NMR (100 MHz, CDCl3) δ 0.0 (3 × CH3), 43.1 (CH2), 71.1 
(CH), 82.7 (CH), 118.4 (CH2), 125.7 (2 × CH), 127.2 (CH), 128.3 (2 × CH), 136.6 (CH), 144.6 
(C); IR ν 3348, 2955, 1420, 1366, 1257, 840 cm-1; MS (FAB/NOBA) m/z (%) 267 [(M + 
H)+,14], 253 (36), 179 (100), 147 (70); HRMS. (FAB+) 267.1410 (C14H23O3Si + H+ requires 
267.1416). 
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TMSO OOH
 
 
(1R,3S)-(+)-3-Hydroperoxy-1-phenyl-1-trimethylsilyloxy-pent-4-ene (388). Method K, 
starting with 304, produced 388 (169 mg, 17% yield) as a viscous colourless oil: [α]D +51.0 (c 
1.1, CHCl3); 1H NMR (400 MHz; CDCl3) δ 0.0 (s, 9H), 1.74 (ddd, J = 14.3, 6.4, 4.9, 1H), 2.25 
(ddd, J = 14.3, 8.7, 7.8 Hz, 1H), 4.39 (q, J = 7.0 Hz, 1H), 4.76 (dd, J = 8.7, 4.4 Hz, 1H), 5.29-
5.33 (m, 2H), 5.88 (ddd, J = 17.5, 10.5, 7.1 Hz, 1H), 7.24-7.35 (m, 5H), 8.35 (s, 1H); ); 13C 
NMR (100 MHz, CDCl3) δ 0.0 (3 × CH3), 42.7 (CH2), 72.5 (CH), 84.3 (CH), 118.7 (CH2), 
125.9 (2 × CH), 127.4 (CH), 128.2 (2 × CH), 136.8 (CH), 144.4 (C); IR ν 3348, 2955, 1420, 
1366, 1257, 840 cm-1 ; MS (CI/isobutane) m/z (%) 249 (M - OH, 20), 179 (100), 159 (59), 149 
(30); HRMS  (CI//isobutene) 249.1307 (C14H21O2Si+ requires 249.1311). 
 
Method L. Deprotection of TMS alkoxy peroxides. TBAF/THF (1M solution, 1 mL, 1 
mmol) was added slowly to a solution of the TMS alkoxy peroxides (0.9 mmol) in THF (8 mL) 
at 0 oC and the reaction mixture was stirred at room temperature, while monitored by 
TLC/KMnO4. After completion (3-4 h), the excess of THF was slowly evaporated and a 
saturated NaHCO3 solution (5 mL) was added. The product was extracted with CH2Cl2 (3 × 20 
mL), and the combined organic extracts were dried over Na2SO4. The 1H NMR spectrum of the 
crude mixture usually showed a partial reduction of the peroxide. The crude mixture was 
submitted for the reduction step without further purifications. 
 
Method M. Reduction of peroxy alcohols.164 PPh3 (350 mg, 1.35 mmol) was added in one 
portion to a solution of the peroxy alcohol/diol (0.9 mmol) in diethyl ether (30 mL) under argon 
and the mixture was stirred overnight at room temperature. After 16 h the solvent was 
evaporated and the 1H NMR spectrum of the crude product confirmed full conversion. The oily 
residue was purified on a column of silica gel (2.5 × 15 cm) using a gradient of petroleum ether 
and ethyl acetate as eluent (5:1 to 1:1).  
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OH OH
 
 
(1R,3R)-(+)-1-Phenylpent-4-ene-1,3-diol (404). Method L followed by Method M, starting 
with 387, produced 404 (112 mg, 76% yield) as a viscous colourless oil: [α]D +22.6 (c 0.9, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.90 (ddd, J = 14.6, 7.7, 3.2 Hz, 1H), 2.04 (ddd, J = 
14.6, 8.7, 3.5 Hz, 1H), 2.60 (br d, J = 4.3 Hz, 1H), 2.93 (br d, J = 3.5 Hz, 1H), 4.10 (br s, 1H), 
5.04 (dt, J = 8.5, 2.9Hz, 1H), 5.16 (dt, J = 10.5, 1.4, 1H), 5.30 (dt, J = 17.2, 1.5 Hz, 1H), 5.95 
(ddd, J = 17.2, 10.5, 5.4 Hz, 1H), 7.25-7.41 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 44.3 
(CH2), 70.6 (CH), 71.7 (CH), 114.7 (CH2), 125.0 (2 × CH), 125.6 (CH), 128.5 (2 × CH), 140.4 
(CH), 144.3 (C); IR ν 3373, 2960, 2859, 1718, 1427, 1269, 1111, 924 cm-1; MS (CI/isobutane) 
m/z (%) 161 (M - OH, 20), 145 (54), 105 (100); HRMS  (CI//isobutene) 161.0965 (C11H13O+ 
requires 161.0966. In agreement with the literature.165 
 
 
 
(1R,3S)-(+)-1-Phenylpent-4-ene-1,3-diol (406). Method L followed by Method M, starting 
with 387, produced 406 (78 mg, 70% yield) as a viscous colourless oil: [α]D +38.0 (c 1.0, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.85 (dt, J = 14.6, 3.1 Hz, 1H), 1.95 (dt, J = 14.6, 9.8 
Hz, 1H), 2.89 (br d, J = 2.4 Hz, 1H), 3.20 (br d, J = 1. Hz, 1H), 4.45 (br s, 1H), 4.91 (dd, J = 
9.0, 3.0 Hz, 1H), 5.04 (dt, J = 10.4, 1.2 Hz, 1H), 5.21 (dt, J = 17.2, 1.3Hz, 1H), 5.89 (ddd, J = 
17.2, 10.4, 5.9, 1H), 7.26-7.39 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 45.3 (CH2), 73.5 (CH), 
74.8 (CH), 114.7 (CH2), 125.7 (2 × CH), 127.7 (CH), 128.6 (2 × CH), 140.4 (CH), 144.3 (C);  
IR ν 3383, 2926, 2857, 1455, 1266, 1062, 911 cm-1; MS (CI/isobutane) m/z (%) 161 (M - 
OH,12), 145 (7), 105 (100); HRMS (CI//isobutene) 161.0962 (C11H13O+ requires 161.0966). In 
agreement with the literature.165 
 
Method N. Epoxidation of the allylic diols.176  VO(acac)2 (1.8 mg, 0.007 mmol) was added  in 
one portion to a solution of the respective diol (0.14 mmol) in toluene or CH2Cl2 (0.5 mL) at 0 
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oC. Subsequently, a solution TBHP (0.16 mmol), prepared by diluting of its 6M solution in 
nonane (27 µL) with toluene or CH2Cl2 (0,.5 mL). The reaction mixture was stirred at this 
temperature for 1 h and then at room temperature overnight. Full consumption of the starting 
material was confirmed by TLC analysis by then. A saturated NaHCO3 solution (1 mL) was 
added and the product was extracted into CH2Cl2 (3 × 5 mL). Combined organic fractions were 
dried over sodium sulfate and the solvents were removed in vacuum. The product was purified 
by chromatography on a column of silica gel (1 × 7 cm) using a gradient of petroleum ether and 
ethyl acetate as eluent (5:1 to 1:1) to collect the epoxide, followed by 100% AcOEt to collect 
the corresponding tetrahydrofurane derivatives.  
 
Method O. Intramolecular opening of the epoxides.177  A solution of BF3•Et2O (0.008 mmol) 
in CH2Cl2 (0.5 mL) was added dropwise to solution of the respective epoxide (0.08 mmol) in 
CH2Cl2 (0.5 mL) and the reaction mixture was stirred at room temperature for 30 min, by which 
time a full conversion was confirmed by TLC analysis. Saturated NaHCO3 solution (1 mL) was 
added and the product was extracted into CH2Cl2 (3 × 5 mL). Combined organic extracts were 
dried over sodium sulfate and the solvents were removed in vacuum. The product was purified 
by chromatography on a column of silica gel (1 × 7 cm) using a gradient of petroleum ether and 
ethyl acetate as eluent (3:1, 2:1, 1:1, 1:2, 1:3) for the best separation of the diastereoisomers. 
 
 
 
(2R,3R,5R)-(+)-2-(Hydroxymethyl)-5-phenyltetrahydrofuran-3-ol (423). Method N, starting 
with 417, produced 423 (30 mg, 49%) as colourless needles, mp: 63-64oC (CH2Cl2/hexane); 
[α]D +7.0 (c 0.9, CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.96 (F, ddd, J = 13.4, 8.3, 4.6 Hz, 
1H), 2.27 (A, dd, J = 7.2, 5.3 Hz, 1H), 2.73 (F, dt, J = 13.4, 7.0 Hz, 1H), 2.81 (E, d,  J = 6.9 
Hz, 1H), 3.97-4.10 (B + C, m, 3H), 4.60-4.66 (D, m, 1H), 4.88 (G, t, J = 7.7 Hz, 1H), 7.26-7.44 
(I + J + K, m, 5H); 13C NMR (100 MHz, CDCl3) δ 44.5 (F, CH2), 61.9 (B, CH2), 74.0 (D, CH), 
79.1 (G, CH), 81.2 (C, CH), 126.3 (I, 2 × CH), 127.9 (K, CH), 128.6 (J, 2 × CH), 141.6 (H, C); 
IR ν 3379, 2924, 2862, 1450, 1257, 1034 cm-1;  MS (EI+) m/z (%) 194 (M+, 15), 163 (5), 145 
(10), 117 (23), 105 (23); HRMS. (EI+) 194.0941 (C11H14O3+ requires 194.0943). 
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(2S,3R,5R)-(+)-2-(Hydroxymethyl)-5-phenyltetrahydrofuran-3-ol (424). Method N, starting 
with 418, produced 424 (3 mg, 14%) as a colourless solid: [α]D +8.0 (c 0.4, CHCl3); 1H NMR 
(400 MHz; CDCl3) δ 1.80 (E, d, J = 5.4 Hz, 1H), 1.93 (A, t, J = 5.5 Hz, 1H), 2.08 (F, ddd, J = 
12.7, 8.2, 7.1 Hz, 1H), 2.70 (F, dt, J = 12.7, 6.7 Hz, 1H), 3.75 (B, dt, J = 11.6, 5.3 Hz, 1H), 
3.84 (B, dt, J = 11.6, 4.4 Hz, 1H), 4.09 (C, td, J = 5.1, 4.3 Hz, 1H), 4.43-4.49 (D, m, 1H), 5.11 
(G, dd, J = 7.9, 7.1 Hz, 1H), 7.34 – 7.41 (I + J + K, m, 5H); 13C NMR (100 MHz, CDCl3) δ 
43.7 (F, CH2), 62.8 (B, CH2), 73.3 (D, CH), 79.6 (G, CH), 85.4 (C, CH), 125.6 (I, 2 × CH), 
127.6 (K, CH), 128.6 (J, 2 × CH), 142.6 (H, C); IR ν  3379, 2924, 2854, 1442, 1087, 1034 
cm-1; MS (CI//isobutene) m/z (%) 195 [(M + H)+, 53], 177 (100), 159 (23), 129 (28), 105 (18);  
HRMS (CI//isobutene) 195.1023 (C11H14O3 +H+ requires 195.1021). 
 
A
B
C
D
E
F
G
H
I
J
K
O
OH
OH
 
 
(2S,3S,5R)-(+)-2-(Hydroxymethyl)-5-phenyltetrahydrofuran-3-ol (425). Method N, starting 
with 420, produced 425 (3 mg, 20% yield) as colourless shining plates: mp: 75-76 oC; [α]D 
+56.2 (c 0.6, CHCl3); 1H NMR (400 MHz; CDCl3) δ 2.07 (F, ddd, J = 13.3, 10.1, 4.6 Hz, 1H), 
2.35 (A, dd, J = 6.9, 5.6 Hz, 1H), 2.44 (F, ddd, J = 13.3, 5.8, 1.4 Hz, 1H), 3.36 (E, d, J = 4.2 
Hz, 1H), 3.98-4.10 (B, m, 2H), 4.24 (C, dd, J = 7.9, 3.9 Hz, 1H), 4.67 (D, t, J = 3.8 Hz, 1H), 
5.33 (G, dd, J = 10.1, 5.8 Hz, 1H), 7.23-7.40 (I + J + K, m, 5H); 13C NMR (100 MHz, CDCl3) 
δ 45.3 (F, CH2), 62.1 (B, CH2), 74.9 (D, CH), 80.0 (G, CH), 81.4 (C, CH), 125.6 (I, 2 × CH), 
127.6 (K, CH), 128.5 (J, 2 × CH), 142.4 (H, C); IR ν 3379, 2924, 2854, 1450, 1257, 1033 cm-1; 
MS (EI+) m/z (%) 194 (M+, 32), 145 (15), 117 (36), 105 (41); HRMS. (EI+) 194.0948 
(C11H14O3+ requires 194.0943). 
 
 177 
 
 
(2R,3S,5R)-(+)-2-(Hydroxymethyl)-5-phenyltetrahydrofuran-3-ol (426). Method N, starting 
with 421, produced 426 (8 mg, 25%) as a colourless solid: [α]D + 42.8 (c 0.4, CHCl3); 1H NMR 
(400 MHz; CDCl3) δ 1.81 (E, br d, J = 4.0 Hz, 1H), 1.84 (A, t, J = 6.3 Hz, 1H), 1.99 (F, ddd, J 
= 13.3, 10.3, 6.3 Hz, 1H), 2.20 (F, ddd, J = 13.3, 5.7, 2.0 Hz, 1H), 3.63 (B, ddd, J = 11.5, 6.5, 
5.0 Hz, 1H), 3.78 (B, ddd, J = 11.5, 5.5, 4.2 Hz, 1H), 3.96 (C, ddd, J = 4.8, 4.2, 3.0, Hz, 1H), 
4.35 - 4.41 (D, m, 1H), 5.19 (G, dd, J = 10.3, 5.6 Hz, 1H), 7.28 -7.38 (I + J + K, m, 5H); 13C 
NMR (100 MHz, CDCl3) δ 44.1 (F, CH2), 63.5 (B, CH2), 73.8 (D, CH), 80.1 (G, CH), 87.3 (C, 
CH), 126.0 (I, 2 × CH), 127.9 (K, CH), 128.6 (J, 2 × CH), 141.1 (H, C); IR ν  3356, 2924, 
1450, 1257, 1087, 1041 cm-1; MS (CI/isobutane) m/z (%) 195 [(M + H)+, 35], 177 (86), 159 
(27), 129 (37); HRMS (CI//isobutene) 195.1019 (C11H14O3 + H+ requires 195.1021).  
 
 
 
tert-Butyl (1S,3R,4S)-(+)-1-Phenyl-4,5-epoxy-1-hydroxy-pentan-3-yl Carbamate (430).172a  
m-Chloroperoxybenzoic acid (44 mg, 0.25 mmol) was added in one portion to a solution of 
296a (64 mg, 0.23 mmol) in dichloromethane (2 mL) at 0 oC. The reaction mixture was stirred 
at this temperature for 2 h and than at room temperature overnight. The reaction was quenched 
with a saturated aqueous solution of sodium hydrogen carbonate solution (2 mL), the product 
was extracted into dichloromethane (3 × 3 mL), the organic solution was dried over sodium 
sulfate and the solvent was evaporated in vacuo. The residue was purified by chromatography 
on a column of silica gel (1 × 7 cm), using a gradient of petroleum ether and ethyl acetate as 
eluent (9:1 to 2:1) to afford 430 (46 mg, 68%) as a viscous colourless oil: [α]D -28.0 (c 1.3, 
CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.43 (s, 9H), 1.97–2.11 (m, 2H), 2.52 (br s, 1H), 2.61 
(dd, J = 4.7, 2.7 Hz, 1H), 2.75 (dd, J = 4.6, 4.1 Hz, 1H), 3.09 (dt, J = 4.0, 2.6 Hz, 1H), 4.01 (br 
s, 1H), 4.59 (br s, 1H), 4.87 (ddd, J = 7.6, 5.9, 3.5 Hz, 1H), 7.26-7.39 (m, 5H); 13C NMR (100 
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MHz, CDCl3) δ 28.3 (3 × CH3), 42.4 (CH2), 44.5 (CH2), 47.4 (CH), 53.5 (CH), 72.0 (CH), 79.8 
(C), 125.8 (2 × CH), 127.8 (CH), 128.6 (2 × CH), 144.1 (C), 156.8 (C); IR ν  3428, 3331, 2978, 
2931, 1691, 1506, 1367, 1166, cm-1; MS (CI/isobutane) m/z (%) 294 [(M + H)+, 20], 238 (100), 
220 (76); HRMS (CI//isobutene) 294.1706 (C16H23O4N + H+ requires 294.1705). 
 
 
 
tert-Butyl (2R,3R,5S)-(-)-2-(Hydroxymethyl)-5-phenyltetrahydrofuran-3-ylcarbamate 
(431). Method N, starting with 430, produced 431 (9 mg, 43%) as a viscous colourless oil: [α]D 
-7.9 (c 0.6, CHCl3); 1H NMR (400 MHz; CDCl3) δ 1.46 (H, s, 9H), 2.13-2.27 (I, m, 2H), 2.83 
(A, br s, 1H), 3.77-3.85 (B, m, 2H), 3.88 (C, dd, J = 9.5, 4.9, 1H), 4.08-4.18 (D, br m, 1H), 4.82 
(E, br s, 1H), 5.05 (J, dd, J = 8.3, 6.9 Hz, 1H), 7.27-7.35 (L + M + N, m, 5H); 13C NMR (100.6 
MHz, CDCl3) δ 28.4 (H, 3 × CH3), 41.2 (I, CH2), 53.0 (D, CH), 63.6 (B, CH2), 79.6 (J, CH), 
80.4 (G, C), 86.3 (C, CH), 125.9 (L, 2 × CH), 127.9 (N, CH), 128.6 (M, 2 × CH), 141.3 (K, C), 
156.9 (F, C); IR ν  3426, 3330, 2979, 2930, 2879, 1684, 1525, 1367, 1287, 1254, 1168, 1050 
cm-1; MS (CI/isobutane) m/z (%) 294 [(M + H)+, 7], 257 (25), 238 (48); HRMS  
(CI//isobutene) 294.1703 (C16H23O4N + H+ requires 294.1705). 
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